The Scottish Renal Association

UK Kidney Week 2014

Jointly hosted by The British Renal Society
& The Renal Association
in co-operation with The Scottish Renal Association
This conference has been awarded 24 CPD Credits

Tuesday 29th April - Friday 2nd May, 2014

Scottish Exhibition and

Conference Centre, Glasgow

…be part of something bigger and better

Wifi Code = UKKW014
 UK KIDNEY WEEK 2014
Dear Colleagues,

A warm welcome to UK Kidney Week, the fifth time the Renal Association and the British
Renal Society are celebrating their annual conference together.

The organising committee has put together a full programme, which takes into account
the interests of nephrology basic scientists and clinicians, and the full multidisciplinary
team. Please make a special effort to attend the plenary sessions, which have been
designed to appeal to the widest possible audience.

We are particularly pleased to offer a full programme of choices on Tuesday afternoon. We

are grateful to the London School of Hygiene & Tropical Medicine for facilitating a Research
Methodology Course, to Baxter-Gambro, Janssen and Fresenius for hosting expert
speakers for their corporate sessions and finally to our colleagues with a specialist interest
in elderly care for addressing an increasingly important aspect of care delivery in all our
units.

For those keen to make an early start during the conference, you may wish to take part in
the Fun Run starting at 06.00am on Wednesday. This is followed by a corporate session
starting with breakfast at 7.30am. Thursday starts early as well, with breakfast and a
corporate session starting at 07.00am. We would also like to draw your attention to the
named lectures throughout the programme: on Wednesday the Mallick Lecture, on
Thursday the Raine award and the Donna Lamping MDT Researcher Lecture and on Friday
the Jane Macdonald BRS MDT Leadership Lecture, the Osman Lecture and the De
Wardener Lecture.

We extend our sincere thanks to our programme co-chairs – Alison Brown, Martin Wilkie,
Amy Jayne McKnight, Jane Tizard, Sharlene Greenwood, Leo Bailey and Jonathan Fox -
all of whom have worked so hard to put this programme together.

During your breaks please take every opportunity to visit our Exhibition Hall where new
and emerging technologies and therapies from companies active in our field can be seen.
This area is an ideal place to network and interact with colleagues and exhibitors. We could
not run this conference without the major contribution from our Exhibitors, and it is
important to them, and to us, that they receive many interested visitors. We hope many of
you are joining us at the Conference Dinner on Thursday evening but most importantly we
want you to maximize your opportunity to meet, exchange views, gain new knowledge and
to return to your place of work with renewed enthusiasm to deliver excellent kidney care.

Simon Ball David Wheeler

President BRS President RA
 TABLE OF CONTENTS
Important Information 1
Renal Association Officers and Trustees 2
BRS Officers and Committees 2
Associations Affiliated to the BRS 2
Abstract Markers 3
Acknowledgements 4
Named Lectures 4
Scientific Programme 5 - 10
Guest Speakers 11 - 25
Moderated Poster Sessions 26 - 40
Exhibitor Information 41 - 44
ERA - EDTA Congress 2015 Inside Back Cover

IMPORTANT INFORMATION
Registration - Registration commences at 08.00 on Tuesday 29th April at WI-FI - Access to the internet via Wi-Fi is freely available
the Scottish Exhibition Conference Centre, Exhibition Way, Glasgow, within the SECC. The access code is UKKW014
G3 8YW
Continuing Professional Development (CPD)
The registration desk, located in Hall 5, will be open from 08.00 on Tuesday The UK Kidney Week 2014 Conference has been awarded
29th April, 07.00 on Wednesday 30th April and Thursday 1st May, and 07.30 24 CPD points from the Federation of the Royal Colleges
on Friday 2nd May of Physicians of the UK. Consultants, Senior Lecturers and
Professors should sign the Register of Attendance and
Scientific Programme record their GMC number at the Registration Desk.
Tuesday 29th April 11.00 – 18.30
Wednesday 30th April 07.30 – 18.10 Lost Property - Any lost property should be handed to
Thursday 1st May 07.00 – 19.00 the Organisers at the Registration Desk.
Friday 2nd May 09.15 – 16.45
Taxis- Glasgow Taxis we are pleased to offer conference
Abstracts are available to view on-line: www.britishrenal.org and on the delegates discounted travel between Glasgow
wristband USB sticks in your delegate bag. International Airport and the city centre.
Delegates can pre book a taxi by calling +44 (0) 141 429
Tuesday Symposia: 11.00 – 17.00 7070 & quoting the appropriate code:
There are five symposia to choose from. Lunches are available at midday • Journeys from Glasgow International Airport to the
in the symposia rooms. Glasgow city centre – quote CM7
• Journeys from Glasgow city centre to Glasgow
Corporate Sponsored Breakfast Sessions have also been planned for International Airport – quote CM5
Wednesday and Thursday mornings. Each journey will be £16, saving you 20% on the usual fare
Civic Welcome Reception in the Exhibition: Tuesday 29th April of £20.
The Civic Welcome Reception will be held on Tuesday 29th April, 18.30 – Taxi rank - There is a Glasgow (Hackney) pick-up and
20.00 in the Exhibition in Hall 5, immediately following the Conference drop-off point at the East entrance adjacent to the Clyde
Opening Key Note Speaker. Auditorium.
Thursday 1st May - 20.00 Glasgow Visitor Information
Traditional Conference Dinner at the Hilton Hotel, 1 William Street, Glasgow, Tel: 0141 204 4400
G3 8HT Alternatively you can look at the website:
Full 3 and 4 Day Registration includes a Conference Dinner ticket, http://www.visitscotland.com/info/services/glasgow-
Tickets can also be purchased separately in advance at a cost of £51.00 information-centre-p332751
through the Conference Secretariat office, subject to availability. Delegate Discount - Conference Rover Ticket
Lunch: Lunch and tea/coffee breaks are included in all registrations and will This discounted rail ticket offers 5 days of unlimited travel
be served inside the Exhibition. within Glasgow city centre for the fixed price of £5 (area
bounded by Partick, High Street and Argyle Street). For
Cloakroom more details check the flyers in your delegate bag at the
Is located on the main concourse and the fee is £1.00 per day. Conference.
ATM The Clydesdale Bank provide a free of charge ATM machine next to the Delegate Discounts - You can see a full list of these via:
ticketSOUP.com Box Office on the main SECC Concourse. http://conventions.seeglasgow.com/attending-a-
conference/special-offers/
Business Centre: Any business centre requests (printing / photocopying
etc) will be facilitated via the Information and Business Centre within the Restaurants - Glasgow has a varied selection of
SECC on the main concourse, open from 09.30 – 17.00 daily. restaurants to suit every taste and budget. You can find
out more at: http://www.peoplemakeglasgow.com/guide-
First Aid/Medical Centre book/tourist-info/eating-out/ and making bookings via the
Is located on the main concourse at the east entrance. Please notify a Glasgow Restaurant Association website
steward or member of events staff in the first instance should you require http://www.glasgowdinearound.com/
first aid assistance.
Excursions - Here are some useful links to visitor
Assistance information
Please contact the Registration Desk if you need any assistance or further http://conventions.peoplemakeglasgow.com/attending-a-
information. conference/visitor-itineraries/
Delegates will also be able to download our Glasgow App
at http://www.peoplemakeglasgow.com/maps-apps/

Conference Secretariat & BRS Office: UK Kidney Week, 26 Oriental Road, Woking, Surrey, GU22 7AW
Tel: 01483 764 114 Fax: 01483 727 816 Email: brs@britishrenal.org web: www.britishrenal.org
The Renal Association: Durford Mill, Petersfield, Hampshire, GU31 5AZ; T: 0870 458 4155, F: 01730 715291
Web address: www.renal.org Email: renal@mci-group.com www.renal.org
1
Renal Association Officers and Trustees British Renal Society
President - Prof David Wheeler (2012-2014) Officers
Past President - Dr Charlie Tomson (2012-2014) Simon Ball, (President) University Hospitals Birmingham
President Elect- Prof Bruce Hendry (2013-2014) Richard Fluck, (Immediate Past President), Royal Derby Hospital
Academic Vice President - Prof Fiona Karet (2013-2016) and National Clinical Director (Renal)
Clinical Vice President - Dr Graham Lipkin (2013-2016) Ken Farrington, (Treasurer), East & North Hertfordshire NHS Trust and
Honorary Secretary - Dr Alison Brown (2012-2016) Visiting Professor, University of Hertfordshire
Honorary Treasurer - Prof Jonathan Fox (2010-2014)
BAPN President - Dr Jane Tizard (2012-2015) Council Members
Treasurer Elect – Prof Neil Sheerin Peter Andrews, British Transplant Society
Martin Christian, BAPN
Renal Association Executive Committee (elected) Marissa Dainton, EDTNA/ERCA
Prof Sunil Bhandari (retires 2015) Jan Flint, Renal Nutrition Group
Dr Indranil Dasgupta (retires 2016) Lucy Galloway, Renal Pharmacy Group
Dr Alastair Hutchison (retires 2014) Vicki Hipkiss, ANSA
Dr Michael Robson (retires 2016) Mick Kumwenda, DGH Nephrologists
Dr Mark Dockrell - Renal Scientist (retires 2016) Gill Manning, Association of Renal Industries
Dr Claire Sharpe (retires 2014) Kirit Modi, National Kidney Federation
Dr Paul Warwicker (retires 2017) Ann Murdoch, British Association of Social Workers, Renal
Dr Rebecca Suckling (retires 2017) Cristina Osorio, Association of Renal Managers
David Wheeler, President, Renal Association
Renal Association Committee Chairs (appointed) Peter Rann, Association of Renal Technologists
Dr Andrew Lewington (Clinical Practice Guidelines) BRS Education Committee
Prof David Goldsmith (International Committee) Chair
Prof Moin Saleem (Research Committee) Edwina Brown, Lead for Geriatric Nephrology Group
Dr Alastair Hutchison (Clinical Services Committee) Committee Members
Dr Jeremy Levy (Education and Training Committee) Louise Wells, Vice-Chair and Lead for Patient Outcome Group
Dr Mark Taylor (Rare Diseases Committee) Richard Baker, Lead for Transplant Group
Dr Claire Sharpe (Equal Opportunities in Nephrology Committee) Helen Hurst, Lead for Dialysis Group
Prof Neil Turner (Renal PatientView) Paula Ormandy, Lead for Patient Education Group
Dr Afzal Chaudhry (Terminology Committee)
Dr Detlef Böckenhauer (Chair Elect of the RADAR Committee) BRS CKD Strategy Group
Chair
Renal Association Committee (ex officio) Karen Jenkins, East Kent Hospitals University NHS Foundation Trust
Dr Yook Mun Woo (rep for non-consultant grades) Members
Dr Partha Das (SpR Club Rep) Amanda Balshaw Greer, Royal Liverpool Broadgreen University
Prof Peter Maxwell (for Northern Ireland) Hospital Trust
Dr Richard Fluck (National Clinical Director for Renal Services, Paula D'Souza, Royal Devon and Exeter Foundation Trust
England) Hugh Gallagher, St Helier Hospital
Dr Simon Davies (Chairman, SAC Renal Medicine) Kathryn Griffith, RCGP Clinical Champion for Kidney Care and General
Prof Phil Kalra (Chairman of the National Institute for Health Research Practitioner
(NIHR) Speciality Group) Robert Lewis, Queen Alexandra Hospital, Portsmouth
Dr Mick Kumwenda (Society of DGH Nephrologists) Breeda McManus, Royal London Hospital
Dr Simon Ball (President British Renal Society) Maarten Taal, Royal Derby Hospital
Martin Christian (Honorary Secretary, BAPN) Nicola Thomas, London South Bank University
Dr Richard Moore (for Wales) Fiona Willingham, Royal Derby Hospital
Dr Mark MacGregor (for Scotland) Nick Wilson, Renal Network (Wales)
Dr Amy Jayne McKnight (Chair, Renal Scientists Working Party)
Dr Andrew Connor (Green Nephrology) BRS Research for Renal Committee
Dr Jim Moriarty (Renal Association Communications Officer) Chair
Paula Ormandy, University of Salford
Members
Joint Programme Committee and Abstract Markers Simon Ball, University Hospitals Birmingham NHS Foundation Trust
Joint Co-Chair: Fergus Caskey, Southmead Hospital, Bristol
Martin Wilkie, Consultant Nephrologist, Northern General Hospital, Maria Da Silva Gane, Lister Hospital, Stevenage
Sheffield Clara Day, University Hospitals Birmingham NHS Foundation Trust
Alison Brown, Consultant Nephrologist, Freeman Hospital, Newcastle Marcelle De Sousa, BKPA
Amy Jayne McKnight, Snr Lecturer & Associate Director PGET, Robin Eady, BKPA
Queen’s University of Belfast Barbara Engel, University of Surrey
Jane Tizard, Consultant Paediatric Nephrologist, Bristol Royal Hospital Ken Farrington, Lister Hospital, Stevenage
Richard Fluck, Royal Derby Hospital
for Children
Colin Geddes, Glasgow Western Infirmary
Sharlene Greenwood, Lead Renal Physiotherapist, King’s College
Sharlene Greenwood, King’s College Hospital
Hospital, London
Nicholas Hoenich, University of Newcastle
Leo Bailey, Matron for Renal Services, Royal Berkshire Hospital,
Chris Jones, King’s College Hospital, London
Reading Jane Macdonald, Salford Royal NHS Foundation Trust
Jonathan Fox, Consultant Nephrologist, Western Infirmary, Glasgow Margaret Mitchell, BKPA
Programme Committee: Angela Summers, Manchester Royal Infirmary
Alison Severn, Consultant Nephrologist, Ninewells Hospital, Veronica Swallow, University of Manchester
Dundee Paddy Tabor, MVO, BKPA
Bruce Hendry, Professor of Renal Medicine,King’s College London Hayley Wells, Guy’s & St Thomas’ NHS Foundation Trust
David Wheeler, Professor of Kidney Medicine, University College Associations affiliated to the BRS
London Medical School Anaemia Nurse Specialist Association
Edwina Brown, Consultant Nephrologist, Hammersmith Hospital,
London Association of Renal Industries
Jane Macdonald, Associate Director of Nursing & Improvement, Association of Renal Managers
Great Manchester Academic Health Science Network Association of Renal Technologists
Richard Fluck, Consultant Nephrologist, Royal Derby Hospital British Association for Paediatric Nephrology
Simon Ball, Consultant Nephrologist, University Hospitals British Association of Social Workers / Renal Special Interest Group
Birmingham NHS Foundation Trust British Dietetic Association / Renal Nutrition Group
Mark Dockrell, Senior Scientist, St Helier Hospital, Carshalton British Kidney Patient Association
Alan Salama, Professor of Nephrology, University College London British Transplant Society
Medical School EDTNA/ERCA
Jill Norman, Reader in Nephrology, University College London National Kidney Federation
Medical School RCN Nephrology Nursing Forum
Renal Association
Renal Pharmacy Group
Society for DGH Nephrologists
2
ABSTRACT MARKERS
Caroline Ashley, Royal Free Hospital London NHS Foundation Trust
Leo Bailey, Royal Berkshire Hospital, Reading
Matthew Bailey, University of Edinburgh
Simon Ball, University Hospitals Birmingham NHS Foundation Trust
Jonathan Barrett, University Hospitals Leicester NHS Trust
Michael Bedford, East Kent University Hospitals NHS Foundation Trust
Hilary Bekker, University of Leeds
Sharon Benton, Royal Cornwall NHS Trust
Sunil Bhandari, Hull Royal Infirmary
Detlef Bockenhauer, University College London
Richard Borrows, University Hospitals Birmingham NHS Foundation Trust
Tim Bowen, Cardiff University
Alison Brown, Freeman Hospital, Newcastle
Edwina Brown, Hammersmith Hospital, London
Lisa Burnapp, NHS Blood and Transplant
Aine Burns, Royal Free Hospital, London
Fergus Caskey, Southmead Hospital, Bristol
Afzal Chaudry, University of Cambridge
Lindsay Chesterton, Royal Derby Hospital
Martin Christian, Nottingham University Hospitals NHS Trust
Mena Clatworthy, University of Cambridge
Paul Cockwell, University Hospitals Birmingham NHS Foundation Trust
Bryan Conway, University of Edinburgh
Richard Coward, University of Bristol
Sue Cox, Guy’s & St Thomas’ NHS Foundation Trust
John Cunningham, Royal Free Hospital London NHS Foundation Trust
Indranil Dasgupta, Heart of England NHS Foundation Trust
Jamie Davies, University of Edinburgh
Clara Day, University Hospitals Birmingham NHS Foundation Trust
Mark Dockrell, St Helier Hospital, Carshalton
Neill Duncan, Imperial College NHS Trust
Robert Elias, King’s College Hospital London
Nick Fardon, Northern General Hospital, Sheffield
Chris Farmer, East Kent University Hospitals NHS Foundation Trust
Ken Farrington, Lister Hospital, Stevenage
David Ferenbach, University of Edinburgh
Charlie Ferro, University Hospitals Birmingham NHS Foundation Trust
Jan Flint, Royal Free London NHS Foundation Trust
Richard Fluck, Royal Derby Hospital
Damian Fogarty, Queen’s University, Belfast
Jonathan Fox, Western Infirmary, Glasgow
Andrew Frankel, Imperial College NHS Trust
Donald Fraser, Cardiff University
Hugh Gallagher, St Helier Hospital, Carshalton
Lucy Galloway, Guy’s & St Thomas’ NHS Foundation Trust
Colin Geddes, Western Infirmary, Glasgow
Luigi Gnudi, King’s College London
Catherine Godson, University College Dublin
David Goldsmith, Guy’s & St Thomas’ NHS Foundation Trust
Roger Greenwood, Lister Hospital, Stevenage
Sharlene Greenwood, King’s College Hospital, London
Jennifer Hanko, Belfast Health and Social Care Trust
Lorraine Harper, University of Birmingham
Steve Harper, University of Bristol
John Haylor, University of Sheffield
Bruce Hendry, King’s College London
Fionnuala Hickey, Trinity College Dublin
Thomas Hiemstra, University of Cambridge
Rob Higgins, University Hospitals Coventry & Warwickshire
Claire Hills, University of Warwick
Jeremy Hughes, University of Edinburgh
Helen Hurst, Central Manchester Hospitals NHS Foundation Trust
Alistair Hutchison, Central Manchester Hospitals NHS Foundation Trust
David Jayne, University of Cambridge
Karen Jenkins, East Kent University Hospitals NHS Foundation Trust
Colin Jones, York Hospital
Phil Kalra, Salford Royal NHS Foundation Trust
Fiona Karet, University of Cambridge
Deepa Kariyawasam, King’s College Hospital, London
Arif Khwaja, Northern General Hospital, Sheffield
David Kluth, University of Edinburgh
Pelly Koufaki, Queen Margaret University, Edinburgh
UK Kidney Week 5K Fun Run 2014
Kick-start your morning before the conference whilst helping to save lives. Join us for a 5K run, jog or walk – along the
banks of the beautiful River Clyde in Glasgow on Wednesday 30th April at 06.00.
Organised by Kidney Research UK on behalf of the British Renal Society, the Renal Association and the Scottish Renal
Association
For more information go to: www.kidneyresearchuk.org/funrun
Robert Lewis, Queen Alexandra Hospital, Portsmouth
Andrew Lewington, St James's University Hospital, Leeds
Liz Lightstone, Imperial College NHS Trust
Graham Lipkin, University Hospitals Birmingham NHS Foundation Trust
Mark Little, Trinity College Dublin
Jane Macdonald, Salford Royal NHS Foundation Trust
Iain Macdougall, King’s College Hospital, London
Mark MacGregor, Crosshouse Hospital, Kilmarnock
Amy Jayne MacKnight, Queens University Belfast
Helen MacLaughlin, King’s College Hospital, London
Iain MacPhee, St George's, University of London
Catherine Marshall, Lister Hospital, Stevenage
Peter Maxwell, Queen’s University Belfast
Chris McIntyre, University of Nottingham
Will McKane, Northern General Hospital, Sheffield
Breeda McManus, Barts Health NHS Trust
Tom Mercer, Queen Margaret University, Edinburgh
Ashraf Mikhail, Morriston Hospital, Swansea
Sandip Mitra, Manchester Royal Infirmary
Shabbir Moochala, Royal Free Hospital London NHS Foundation Trust
Ann Murdoch, Royal Infirmary, Edinburgh
Patricia Murray, University of Liverpool
Fliss Murtagh, King’s College London
Chas Newstead, St James's University Hospital, Leeds
Jill Norman, University College London
Donal O’Donoghue, Salford Royal NHS Foundation Trust
Albert Ong, University of Sheffield
Pauly Ormandy, University of Salford
Aled Phillips, Cardiff University
Albert Power, Imperial College London
Vicky Pursey, York Hospital
Venkat Ramen, Queen Alexandra Hospital, Portsmouth
Hugh Rayner, Heart of England NHS Foundation Trust
John Reynolds, University of Bedford
Alan Salama, University College London Medical School
Moin Saleem, University of Bristol
John Sayer, Newcastle University Teaching Hospitals
Nick Selby, Royal Derby Hospital
Claire Sharpe, King’s College London
Edward Sharples, Oxford University Hospitals NHS Trust
Neil Sheerin, University of Newcastle
Simon Steddon, Guy’s & St Thomas’ NHS Foundation Trust
Andy Stein, University Hospitals Coventry & Warwickshire
Rebecca Suckling, St Helier Hospital, Carshalton
Maarten Taal, Royal Derby Hospital
Fred Tam, Imperial College London
Mark Thomas, Heart of England NHS Foundation Trust
Nicola Thomas, London South Bank University
Paul Thornalley, University of Warwick
Jane Tizard, Bristol Royal Hospital for Children
Laurie Tomlinson, London School of Hygiene and Tropical Medicine
Charlie Tomson, Southmead Hospital, Bristol
Neil Turner, University of Edinburgh
Robert Unwin, University College London
Emma Vaux, Royal Berkshire Hospital, Reading
Mike Venning, Central Manchester Hospitals NHS Foundation Trust
Graham Warwick, University Hospitals Leicester NHS Trust
Paul Warwicker, Lister Hospital, Stevenage
Louise Wells, York Hospital NHS Foundation Trust
Gavin, Welsh, University of Bristol
David Wheeler, University College London Medical School
Martin Wilkie, Northern General Hospital, Sheffield
Heather Wilson, University of Aberdeen
Pat Wilson, University College London Medical School
Graham Woodrow, Leeds Teaching Hospitals NHS Trust
Adrian Woolf, University of Manchester
Mark Wright, Leeds Teaching Hospitals NHS Trust
Mick Kumwenda, Glan Clwyd Hospital
Chris Laing, Royal Free London NHS Foundation Trust
Rachel Lennon, University of Manchester
Jeremy Levy, Imperial College NHS Trust
3
 ACKNOWLEDGEMENTS
The British Renal Society and the Renal Association wish to thank the sponsors of UK Kidney Week 2014. We are grateful to all our exhibitors for their
support of the Conference and the Exhibition. Your presence adds so much to our overall success and is a perfect accompaniment to an excellent
programme of clinical and scientific lectures.

Our special thanks go to the following companies who have contributed extra support for UK Kidney Week, and this warrants individual recognition:

Amgen - Breakfast Session on Thursday 1st May at 07.00 in Alsh: “Treatment Options in SHPT: What does the Evidence
Tell us?”

Baxter-Gambro Renal - Satellite session, on Tuesday, 29th Apr at 12.00 in Alsh: “The Right Therapy, The Right Place, The
Right Time”

Janssen - Satellite session on Tuesday, 29th April at 14.30 in Dochart: “So my patient also has diabetes, what do I need to
know?”. In addition, they have generously sponsored the wristband USB sticks containing the UK Kidney Week
abstracts.

Fresenius Medical Care - Satellite session on Tuesday, 29th April at 14.30 in the Carron: “Dialysis Challenges”

Mitsubishi Pharma Europe Ltd – Breakfast Session on Wednesday, 30th April at 07.30 in Alsh: “Managing
hyperphosphataemia: have we got the tools to improve patient choice?”
In addition, Mitsubishi Pharma Europe Ltd have generously sponsored the UK Kidney Week lanyards, a Delegate bag
insert and an Advisory Board.

Shire Pharmaceuticals Ltd - Delegate bag inserts

University Hospitals Birmingham - Delegate bag insert

The Renal Association and The British Renal Society award their highest honours each year to
those individuals invited to present their Named Lectures at Conference
Renal Association Named Lectures
The Osman Lecture
The Osman Lecture was endowed by Mrs Ruth Osman, widow of Arnold Osman, the first President and founding member of the Renal Association, who
died in 1972. It has been delivered by a distinguished series of UK and international nephrologists and renal scientists.

This year, The Osman Lecture is presented by Professor Caroline Savage, Vice-President and Head of Experimental Medicine Unit, GlaxoSmithKline,
Stevenage. Her talk is entitled “How can industry and academia collaborate to deliver clinical research?”

The De Wardener Lecture

The De Wardener lecture was established in 2004 in honour of Hugh De Wardener, Emeritus Professor of Medicine at Charing Cross Hospital, and one
of our most distinguished nephrologists and clinical scientists. He was a former President of both the Renal Association (1974-77) and the International
Society of Nephrology (1969-72).

The first lecture was given by Professor de Wardener himself. From 2006 onwards, it has become a regular feature of Renal Association meetings, and
chosen lecturers have a distinguished record in clinical research related to kidney disease.

The De Wardener Lecture will be presented this year by Neil Turner, Professor of Nephrology, University of Edinburgh, who will talk about Alport’s Syndrome
and the structure of the glomerulus.

Prior to the lecture, Professor Edwina Brown, a former student of Professor De Wardener, will give a tribute to mark his recent death.

The Raine Award was established in memory of Tony Raine, Professor of Renal Medicine at St Bartholomew’s Hospital, following his tragically early death
in 1995. This prestigious annual award is made to a relatively junior investigator (usually 35 years of age or less), who has made a significant contribution
to kidney research. The 2013 Raine Award winner is Thomas Hiemstra, Senior Clinical Research Associate and Honorary Consultant Nephrologist from
Addenbrookes Hospital, Cambridge. His lecture is entitled: “Waste not: The business of urine exosomes”.

*****
British Renal Society Named Lectures
The Mallick Lecture is awarded by the British Renal Society to acknowledge Lifetime Services to the Renal Community. This key honour recognises
outstanding individual contribution to the development and delivery of care to patients with kidney disease

Previous recipients include Sir Netar Mallick and Dr Roger Greenwood.

The Mallick Lecture this year will be presented by Professor Donal O’Donoghue, Consultant Renal Physician and Professor of Renal Medicine, Salford
Royal NHS Foundation Trust and University of Manchester. The title of his talk is “Perfect Storm: Perfect Opportunity – Where could Kidney Research Go
in the Next Decade?”

The Jane Macdonald BRS Leadership Award

This recognises the importance of an individual who has led the development of multi-disciplinary team working in the field of kidney disease.
Previous recipients include Mrs. Jane Macdonald and Mrs. Louise Wells

This year, The Jane Macdonald BRS Leadership Lecture will be presented by Ms. Lisa Burnapp, Lead Nurse, Living Donation Directorate of Organ
Donation and Transplantation, NHS Blood & Transplant and Consultant Nurse, Living Donor Kidney Transplantation, Guy’s and St. Thomas’ NHS
Foundation Trust.
Lisa’s talk is entitled, “My life in transplantation: defining moments”.

The Donna Lamping Multidisciplinary Researcher Award for Outstanding Research in Kidney Care
This BRS honour is awarded for an outstanding contribution to patient-centred multi-professional research in the field of kidney disease.

Previous recipients include Professor Paula Ormandy and Dr Joseph Chilcot

The Donna Lamping MDT Researcher Lecture on End of Life Care will be presented by Maria Da Silva Gane, Lead Clinical Counsellor – Renal
Medicine, Lister Hospital, Stevenage and Visiting Research Fellow, University of Hertfordshire.

4
 UK Kidney Week 2014
“Driving quality through Research and Team Working”

Programme Co-Chairs:
Martin Wilkie, Consultant Nephrologist, Northern General Hospital, Sheffield
Alison Brown, Consultant Nephrologist, Freeman Hospital, Newcastle
Amy Jayne McKnight, Senior Lecturer & Associate Director PGET, Queen’s University of Belfast
Jane Tizard, Consultant Paediatric Nephrologist, Bristol Royal Hospital for Children
Sharlene Greenwood, Lead Renal Physiotherapist, King’s College Hospital, London
Leo Bailey, Matron for Renal Services, Royal Berkshire Hospital, Reading
Jonathan Fox, Consultant Nephrologist, Western Infirmary, Glasgow

TUESDAY 29th APRIL 2014

08.00 Registration

11.00- Understanding Clinical Research – Making Sense of Methodology Boisdale

17.00 a) writing/aims and objectives, PICO
+ exercise to consolidate learning
b) sampling variation/power
+ exercise to consolidate learning
c) study designs in epidemiology (RCT, cohort, case control, ecological, cross-sectional)
+ exercise to consolidate learning
d) Bias (selection, and information) + confounding + reverse causality
+ exercise to consolidate learning
Speakers and Facilitators:
Dr Laurie Tomlinson, Lecturer, London School of Hygiene and Tropical Medicine and Honorary Consultant Nephrologist, Brighton and Sussex University
Hospitals NHS Trust
Dr Catriona Shaw, Research Fellow, UK Renal Registry and University College London
Dr Ben Caplin, Senior Clinical Lecturer, UCL Centre for Nephrology
Dr Rebecca Suckling, Consultant Nephrologist, Epsom and St Helier University Hospitals
Dr Angharad Marks, Senior Lecturer and Honorary Renal Consultant, University of Aberdeen
Dr James Ritchie, Research Fellow, Salford Royal NHS Foundation Trust

11.30-12.30 LUNCH AVAILABLE IN THE SESSION YOU ARE ATTENDING

12.00- Alsh Carron 12.15 - 14.15 Dochart

Baxter Gambro Symposium
17.00 The Right Therapy, The Right
Place, The Right Time
12.00 Lunch
13.00 The patient’s journey
Mr. Ian Hazel, Derby
13.15 Introduction
Professor Maarten Taal,
Consultant Nephrologist,
Royal Derby Hospital
13.30 Why we need to
standardise Pre-Dialysis
education
Kate McCarthy, Nurse
Researcher and Patient Self-
Care Advocate, University
Hospitals Coventry and
Warwickshire
14.00 A strong start to dialysis
with PD
Dr. David Lewis, Consultant
Nephrologist, Salford Royal
Hospital
14.30 Exploring the evidence for
High Dose HD
Dr. Cormac Breen,
Consultant Nephrologist,
Guy’s Hospital
15.00 Break
15.30 Individualising
haemodialysis
Dr. Clara Day, Consultant
Nephrologist, University
Hospitals Birmingham
16.00 What it’s really like to have
kidney failure
Mr. Ian Hazel & Mrs.
Emma Hazel, Derby
16.30 Panel Discussion
17.00 Closing Remarks
“Dialysis Challenges”
Sponsored by Fresenius Medical
Care
11.30 Lunch provided
12.10 Introduction
12.15 The evolution and
benefits of Renal Patient
View for haemodialysis
units
Professor Neil Turner
(Edinburgh)
12.45 Getting the (fluid) balance
right in Peritoneal
Dialysis
Professor Simon Davies
(Staffordshire)
13.15 Meeting challenges in
Dialysis Therapy Through
Advanced Technology
Sudhir Bowry (Germany)
13.45 The elderly patient on
haemodialysis – treatment
challenges
Professor Ken Farrington
(Stevenage)
14.15 Close
Kidney Disease in Older People - network launch event
Chairs: Miles Witham & Edwina Brown
Aims of session
Edwina Brown, Consultant Nephrologist, Hammersmith Hospital and Miles Witham
Consultant in Geriatric Medicine and Clinical Reader in Ageing and Health,
University of Dundee
Overview of developing guidelines
Invited Speaker: Ken Farrington, Consultant Nephrologist, Lister Hospital,
Stevenage
Value of geriatric referral
Invited Speaker: John Baxter, Consultant in Geriatric Medicine and Clinical Lead
for Heart Failure, Sunderland Royal Hospital
Use of the Distress Thermometer
Invited Speaker: Helen Alston, Research Fellow, Royal Free Hospital, London
Is dietetic support of value for older CKD patients?
Invited Speaker: Lina Johansson, Clinical Lecturer, Hammersmith Hospital
Exercise and CKD
Invited Speaker: Sharlene Greenwood, Lead Renal Physiotherapist, King’s College
Hospital, London
Bicarbonate trial update
Miles Witham, Consultant Geriatrician and Clinical Reader in Ageing and Health,
University of Dundee
Future plans for group Group discussions
Wrapping up
Edwina Brown, Consultant Nephrologist, Hammersmith Hospital and Miles Witham
Consultant in Geriatric Medicine and Clinical Reader in Ageing and Health, University
of Dundee
14.30 - 17.00 Dochart
“So my patient also has diabetes, what do I need to know?
Sponsored by Janssen
Facilitated by Dr. Andrew Frankel, Postgraduate Dean, Health Education South
London

17.30- Conference Opening Lomond Auditorium

18.30 Chairs: Simon Ball & David Wheeler
Dominance to Deprivation
Key Note speaker: Sam Galbraith, Neurosurgeon and Health Minister

Exhibition Hall 5
18.30- Civic Reception: Welcome to Glasgow & Exhibition Opening - Pipe band leading delegates from the Auditorium to the Exhibition area
20.00

5
 WEDNESDAY 30th APRIL 2014
06.00- UK Kidney Week Fun Run 2014
The UK Kidney Week 5K Fun Run is being organised by Kidney Research UK on behalf of the British Renal Society, the Renal Association and the Scottish Renal
07.30 Association. Register at: https://www.kidneyresearchuk.org/get-involved/events/kidney-week-fun-run-2014-registration

07.00-onwards REGISTRATION
Corporate Breakfast Session - Sponsored by Mitsubishi Pharma Europe Ltd Alsh
07.30- Managing hyperphosphataemia: have we got the tools to improve patient choice?
09.00 Chair: David Wheeler
Improving patient choice: have we got the right tools? David Wheeler, President of the Renal Association & Professor of Kidney Medicine, UCL Centre for Nephrology,
Royal Free Hospital, London
Who is talking with the patient? Nicola Thomas, Principal Lecturer (Research), Faculty of Health and Social Care, London South Bank University,
London
How important is adherence in managing Rebecca Walker, Renal Dietician, Royal Free Hospital, London
hyperphosphataemia?
Panel discussion and audience questions David Wheeler, Nicola Thomas, Rebecca Walker

09.15- Lomond Auditorium Hall 1 Alsh Boisdale Carron

What’s new in Clinical Nephrology Improving outcomes in Renal Novel dietary treatments & CPD – Decision Novel approaches &
10.45 Chairs: Lorraine Harper & Jane Tizard Transplantation: research presented by the making in the renal concepts
Chairs: Anthony Warrens & Renal Nutrition Group pathway Chairs: Alan Salama &
O1 Remaining anti-neutrophil cytoplasm antibody Simon Ball Chairs: Jan Flint & Helen Chairs: Edwina John Reynolds
positive after induction therapy increases relapse MacLaughlin Brown & Paula
risk in ANCA vasculitis: Observation from the O10 Deceased donor renal Ormandy O22 Reduced renal
long term follow up of the CYCLOPS and transplants from older donors; O16 Kidney Function DDAH1 activity
IMPROVE trials does the age of the recipient Adipokines, and quality of Learning protects against
Matthew Morgan, Clinical Senior Lecturer, influence transplant outcomes? life after weight loss surgery outcomes: progressive kidney
University of Birmingham Maria Pippias, Renal SpR, ERA- in obese patients with 1. Understand value fibrosis and eGFR
EDTA Registry, Amsterdam, The Stages 3-4 CKD: of patient-centred decline
O2 HIV- Immune Complex Kidney Disease: Risk Netherlands A randomised controlled decision-making James Tomlinson,
Factors and Progression to End Stage Kidney pilot study throughout renal Junior Doctor, MRC
Disease O11 Hypervolemia and Blood Helen MacLaughlin, Lead pathway Clinical Sciences
John Booth, Specialty Registrar, UCL Centre for Pressure in Prevalent Kidney Renal Dietician, King’s College 2. Highlight risk Centre, London
Nephrology, London Transplant Recipients Hospital, London communication and O23 Disruption of
O3 Eculizumab treatment of Paediatric patients Winnie Chan, Research Dietician, decision-making at renal ADMA
Queen Elizabeth Hospital, O17 Use of the standard distinct parts of
with atypical haemolytic uraemic syndrome urine phosphate assay for metabolism leads to
Lesley Rees, Consultant Paediatric Nephrologist, Birmingham pathway salt-sensitive
measuring the phosphate 3. Review aids that
Great Ormond Street Hospital for Children, London content of beverages: hypertension
AB removal vs best use of the may enhance Ben Caplin, Clinical
O4 Accelerated progression of vascular paired pool – what is best? Validation and variation patient evidence-
Elizabeth Lindley, Clinical Scientist, UCL Centre
calcification in children with CKD is associated Invited Speaker: Phil Mason, based informed for Nephrology, London
with baseline fetuin-A and vessel characteristics Clinical Renal Lead, Oxford Scientist in Renal Care, Leeds choice and decision
Rukshana Shroff, Consultant in Paediatric Kidney Unit, Oxford University Teaching Hospitals NHS Trust making O24 An Interferon
Nephrology, Great Ormond Street Hospital for Hospitals NHS Trust O18 Determining the transcription signature
Children, London sensitivity and specificity of Invited Speakers: detected in peripheral
O12 Effect of Donor Ethnicity a renal specific nutrition Antonia Cronin, leucocytes is a
O5 CKMAPPS national survey: The delivery and on Kidney Allograft Survival in Consultant hallmark of End Stage
practice patterns in UK renal units in the use of screening tool (RENST) in
Live Donor Transplantation the dialysis population: A Nephrologist, Guy’s Renal Failure
conservative kidney management to treat people Konstantinos Koutroutsos, Post & St. Thomas’ NHS Elaine Jolly, Specialist
aged 75 years and over with chronic kidney multi-centre pilot study
CCT Renal Clinical Fellow, Fiona Willingham, Clinical Foundation Trust Registrar and Clinical
failure Hammersmith Hospital, London Research Fellow,
Ikumi Okamoto, Research Fellow, University of Lead Renal Dietician, Royal
Derby Hospital Addenbrookes Hospital,
Southampton Cambridge

Lomond Auditorium Hall 1 Alsh Boisdale Carron

09.15-
O6 Withdrawal from dialysis in Scotland O13 Steroid-free
10.45 Mark Findlay, Renal SpR, Western Infirmary, immunosuppression is
Glasgow associated with long-term
improvement in post
O7 Evidence for a Gender Specific Minimum transplantation growth: the
Haemodialysis Dose twist study
Sivakumar Sridharan, Research Fellow, Lister Nicholas Webb, Consultant
Hospital, Stevenage Paediatric Nephrologist, Royal
Manchester Children’s Hospital
O8 Factors influencing admissions and deaths
over the two day gap in three times a week
O14 Increased Graft Failure and
haemodialysis in England Mortality Following
James Fotheringham, Specialist Registrar, Northern Cytomegalovirus Disease in
General Hospital, Sheffield Kidney Transplant Recipients
O9 Patients’ Perceptions And Awareness About undergoing contemporary
immunosuppression and CMV
Medicines Management To Prevent Acute Kidney
Injury prophylaxis
Matthew McCloskey, Medical
Gang Xu, Renal SpR, Leicester General Hospital
Student, University of Birmingham
O15 Poor HLA matching and
post-operative blood
transfusions are associated
with the development of de
novo DSA post renal
transplantation
Michelle Willicombe, Clinical
Lecturer, Hammersmith Hospital,
London
How nitrates in certain Richard Thomson, O25 Treatment of
vegetables can lower BP. Professor of Experimental
Invited Speaker: Professor Epidemiology & Autoimmune Vasculitis
Amrita Ahluwalia, Ph.D., Public Health, with a SYK inhibitor
Professor of Vascular Institute of Health & Stephen McAdoo,
Pharmacology, Barts and The Society, Newcastle Clinical Research
London Hospital University Fellow, Imperial College
London
O19 Changes in body James Hutchinson,
composition after initiation O26 Investigation of
Patient
of haemodialysis the role of the
David Keane, Clinical Inflammasome
Scientist, Leeds Teaching triggering HIN200
Hospitals NHS Trust gene family in the
Systemic Lupus
O20 Ongoing dietetic Erythematosus murine
education is associated with
model BXSB
greater awareness of dietary Allyson Egan, Renal
sodium intake in people on
SpR, Hammersmith
haemodialysis Hospital, London
Fiona Willingham, Clinical
Lead Renal Dietician, Royal O27 An important role
Derby Hospital for suppressor of
cytokine signalling
O21 Long term influence of
urinary sodium, creatinine (SOCS)3 in promoting
MI macrophage
and albumin excretion on
survival in chronic kidney activation and function
in Glomerulonephritis
disease
Emily McQuarrie, Specialty Peter Gordon,
Registrar, Western Infirmary, Scientist, University of
Glasgow Aberdeen

10.15 - 11.15 COFFEE Exhibition Hall 5

Lomond Auditorium Carron
11.15-
The Mallick Lecture Breaking the translational barrier
12.15 Chair: Simon Ball & Richard Fluck Chairs: Amy Jayne McKnight & Gavin Welsh

The Mallick Lecture - Perfect Storm: Perfect Opportunity - Where could Kidney
Research Go in the Next Decade?
Invited Speaker: Professor Donal O’Donoghue, Consultant Renal Physician and
Professor of Renal Medicine, Salford Royal NHS Foundation Trust and University of
Manchester
Kidney Health: Delivering Excellence
Invited Speaker: Fiona Loud, Project Leader for Kidney Health: Delivering Excellence
Wearable Kidney
Invited Speaker: Andrew Davenport, Consultant Renal Physician and Honorary
Senior Lecturer, University College London Center for Nephrology, Royal Free
Hospital, London
Connexins as a novel target in wound healing
Invited Speaker: David Becker, Professor in Tissue Repair and Regeneration at
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

12.15 - 13.30 LUNCH Exhibition Hall 5

13.30 - 14.30 Moderated Poster Session Exhibition Hall 5
6
 Lomond Auditorium
14.35- Quality Improvement
16.05 Chairs: Jane Macdonald &
Helen Crisp
O28 Renal Patient View
users are more likely to
begin RRT on a home-
based modality: an
effective source of pre-
dialysis education?
Anirudh Rao, UK Renal
Registry Research Fellow,
Southmead Hospital, Bristol
O29 Sustained
improvement in PD
peritonitis rates over 18
months following
completion of a formal
quality improvement
collaborative project
Sajeda Youssouf, Clinical
Research Fellow, Salford
Royal NHS Foundation Trust
Embracing quality
improvement to enhance
patient experience
Invited Speaker: Prof
Jason Leitch, Clinical
Director, The Quality Unit,
Scottish Government
O30 Community-wide
Chronic Kidney Disease
management leads to
reduced incidence and
improved initiation of
Renal Replacement
Therapy
Hugh Rayner, Consultant
Nephrologist, Birmingham
Heartlands Hospital
O31 Shared Haemodialysis
Care – A quality
improvement programme
facing the sustainability
challenge
Martin Wilkie, Consultant
Nephrologist, Northern
General Hospital
Hall 1
Rare diseases RADAR session
Chairs: Mark Taylor & Fiona
Karet
Genetic insights into renal
Fanconi Syndrome
Invited Speaker: Detlef
Bockenhauer,
Reader & Honorary Consultant,
Great Ormond Street Hospital
for Children, London
O32 Development of distal
tubular dysfunction
associated with mutations in
HNF1B
Shazia Adalat, Clinical
Research Fellow,
Great Ormond Street Hospital
for Children, London
O33 Initial patient
characteristics from the
observational, non-
interventional, multinational
registry of patients with aHUS
Sally Johnson, Consultant
Paediatrician, Great North
Children’s Hospital, Newcastle
upon Tyne
O34 Adult Cystinosis: does the
timing of Cystagon Therapy
affect the timing of End Stage
Renal Failure and the
development of organ
dysfunction
Shoumik Choudhury, Medical
Student, University of Leeds
O35 Outcome of patients with
pregnancy-associated
haemolytic uraemic syndrome
Edwin Wong, Clinical Research
Fellow, Newcastle University
O36 Alport’s/thin basement
membrane disease,
pregnancy and proteinuria
Matt Hall, Consultant
Nephrologist, Nottingham
University Hospitals NHS Trust
Alsh
Psycho-social Health of the
Renal Patient presented by the
British Association of Renal
Social Workers
Chairs: Ann Murdoch & Lisa
Robertson
O37 Measuring Shared Decision-
Making in routine clinical
practice amongst patients
approaching ESKD: A pilot audit
Charlie Tomson, Consultant
Nephrologist, North Bristol NHS
Trust
O38 Renal Patient View (RPV): A
survey of inactive users
Adil Hazara, Clinical Scientist, Hull
Royal Infirmary
O39 Attitudes towards Prenatal
Diagnosis and Pre-implantation
Genetic Diagnosis in Patients
with Autosomal Dominant
Polycystic Kidney Disease
Oscar Swift, Junior Doctor, Lister
Hospital, Stevenage
O40 Inflammatory Activity is an
Independent Predictor of
Depression and Fatigue in
Stable Kidney Transplant
Recipients
Winnie Chan, Research Dietician,
Queen Elizabeth Hospital,
Birmingham
O41 An evaluation of
interventions to support the
emotional and psychological
needs of patients with end-stage
renal disease
Gill Coombes, Principal
Investigator, Honorary Senior
Lecturer & Francesca Taylor,
Research fellow, University of
Birmingham
O42 Psychological distress
among haemodialysis patients:
The relationship between self-
care, anxiety, and depression
Jonathan Reston, Research
Fellow, University of Hertfordshire
Boisdale
Developments in Peritoneal
Dialysis
Chairs: Simon Davies &
Sally Punzalan
O43 A Prognostic Model for Risk
of Encapsulating Peritoneal
Sclerosis Incorporating the Risk
of Death During Peritoneal
Dialysis: Results from PD-CRAFT
Mark Lambie, Clinical Scientist,
University Hospital of North
Staffordshire
O44 Peritoneal membranes are
more inflamed in patients with
subsequent Encapsulating
Peritoneal Sclerosis: Results from
the GLOBAL Fluid Study
Mark Lambie, Clinical Scientist,
University Hospital of North
Staffordshire
O45 Acute peritoneal dialysis: a
service evolution
David Lewis, Consultant
Nephrologist, Salford Royal NHS
Foundation Trust
Peritoneal dialysis - Water
channels from bench to bedside
and back
Invited Speaker: Professor Olivier
Devuyst, Ordinarius Professor of
Physiology & Medicines, University
of Zurich
O46 Increasing Social Support
for Patients at Home
Linsey Worsey, Lead Peritoneal
Dialysis Nurse Specialist, Royal
Derby Hospital
O47 A Pilot Study to Investigate
the effect of Routine Warming On
the Level of a Glucose
Degradation Product (GDP) in
Conventional Peritoneal Dialysis
(PD) Fluids in
a Clinical Environment
Caroline Judge, Matron, East Kent
Hospitals NHS Foundation Trust
Carron
Modelling Kidney Disease
Chairs: Tim Bowen & Bryan
Conway
“Good bad and the ugly of
in vivo research”
Invited Speaker: Professor
Malcolm MacLeod, Chair
in Neurology and
Translational Neuroscience,
University of Edinburgh and
Clinical Lead for Neurology
at NHS Forth Valley
O48 3-Dimensional
Modeling Of Human
Glomerulosclerosis
John Waters, SpR
Nephrology, Addenbrooke’s
Hospital, Cambridge
O49 Human proximal
tubular cell models of
cystinuria
Hannah Rhodes, PhD
Research Fellow, University
of Bristol
O50 Restoration of
endothelial glycocalyx and
improved outcomes in
diabetic nephropathy
Andrew Salmon, MRC
Clinician Research Fellow,
University of Bristol
O51 Robust induction of
hemeoxygenase-1
expression does not
augment tubular
regeneration in 20 month
old mice following Acute
Kidney Injury
Jeremy Hughes, Clinical
Scientist, University of
Edinburgh

16.05 - 16.35 COFFEE Exhibition Hall 5

Lomond Auditorium Boisdale

16.40- Lessons from Diabetes DOPPS Session
18.10 Chair: Maarten Taal & Nigel Brunskill Chairs: Hugh Rayner & Francesca Tentori
Pathways in diabetic nephrology DOPPS - past, present and future
Invited Speaker: Dr John Crean, Lecturer in Pharmacology, Conway Fellow, DOPPS overview and expansion into new clinical areas
UCD School of Bimolecular and Biomedical Science, Conway Institute, Dublin Francesca Tentori, MD MS, Senior Research Scientist, Arbor Research
Population issues, informatics as a research tool Collaborative for Health, Ann Arbor MI USA and Hugh Rayner, Consultant
Invited Speaker: Helen Colhoun, Professor of Public Health, University of Nephrologist, Birmingham Heartlands Hospital
Dundee Anaemia management: a comparison of practices within and outside of Europe
Introduction to DAFNE Francesca Tentori, MD MS, Senior Research Scientist, Arbor Research
Invited Speaker: Helen Hopkinson, Consultant Physician and Chair of the UK Collaborative for Health
DAFNE Executive Board Haemodialysis Session Length and Ultrafiltration Rate: Are we heading in the
right direction?
DAFNE: Leading Change and Empowering Life Roger Greenwood, Consultant Nephrologist, Lister Hospital Stevenage
Invited Speaker: Neil MacGowan, Head of Operations at the Scottish
Qualifications Authority and DAFNE user Trends in vascular access use and associated practices
Richard Fluck, National Clinical Director (Renal), NHS England and Consultant
Nephrologist, Royal Derby Hospital
Patient-centered outcomes in haemodialysis: what we know and what remains
to be learned.
Hugh Rayner, Consultant Nephrologist, Birmingham Heartlands Hospital

THURSDAY 1st MAY 2014

07.00 REGISTRATION & COFFEE Exhibition Hall 5
07.00- Alsh
Corporate Breakfast Session: sponsored by Amgen
08.15 Chair: David Wheeler
Treatment Options in SHPT: What does the Evidence Tell us?
Professor Jurgen Floege, University Hospital, RWTH Aachen, Germany

08.30- Lomond Auditorium

The Raine Award Session with Best Abstracts
10.00 Chairs: David Wheeler & Simon Ball
Tribute to Tony Raine
Prof David Wheeler, President of the Renal Association & Professor of Kidney Medicine, UCL Centre for Nephrology, Royal Free Hospital, London
Raine Award Lecture – Waste not. The business of urine exosomes
Invited Speaker: Thomas Hiemstra, Senior Clinical Research Associate and Honorary Consultant Nephrologist, Addenbrookes Hospital, Cambridge
O52 Initial Steroid – Sensitivity in children with steroid- resistant nephrotic syndrome predicts post-transplant recurrence
Wen Yi Ding, Junior Doctor, University of Bristol
O53 Understanding the structure of PLA2R: insights into formation of the immunodominant epitope recognised by autoantibodies in patients with idiopathic
membranous nephropathy
Paul Brenchley, Professor and Director of Renal Research Labs, Manchester Royal Infirmary
O54 Exercise training improves kidney function, cardiovascular health, cardio-respiratory fitness and quality of life in patients with progressive stages 3-4 chronic
kidney disease: A randomised controlled pilot study
Sharlene Greenwood, Lead Renal Physiotherapist, King’s College Hospital NHS Trust
O55 Frail Elderly Patient Outcomes on Dialysis (FEPOD) Part 1: A Cross-Sectional Comparison of Assisted Peritoneal Dialysis and Haemodialysis
Edwina Brown, Professor of Renal Medicine, Hammersmith Hospital

7
10.00-10.30 COFFEE
Lomond Auditorium
10.30-
12.00 Exercise in CKD presented by the BRS
Renal Rehabilitation Network
Chairs: Sharlene Greenwood & Tom
Mercer
O56 Minimum accelerometer wear
time to accurately monitor habitual
physical activity and sedentary
behaviour of haemodialysis patients?
Sean Prescott, Physiotherapist, Queen
Margaret University, Edinburgh
O57 The Mechanisms of Physical
Fatigue in Prevalent Kidney Transplant
Recipients
Winnie Chan, Research Dietician, Queen
Elizabeth Hospital, Birmingham
Exercise In CKD
Invited speaker: Patricia Painter,
Associate Research Faculty, University of
Utah, USA
O58 Facilitating intradialytic exercise
self-management in haemodialysis
patients: A single centre pilot study
evaluating motivational interviewing
Ben Davis, Research Assistant,
University of Hertfordshire
O59 Effects of resistance exercise
training on myogenic response to
acute exercise in Chronic Kidney
Disease
Emma Watson, Exercise Physiologist,
Leicester General Hospital
12.00-12.45 LUNCH
12.45-13.45 Moderated Poster Session
Lomond Auditorium
14.00-
Registry Session
15.30 Celebrating the 50th anniversary
of the ERA/EDTA Registry
Chairs: Damian Fogarty & Wendy
Metcalfe
The ERA-EDTA Registry: past
present and future!
Invited Speaker: Kitty Jager,
Senior Epidemiologist & Managing
Director, ERA-EDTA Registry,
Amsterdam, The Netherlands
The HSCIC and care.data:
opportunities for the Registry
Invited Speaker: Jeremy Thorp,
Director of Business Architecture,
Health & Social Care Information
Centre, Leeds
O70 Establishing a Renal Data
Observatory using healthcare
data linkage methodology
Corri Black, Senior Clinical
Lecturer and Honorary Consultant
in Public Health, University of
Aberdeen
O71 National burden of acute
stroke in patients on Renal
Replacement therapies
Albert Power, NIHR Clinical
Lecturer in Renal Medicine,
Hammersmith Hospital, London
O72 Renal graft outcomes after
pregnancy: follow-up from the
UK Obstetic Surveillance Study
Kate Bramham, Doctoral Fellow,
St Thomas’ Hospital, London
15.30 - 16.00 COFFEE
Hall 1
CPD session – pregnancy in renal
disease
Chairs: Jeremy Levy and Graham
Lipkin
CKD/Lupus
Invited Speaker: Liz Lightstone,
Reader in Renal Medicine and
Honorary Consultant Physician,
Imperial College Kidney & Transplant
Centre, London
CKD
Invited Speaker: Matt Hall,
Consultant Nephrologist, Nottingham
University Hospitals
Transplant
Invited Speaker: Graham Lipkin,
Consultant Nephrologist, University
Hospitals Birmingham
Drug issues, pre/ante natal and
breast feeding
Invited Speaker: Stephen Hughes,
Renal Pharmacist, Central
Manchester Hospitals NHS
Foundation Trust
Hall 1
Optimizing the care of patients with Chronic
Renal Failure presented by EDTNA/ERCA
Chairs: Marissa Dainton & Paul Warwicker
O73 The effects of oral sodium bicarbonate
on extracellular water in patients with
chronic renal failure
Colin Jones, Renal Physician, York Teaching
Hospital
O74 Can a self-affirmation intervention
improve fluid control in haemodialysis
patients: interim findings from a pilot cluster
randomised controlled trial
Vari Wileman, PhD Student, University of
Hertfordshire
Fluid status management in dialysis patients
Invited Speaker: Elizabeth Lindley, Clinical
Scientist in Renal Care, Leeds Teaching
Hospitals NHS Trust
O75 Cardiac Dysfunction in Asymptomatic
Chronic Kidney Disease Patients Relative to
Healthy Controls and Heart Failure Patients
Shanmugakumar Chinnappa, SpR, Northern
General Hospital, Sheffield
O76 Exercise during haemodialysis: The
acute effects on markers of systemic
inflammation and neutrophil degranulation
Maurice Dungey, PhD Student, Loughborough
University
O77 Cognitive Changes during a
Haemodialysis Session in Stable
Haemodialysis Patients over the age of 60
years- a prospective pilot study
Hannah Currie, Junior Doctor, Birmingham
Heartlands Hospital
O78 Development of lower limb peripheral
vascular disease in the diabetic
haemodialysis population – a 24 year
retrospective study
Paul Warwicker, Consultant Nephrologist,
Lister Hospital, Stevenage
8
Alsh
Improving Patient Safety using
Information Technology
Chairs: Karen Jenkins & Paul Wilson
Improving patient safety using
Information Technology
Invited Speaker: Jamie Coleman, Senior
Clinical Lecturer in Clinical Pharmacology &
Medical Education, University of
Birmingham
O60 Major Bleeding in Haemodialysis
patients using Unfractionated or Low
Molecular Weight Heparin: A single
centre study
Luxme Nadarajah, Junior Doctor, The
Royal London Hospital
O61 Erythropoietin Stimulating Agents
Resistance and Survival in the UK
Dialysis population
Anirudh Rao, UK Renal Registry Research
Fellow, Southmead Hospital, Bristol
O62 Hydroxychloroquine levels define
high rates of non adherence and predict
worse renal outcomes in patients with
Lupus Nephritis
Tom Cairns, Consultant Nephrologist,
ICHNT Renal and Transplant Centre,
Hammersmith Hospital
O63 Prescribing safety in patients with
n
impaired renal function: results of audit
raw
and re-audit following focused
d
h
wit
interventions
Laetitia Clarke, Junior Doctor, North
Middlesex University Hospital
O64 Comparing outcome for renal
patients admitted to hospital at
weekends and overnight versus normal
working hours
Darren Green, Clinical Lecturer, University
of Manchester
O65 Optimal medical therapy in
atherosclerotic renovascular disease
James Ritchie, Research Fellow, Salford
Royal NHS Foundation Trust
Alsh
CPD – Obesity and management of
kidney disease:
Chairs: Richard Baker & Louise Wells
Learning outcomes:
1. Review underlying mechanisms
causing obesity
2. Discuss how obesity can be
managed in CKD
3. Review reasons for weight gain
and diabetes post-transplantation
4. Discussion of risks and benefits for
obese donors and transplant
recipients
Invited Speakers:
Dr Bryan Conway, MRC Clinician
Scientist/Honorary Senior Lecturer,
MRC Centre for Inflammation
Research, University of Edinburgh
Helen MacLaughlin, Lead Renal
Dietician, King’s College Hospital,
London
Richard Baker, Consultant
Nephrologist, St James's University
Hospital, Leeds
Dan Ridgway, Consultant Surgeon,
Royal Liverpool Hospital
Exhibition Hall 5
Carron
Best Young Scientist Award Session
Chairs: Andrew Hall & Moin Saleem
Translational therapy
Invited Speaker: Andrew Baker,
BHF Professor of Translational
Cardiovascular Sciences, University of
Glasgow
O66 Tin Mesoporphyrin a novel
treatment in Acute Kidney Injury
Alicja Czopek, Postdoctoral Research
Fellow, University of Edinburgh
O67 Silencing the Expression of Kras
Protects Renal Function and Reduces
Jag1 Expression in Mouse Models of
Renal Fibrosis
Lucy Newbury, PhD Student, Kings
College London
O68 RIP3-mediated necroptosis is not
an important pathological process in
murine nephrotoxic nephritis
Nicola Hill, Research Technician,
Imperial College London
O69 Biological Aging and Chronic
Kidney Disease: Telomere and
Mitochondrial Interaction as a Novel
Risk Factor
Seamus Duffy, PhD Student, Queen’s
University Belfast
Exhibition Hall 5
Exhibition Hall 5
Carron
Molecular Signals in Kidney Diseases
Chairs: Mark Dockrell & Rachel Lennon
Role of protein tyrosine phosphatases
PTP1B and SHP2 in diabetes and
inflammation
Invited Speaker: Mirela Delibegovic,
Senior Research Fellow, University of
Aberdeen
O79 Glomerular Spleen Tyrosine
Kinase (SYK) expression correlates
with disease activity and outcome in
proliferative glomerulonephritis
Stephen McAdoo, Clinical Research
Fellow, Imperial College London
O80 DNA Methylation and
Cardiovascular Disease: Getting to the
Heart of the Issue
Mark Elliot, Junior Doctor, Queen’s
University, Belfast
O81 Isolation of MicroRNA from the
Proximal Tubules of Archival Renal
Biopsies utilising Laser Capture
Microdissection
Geraint Dingley, Junior Doctor, Queen
Alexandra Hospital, Portsmouth
O82 A role for platelet-derived growth
factor (PDGF) receptor(R)
signaling/pathway in the fibrosis of
Autosomal Dominant Polycystic
Kidney Disease (ADPKD): potential for
therapy
Johanna Donovan, Post Doctoral
Research Associate, UCL Centre for
Nephrology, London
Exhibition Hall 5
 Lomond Auditorium
16.00-
17.30 ISN / RA International
Nephrology
Chairs: David Goldsmith & John
Feehally
Renal transplantation outcomes
in India (ISN)
Invited Speaker: Vivekanand Jha
Executive Director, George Center
for Global Health, India & Professor
of Nephrology, University of Oxford
HIV nephropathy in Africa
Invited Speaker: Charles
Swanepoel, Associate Professor in
the Division of Nephrology and
Hypertension, University of Cape
Town and Groote Schuur Hospital,
South Africa
Balkan nephropathy – an update
Invited Speaker: Adrian Covic,
Dept of Nephrology (Head),
University of Medicine “Grigore T.
Popa” Iasi and University Hospital
“C.I. Parhon” Iasi, Romania
ISN Fellows report
Invited Speaker: Gavin Dreyer,
Renal SpR, Royal Free Hospital,
London
Hall 1
Dialysis Debates
Chairs: Ken Farrington & Sandip Mitra
An RCT of conservative care v dialysis in the
frail elderly is urgently required
Invited Speakers:
For: Fergus Caskey, Consultant Nephrologist,
Southmead Hospital, Bristol
Against : Andrew Davenport, Consultant Renal
Physician and Honorary Senior Lecturer,
University College London Center for
Nephrology, Royal Free Hospital, London
Kt/V has had its day
For: Maarten Taal, Professor in Medicine,
University of Nottingham & Consultant
Nephrologist, Royal Derby Hospital
Against: Roger Greenwood, Consultant
Nephrologist, Lister Hospital, Stevenage
O83 Evaluation of the contribution of
atherosclerotic and non-atherosclerotic
events to cardiovascular morbidity and
mortality in haemodialysis patients in the
EVOLVE clinical trial
David Wheeler, Professor of Kidney Medicine,
UCL Centre for Nephrology, London
O84 Arteriovenous fistula failure in
haemodialysis patients risk factors
Khaled Abdulnabi, Nephrology SpR, The Royal
Liverpool Hospital
O85 Relationship of Physical Activity and
Urea Generation Rate in Haemodialysis
Patients
Sivakumar Sridharan, Research Fellow, Lister
Hospital, Stevenage
Alsh Carron
BRS/BKPA Research Initiatives BAPN Science Session
Forum Complement, Genes and the kidney
Chairs: Paula Ormandy & Colin Chairs: Sally Johnson & Daniel Gale
Geddes
Complement pathways
The Donna Lamping MDT Invited Speaker: Matthew Pickering,
Researcher Lecture - End of Life Professor & Welcome Trust Senior
Care Fellow, Centre for Complement &
Invited Speaker: Maria Da Silva Inflammation Research, Imperial College
Gane, Lead Clinical Counsellor - London
Renal Medicine, Lister Hospital,
Stevenage and Visiting Research Eculizumab and aHUS – the UK
experience
Fellow, University of Hertfordshire
Invited Speaker: Tim Goodship,
The BKPA: Now and in the future Professor of Renal Medicine, Newcastle
Invited Speaker: Mr Paddy Tabor, University
Chief Executive of the British Kidney
Patient Association (BKPA) O86 Next generation sequencing of
>30 genes associated with steroid
Grant Awardee presentation resistant nephrotic syndrome
A qualitative study exploring the Agnieszka Bierzynska, PhD Student,
benefits of a new joint speciality University of Bristol
renal genetic clinic for children and
their families O87 Atypical Haemolytic Uraemic
Adrian Woolf, Professor and Chair in Syndrome associated with a novel
Paediatric Science, Manchester hybrid CFH/CFHR3 gene
University Rachel Challis, PhD Student, Newcastle
University
Grant Awardee presentation
Increasing Organ Donation in the
North West South Asian
Community through Strategic
Intervention
Agimol Pradeep, Transplant
Recipient Co-ordinator, Central
Manchester University Hospitals NHS
Foundation Trust
Gaining BRS funding – Ask the
panel for tips for success
Questions and Discussion

Lomond Auditorium Boisdale Carron

17.45-
19.00 Clinical guidelines - supporting high quality care
Chairs: Andy Lewington & Martin Wilkie
Electronic AKI alert guidelines: the need for joint
guidelines
Invited Speaker: Andrew Lewington, Consultant
Nephrologist, Leeds Teaching Hospitals NHS Trust
Developing Paediatric Guidelines: Finding the
balance between rigour and Pragmatism
Invited Speaker: Jan Dudley, Consultant Paediatric
Nephrologist, Bristol Royal Hospital for Children
Harmonisation of Guidelines: The Pros and Cons
Invited Speaker: Wim Van Biesen, Chair of ERBP,
University Hospital, Ghent, Belgium
What role do guidelines play in improving
outcomes from AKI?
Invited Speaker: Richard Fluck, National Clinical
Director (Renal), NHS England and Consultant
Nephrologist, Royal Derby Hospital
Academic Trainees Session
Chairs: Fiona Karet & Rachel Lennon
Introduction: combining clinical and academic
training
Professor Fiona Karet, Cambridge
My story
Dr Patrick Mark, Glasgow - inc Q/A
Career snapshots:
Drs Elaine Jolly, Laurie Tomlinson
Round tables for RTFs and ICF/CLs (including
parallel optional CV surgery)
Careers session for renal scientists
Chairs: Heather Wilson & Jill Norman
What makes a good fellowship candidate, excellent
grant applications and current research priorities for
renal disease
Invited Speaker: Professor Richard Cornall, Wellcome
Trust Centre for Human Genetics, University of Oxford and
Chair of KRUK Research Grants Committee 2009 – 2013
Experiences from successful candidates on their
fellowships
Invited Speaker: Laura Denby, Research Fellow,
University of Glasgow
Invited Speaker: Richard Coward, MRC Clinician
Scientist and Senior Lecturer Paediatric Nephrology, Bristol
Royal Hospital for Children
Panel – audience participation and networking

20.00 UK Kidney Week 2014 CONFERENCE DINNER – HILTON HOTEL, 1 William Street, Glasgow, G3 8HT

FRIDAY 2nd MAY 2014

07.30 REGISTRATION AND COFFEE

07.45 - 09.00 RENAL ASSOCIATION AGM (MEMBERS ONLY)

Lomond Auditorium
09.15-
10.15 The Jane Macdonald BRS MDT Leadership Lecture
Chairs: Simon Ball & Jane Macdonald
My life in transplantation: defining moments
Invited Speaker: Lisa Burnapp, Lead Nurse, Living Donation Directorate of 0rgan Donation
and Transplantation, NHS Blood & Transplant and Consultant Nurse, Living Donor Kidney
Transplantation, Guy's and St Thomas' NHS Foundation Trust
O88 Weekend hospital mortality: An analysis of admissions to a tertiary renal unit
Rosie Haddock, Junior Doctor, Western Infirmary, Glasgow
O89 The influence of the presence of renal services on hospital associated mortality in
patients receiving chronic dialysis in England
James Fotheringham, Specialist Registrar, Northern General Hospital
O90 Major Bleeding in Incident Haemodialysis Patients: A single centre study
Suzanne Forbes, Specialist Registrar, Royal London Hospital
Carron
Stem cells and Renal Development
Co-Chairs: Adrian Woolf & Prabal Chatterjee
Progenitors, Wilms’ tumours and the role of Wt1 and beta-catenin
Invited Speaker: Peter Hohenstein, Group Leader, The Roslin Institute,
University of Edinburgh
O91 Active LIM kinase is required for metanephric mesenchyme
migration, SIX2 expression and Mitosis in mesenchymal cells
Simon Welham, Lecturer, University of Nottingham
O92 Glycogen synthase kinase 3 is critical for podocyte development and
survival
Jenny Hurcombe, Research Assistant, University of Bristol

10.15-10.45 COFFEE Exhibition Hall 5

9
10.45- Lomond Auditorium
12.15 Research – raising the game
Chairs: Phil Kalra & Michael Nation
PPI - patients setting the
research agenda
Invited Speaker: Keith
Hodkinson, Chair of KRUK Lay
Advisory Committee and Chair of
the Scottish Kidney Federation,
Sponsored by Kidney Research UK
Hot topics in clinical research –
from the NIHR perspective
Invited Speaker: Professor Phil
Kalra, Consultant Nephrologist and
Honorary Professor, Salford Royal
NHS Foundation Trust and
University of Manchester
Osman Lecture – “How can
industry and academia
collaborate to deliver clinical
research?”
Invited Speaker: Professor
Caroline Savage, Vice-President
and Head Experimental Medicine
Unit, GlaxoSmithKline, Stevenage
Hall 1
BRS CKD Strategy Group presents: CKD
Care Closer To Home
Chairs: Karen Jenkins & Maarten Taal
The way forward with the BRS CKDSG
Karen Jenkins, Chair BRS CKD Strategy
Group and Consultant Nurse, East Kent
Hospitals University NHS Foundation Trust
The union between primary and secondary
care to deliver high quality kidney care
Invited Speaker: Kathryn Griffith, RCGP
Kidney Care Champion and GP, Unity Health,
York University
O93 Socio-economic deprivation influences
survival and eGFR: Results from a
community – based CKD Cohort
Beng Hock So, Clinical Teaching Fellow,
University Hospital, Crosshouse, Kilmarnock
O94 Obesity as a risk factor for Chronic
Kidney Disease: Health survey for England
2010
Helen MacLaughlin, Lead Renal Dietician,
King’s College Hospital, London
O95 Bone mineral density and micro-
architectural changes in CKD Stages 4-5D
Syazrah Salam, Clinical Research Fellow,
Northern General Hospital, Sheffield
O96 High-density lipoprotein in children
with chronic kidney disease promotes
endothelial dysfunction and early
atherosclerosis
Rukshana Shroff, Consultant in Paediatric
Nephrology, Great Ormond Street Hospital
for Children, London
Alsh
CPD: Challenging Dialysis
Situations:
Chairs: Helen Hurst & Edwina Brown
Learning outcomes:
1. Review evidence for hours and
frequency of HD for the home patient
2. Understand nutritional and other
complex needs of patient developing
EPS
3. Consider choices for the frail
patient failing on HD
Invited Speakers:
Sandip Mitra, Consultant
Nephrologist, Manchester Royal
Infirmary
Rosie Campbell, Senior Renal
Dietitian, Manchester Royal Infirmary
Maria Da Silva-Gane, Lead Clinical
Counsellor - Renal Medicine, Lister
Hospital, Stevenage and Visiting
Research Fellow, University of
Hertfordshire
Carron
Advances in Transplantation Science
Chairs: Richard Borrows & Alan Salama
Treatment and prevention of chronic
antibody-mediated rejection
Invited Speaker: Anthony Dorling,
Professor of Transplant Inflammation and
Repair Honorary Consultant Nephrologist,
King’s College London, MRC Centre for
Transplantation, NIHR Biomedical
Research Centre-Transplant Theme, Guy’s
Hospital
O97 IQCJ podocytopathy associated
with primary renal failure and de novo
membranous nephropathy post
transplantation
Rachel Lennon, Senior Clinical Lecturer,
University of Manchester
O98 Ciclosporin Nephrotoxicity is
Independent of TGF!1
Seema Jain, Research Fellow, South West
Thames Institute for Renal Research, St
Helier Hospital, Carshalton
O99 Candidate gene SNP association
could offer new insights in post renal
transplant hyperglycaemia development
Sourabh Chand, Clinical Academic
Fellow, Queen Elizabeth Hospital,
Birmingham
O100 Interstitial Fibrosis and Tubular
Atrophy (IFTA), Antibody Mediated
Rejection (ABMR) and Recurrent
Disease as the Major Causes of Late
Renal Allograft Loss
Patrick Horgan, Medical Student,
University of Birmingham

12.15-13.00 LUNCH Exhibition Hall 5

12.15-13.00 BAPN AGM Boisedale

13.00-14.00 Moderated Poster Session (Exhibition Hall will close at 14.30) Exhibition Hall 5

Lomond Auditorium Hall 1

14.05-
15.35 BAPN / Adult paediatric interface NKF Question Time
Chairs: Bruce Hendry & Jane Tizard Chairs: Kirit Modi & Louise Wells
Alport syndrome: clinical management and therapeutic advances Improving provision for patients
Invited Speaker: David Milford, Consultant Paediatric Nephrologist, Expert Panel:
Birmingham Children’s Hospital Charlie Tomson, Consultant Nephrologist, Southmead Hospital, Bristol
Nick Palmer, Head of Advocacy Services, NKF
Alport Syndrome: patient journeys Jane Macdonald, Assistant Director of Nursing, Salford Royal Hospital NHS Trust
Invited Speaker: Susie Gear, Trustee and Founding Member of Alport UK:
a brighter future for people living with Alport Syndrome Questions to be discussed will include the following:
Tribute to Professor De Wardener What is the impact of the dialysis and transplant service specifications on the quality
Professor Edwina Brown, Consultant Nephrologist, Hammersmith Hospital, of provision for patients in England?
London How have kidney patients been affected by changes in the benefit system?
Do patients have a genuine choice of dialysis options?
The De Wardener Lecture - Alports and the structure of the glomerulus
Invited Speaker: Neil Turner, Professor of Nephrology, University of O101 Patient-Reported Symptoms in Early and Pre-Dialysis Chronic Kidney Disease
Edinburgh Stephanie Brown, Intercalculating Medical Student, University Hospitals of Leicester
O102 An evaluation of patient and carer involvement in a renal nursing education and
research interest group
Nicola Thomas, Principal Lecturer, London South Bank University
O103 Role of expert dedicated financial advice to service users on dialysis: Pilot project
Christine Beaty, Senior Renal Social Worker, Lister Hospital, Stevenage

Lomond Auditorium Boisdale Alsh

15.45-
16.45 The Scottish Renal Association presents:
Lipid management in chronic kidney
disease
Chair: Alison Severn
Debate: 'All patients with stage 4 or 5 CKD
should be treated with a statin'
Proposing the motion:
Invited Speaker: Chris Deighan,
Consultant Physician and Clinical Director,
Renal Services, Western Infirmary, Glasgow
Opposing the motion:
Invited Speaker: Professor Chris Isles,
Consultant Nephrologist, Dumfries &
Galloway Royal Infirmary
Service Delivery & Sustainability presented by the Association of Renal Renal denervation – defining who would
Managers benefit.
Chairs: Leo Bailey & Charlie Tomson Chairs: Will McKane & Patrick Mark
O104 Economic evaluation of more frequent and/or longer duration Device based therapies for resistant
haemodialysis (high dose haemodialysis) in the UK hypertension – an overview
Murat Arici, Payer & Reimbursement Strategy Manager, Baxter Healthcare Ltd Invited speaker: Mel Lobo, Consultant
Physician in Cardiovascular Medicine and
O105 A snapshot of current UK home haemodialysis practice; widespread General Internal Medicine, Barts Health
availability of non-traditional regimes Trust
Clara Day, Consultant Nephrologist, Queen Elizabeth Hospital, Birmingham
O108 Endovascular Renal Denervation
O106 The utility of dialysis fluid autoflow technology to reduce
consumption of water, acid concentrate and bicarbonate in a in Dialysis-Dependent Renal Failure to
haemodialysis population Reduce Cardiovascular Risk
John Stoves, Consultant Nephrologist, St Lukes Hospital, Bradford Neil Hoye, Specialty Registrar, University
of Otago, New Zealand
O107 Wessex Renal and Transplantation Service
Experience of Home Haemodialysis using the NxStage System One
Natalie Borman, Consultant Nephrologist, Queen Alexandra Hospital,
Portsmouth

16.45 MEETING CLOSES

10
 GUEST SPEAKERS
Amrita Ahluwalia
Professor of Vascular Pharmacology and Deputy Director of the William Harvey Research Institute,
Barts and the London School of Medicine and Dentistry.

Prof Ahluwalia is currently Senior Editor of The British Journal of Pharmacology. She is also a member of The
American Heart Association and The American Society for Pharmacology and Experimental Therapeutics.
During her time serving on the Executive Committee of The British Pharmacological Society she set up a
nation-wide mentoring scheme for young female pharmacologists.

The scheme is being used as ‘best successful practice’ by the UKRC and has been cited in the recent CEO
charter launched by the UKRC for equality for women in the SET workplace. In addition she was Chair of
the BPS Women in Pharmacology Committee and organised ‘Leadership seminars’ for members. In addition
she established a prize for women pharmacologists for excellence in pharmacology, the first award of which occurred in 2009. She
currently sits on the Athena Committees of both Queen Mary and the Medical School and has organised and set up a Medical School
Mentoring Scheme for Women at Lecturer level. She was invited as a panel member to speak at The House of Commons at the
Parliamentary Science Links Day in June 2013.

Prof Ahluwalia has been awarded some major Grants including several from the British Heart Foundation. Her research focuses on
enhancing understanding of the processes involved in diseases of the cardiovascular system and in this way, identifying novel therapeutic
targets.

She is a world wide renowned invited speaker and has published extensively.

Helen Alston
Research SpR, UCL Centre for Nephrology, Royal Free Hospital

Helen gained her MBBS at Guy’s, King’s and St Thomas’s Medical School from1998-2004. Her MRCP, Royal
College of Physicians in 2008 and SCE (Nephrology), Royal College of Physicians in 2012.

Helen is currently taking time out from her programme of higher specialist nephrology training to complete
her PhD “Psychosocial Distress in Older Renal Patients”, at UCL which is, funded by KRUK and the UCL
Impact Awards.

She is particularly interested in the care of elderly renal patients, and in decisions around the end of life.
Helen has several publications on Conservative Kidney Management to her name and has presented at
Renal Conferences in the UK and in the USA

Andrew Howard Baker

Senior Lecturer in Molecular Medicine Institute of Cardiovascular and Medical Sciences, University
of Glasgow

Since 2011, Andrew has been BHF Chair of Translational Cardiovascular Sciences and Deputy Director,
Institute of Cardiovascular and Medical Sciences at the University. He was also Professor of Molecular
Medicine from 2005-2011.

He has received numerous awards including the Royal Society Wolfson Research Merit Award, Outstanding
Achievement Award, European Society of Cardiology, 2010 and was also awarded the Fellowship of the
Royal Society of Edinburgh in 2010.

He also received the Blandsford Prize in pharmacology for the best overall performance in the final year of his degree course which was
awarded by HRH, Princess Anne.
Andrew has published extensively.

Richard James Baker

Consultant in Renal Medicine, Renal and Transplantation Unit, St. James’ Hospital, Leeds & Head of
Renal Transplant Service Team

Richard was appointed Honorary Associate Professor by Leeds University in 2013, and is the British
Transplantation Society Treasurer and Trustee from 2011- present.

He spent 4 years in the Immunology Department at Hammersmith Hospital attached to the Tissue Typing
Unit under the direction of Dr Nick Davey. Worked closely with Dr Paul Brookes measuring Precursor
frequencies in Bone Marrow, Heart and Renal Transplant patients.

Richard also trained in cellular immunology, flow cytometry and ELISA techniques associated with
histocaompatibility testing. His PhD was awarded in August 2001, “Human Immune Responses to Alloantogens”. Richard is a member
of several Societies including British Transplantation Society, the American Society of Nephrology and the American Society of
Transplantation.
He has published extensively.

11
 Dr John Baxter
Consultant Geriatrician, Sunderland Royal Hospital

He has a specialist interest in heart failure in older persons and is a Committee Member of the British
Geriatric Society, Cardiovascular Section.

He is also a Clinical Advisor on the Long Term Conditions Steering Group for the National Council of Palliative
Care.

John is a past Committee Member of the British Society for Heart Failure and is involved in a number of
network heart failure trials.

Detlef Böckenhauer
Reader, Institute for Child Health, University College London and Honorary Consultant Nephrologist,
Great Ormond Street Hospital for Children

Detlef was awarded his Dr med (PhD) at the Medizinische Universitaet Luebeck, Germany in 1994.

He has worked at New York University-Bellevue, USA and held several posts at Yale University School of
Medicine, New Haven, CT, USA including:
Associate Research Scientist and Assistant Professor in the Department of Pediatrics (Nephrology).

He was a Consultant Nephrologist and Honorary Senior Lecturer at Great Ormond Street Hospital for
Children and Institute for Child Health, University College London from 2004-2010 and Senior Lecturer from 2010-2012

Detlef has co-published the Paediatric Nephrology, 2nd edition and published numerous Journal articles, reviews and editorials.

Edwina Brown
Consultant Nephrologist, Imperial College Renal and Transplant Centre, Hammersmith Hospital,
London. Professor of Renal Medicine, Imperial College London

Edwina’s main clinical and educational interests are peritoneal dialysis, dialysis in the elderly and renal
palliative care. She has been the principal investigator for BOLDE (Broadening Options for Long-term
Dialysis in the Elderly) and currently running FEPOD (Frail Elderly Patient Outcomes on Dialysis) comparing
outcomes on assisted PD and haemodialysis with conservative care.

She has published extensively on peritoneal dialysis and dialysis in the elderly and is the author/editor of
several books.

Oxford Handbook of dialysis, 3rd Edition, Levy J, Brown E, Daley C, Lawrence A. Oxford University Press 2009; 4th edition due 2014.
Supportive Care for the Renal Patient., 2nd Edition, Ed., Chambers EJ, Brown EA, Germain M. Oxford University Press 2010.
Kidney Disease: From advanced disease to bereavement, 2nd edition. Brown EA, Murtagh FEM, Murphy E. Oxford University Press
2012.

Lisa Burnapp
Lead Nurse, Living Donation, Organ Donation and Transplantation and Consultant Nurse, Living Donor
Kidney Transplantation. NHS Blood and Transplant and Guy's & St Thomas' NHS Foundation Trust

Lisa Burnapp has a background in nephrology and transplantation and was appointed as a Consultant Nurse
in Living Donor Kidney Transplantation at Guy’s & St. Thomas’ NHS Foundation Trust, following completion
of her MA in Medical Law and Ethics in 2002.

She retains a clinical attachment there with a special interest in altruistic organ donation. As Lead Nurse for
Living Donation within NHS Blood & Transplant (NHSBT) she has led on the development of UK Strategy for
Living Donor Kidney Transplantation. She is an active member of the British Transplantation Society (BTS),
having Co-Chaired the Living Donor Transplantation Forum since it was established in 2004 and served on Council and the Ethics
Committee. She is a member of the BTS Standards Committee, through which she has co-edited and published best practice guidelines
in areas of donation and transplantation practice. Within the European Society for Organ Transplantation (ESOT), she Chairs the European
Donation and Transplant Co-ordination Organisation (EDTCO) and is a member of the living organ donation working group within the
Ethical, Legal and Psychological Aspects of Transplantation (ELPAT).

She is a member of the Human Tissue Authority Transplantation Advisory Group and supports the training and development of healthcare
professionals in organ donation and transplantation in a variety of national and international settings. She was awarded a fellowship of
the British Renal Society in May 2012.

12
 Rosalind Campbell
Renal Dietitian, Dietetics Department, Central Manchester University Hospitals NHS Foundation Trust,
Manchester

Rosalind studied at Queen Margaret University College, Edinburgh and is a Registered Dietitian with the
Health Professionals Council and a Member of the British Dietetic Association.

She is Clinical dietetic lead at the Hospital for encapsulating peritoneal sclerosis (EPS) and renal parenteral
nutrition (TPN). She carries out clinical supervision and appraisal of other Dietitians and manages team
workloads and student training.

She is a member of renal nutrition group (RNG) and has not only has she published extensively, she has also presented at Conferences
worldwide

Fergus J Caskey
Having graduated from the University of Glasgow in 1993, Fergus went on to obtain a Masters in Public
Health and Health Services Research and then an MD in the Cost-effectiveness of Dialysis in Europe from
the University of Aberdeen.

He became a Consultant Nephrologist in Bristol in 2005 and was appointed Medical Director of the UK
Renal Registry in 2013.

His research interests include the epidemiology of CKD and ESRD, equity in the provision of healthcare and
patient reported outcomes.

Dr Jamie Coleman
Senior Lecturer in Clinical Pharmacology, University of Birmingham and Honorary Consultant
Physician, University Hospitals Birmingham NHS Foundation Trust

Dr Coleman obtained his MBChB and MD at the University of Birmingham and has been on the faculty there
since 2009 holding a competitively HEFCE funded senior clinical lectureship. He is deputy programme lead
for the medical degree programme and has an extensive portfolio of teaching and research activities. His
current NHS post involves directing the clinical pharmacology input into the electronic prescribing system
of a large teaching hospital in Birmingham and he is also the co-principal investigator of an NIHR-funded
programme grant investigating the use of electronic prescribing systems in hospitals in England (see
http://www.eprescribingtoolkit.com/ for details).

One of his main interests is in using computerised data to optimize prescribing practice and medicines management.

Professor Helen M Colhoun

Professor Colhoun is an internationally acknowledged expert in the field of diabetes and its complications. In her research she uses large
scale epidemiological approaches to i) understand the determinants and pathogenesis of diabetic complications ii) study the response
to treatments and safety of treatments in diabetes and iii) contribute to the development of new treatments in diabetes.
She has previously held full tenure professorial posts at the University College London and University College Dublin.

Supported by a large support group, her current research programme includes:

• Discovery and validation studies for biomarkers of diabetic complications.
• Clinical trials in diabetes patients.
• Studies that utilise large scale national datasets to explore diabetes epidemiology including the detection of unexpected adverse
and beneficial drug effects.
• Large-scale genetic epidemiology studies.

Professor Colhoun has received a number of very significant Grant awards, she has published extensively and is a world wide renowned
invited speaker.

Bryan Conway
Scottish Senior Clinical Fellow, BHF/University of Edinburgh, Centre for Cardiovascular Science and Honorary Consultant
Nephrologist, Royal Infirmary, Edinburgh

Bryan was awarded a Scottish Senior Clinical Fellowship in 2012 and was presented with the Raine Award for outstanding young
researcher by the UK Renal Association in 2008.

He is an active member of the UK Renal Association, the Scottish Renal Association, the American Society of Nephrology and the
European Diabetic Nephropathy Study Group. Bryan has acted as a referee for several journals including: Kidney International, The
American Journal of Kidney Disease, Nephrology Dialysis Transplantation and the American Journal of Hypertension.

He is also a reviewer of program grants for the Wellcome Trust and Medical Research Council. Bryan has published extensively.

13
 Prof Adrian Covic
Professor of Nephrology and Internal Medicine at the “Grigore T. Popa” University of Medicine and
Pharmacy and the Director of the Nephrology Clinic and the Dialysis and Transplantation Center in
Iasi, Romania

Prof. Covic started his clinical and research activity as a fellow in Nephrology in Manchester and Amiens.
Later he performed clinical research at the Case Western University in Cleveland, Ohio. He received a Ph.D.
on cardiovascular abnormalities and its determinant factors in chronic renal failure in 1997. Since 2007, he
is a FRCP (London) and became in 2009 a member of the Romanian Academy of Medical Sciences. From
2011 he is also a Fellow of the ERA EDTA (FERA).He is also Vice-Rector of the University of Medicine
“Gr. T. POPA” Iasi, Romania.

He is an Associate Editor for NDT, and Editor in Chief (Nephrology) for the International Journal of Urology and Nephrology, and editor /
reviewer for several prestigious journals. His main areas of interest are: cardiovascular complications in renal disease, renal anaemia, CKD-
MBD, peritoneal dialysis, and acute renal failure.

Prof. Covic is the president of Romanian Society of Nephrology and a board member of KDIGO, ERBP, ERA-EDTA working group -
EURECAM and ISN/COMGAN.

Prof. Covic published more than 370 original and review papers in peer-reviewed journals, 14 books and 22 chapters.

Dr Richard Coward
MRC Senior Clinical Fellow, Reader and Consultant Paediatric Nephrologist, Bristol Children’s
Hospital and Bristol University

Richard is currently:
• Head of Research for the school of Clinical Sciences Bristol University (approximately 350 members of staff
and over 120 postgraduate doctoral research students)
• Research lead for the British Association of Paediatric Nephrology
• Chair of the Paediatric Nephrology Clinical study group (CSG)
• Joint lead for the INSPIRE scheme for medical students in the University of Bristol

He has been a Member of the Royal College of Paediatrics and Child Health (MRCPCH) since 1995. Over the last 5 years, Richard has
received significant Grant awards from Kidney Research UK, the Medical Research Council and Diabetes UK.

He has numerous Peer reviewed publications and is invited to speak Worldwide.

Christopher J Deighan
Consultant Nephrologist, Glasgow Renal & Transplant Unit, NHS Greater Glasgow & Clyde

Christopher has been a Consultant Physician in the Glasgow Renal & Transplant Unit based at Glasgow
Royal Infirmary and now Glasgow Western Infirmary for over 14 years. He graduated from the University of
Glasgow Medical School in 1989 and completed his postgraduate training in Nephrology and General
Medicine in the West of Scotland, gaining his CCST in 2000.

During this time he undertook research in the field of lipoprotein metabolism, completing his MD thesis on
The Atherogenic Lipoprotein Phenotype in Renal Disease.

He was appointed Clinical Director with responsibility for Renal Services (Nephrology and Renal Transplantation) in November 2009. He
has served on the end-points committee for the AURORA multicentre international trial of rosuvastatin in end stage renal failure.
His main publications have been in the fields of lipid & lipoprotein metabolism and proteinura & albuminuria.

Mirela Delibegovic
Senior Research Fellow, University of Aberdeen School of Medical Sciences

Mirela gained her PhD in Biochemistry, MRC Protein Phosphorylation Unit, Dundee and her BSc in Biological
Sciences with Honours in Pharmacology, at the University of Edinburgh. She is an elected member of several
professional bodies including the European Association for the Study of Diabetes (EASD).

From 2007- 2012, she was the Group Leader/Research Councils UK (RCUK) 5-year tenure-track Fellow,
investigating molecular aspects of ageing and obesity in animal models.

Mirela has won numerous Grant awards and is principal investigator on a project grant awarded by the
British Heart Foundation Project
Mirela has travelled the World speaking and she has published extensively.

14
 Dr Laura Denby
Research Fellow, BHF Cardiovascular Research Centre, University of Glasgow

She was awarded her PhD in 2004 at the University of Glasgow, MRC funded. Entitled Gene Therapy for
Cardiovascular Disease.

Laura was also selected to give an oral presentation at the Renal Association’s Young Renal Scientist Award
Session for outstanding renal research performed by young renal basic scientists in 2007 and 2001.

She is a member of the External Referee Panel for Kidney Research UK and has reviewed grant applications
as an expert reviewer for the Portuguese Foundation for Science and Technology and OTKA (Hungarian
Scientific Research Fund.

She also reviews publications for journals including Molecular Therapy, NDT, Journal of Gene Medicine, Journal of Virological Methods,
Molecular & Cellular Endocrinology. Laura has received significant Grant awards and has published extensively

Olivier Devuyst
MD, PhD, is Full Professor in the Institute of Physiology of the UZH and invited Professor at the
Université catholique de Louvain (UCL) Medical School in Brussels, Belgium.

He has a joint appointment in the Division of Nephrology of the USZ in Zurich and the Saint-Luc Academic
Hospital in Brussels. Dr. Devuyst and his group investigate the molecular mechanisms of the transport of
water and solutes across epithelia, and the pathophysiology of inherited renal tubular diseases and their
progression. He also launched a systematic approach of the molecular mechanisms involved in the transport
of water and solutes across the peritoneal membrane, which is relevant to understand - and hopefully
improve- peritoneal dialysis.

These studies, which have generated 18 PhD theses and more than 240 peer-reviewed articles, are funded
by national and international agencies, including the European Union (FP6, FP7), the Baxter Extramural Foundation and the Cystinosis
Research Foundation (USA).

Dr. Devuyst has given more than 160 invited lectures and has been the laureate of several international prizes (including the Galien Prize
in 2003, the International Spa Foundation Prize in 2007, and the Prix de la Fondation du Rein in 2009). He has been elected at the Royal
Academy of Medicine of Belgium in 2005.

Dr. Devuyst is Associate Editor of Peritoneal Dialysis International, Nephrology Dialysis Transplantation, Nephron Physiology, and Frontiers
in Physiology, and he serves in the Editorial Board of Kidney International, Pflügers Archiv and Frontiers in Renal and Epithelial Physiology.

Anthony Dorling
Professor of Transplant Inflammation and Repair, Honorary Consultant in Renal Medicine and Head of Innate Immunity Section,
Division of Transplantation Immunology and Mucosal Biology, MRC Centre for Transplantation, King’s College London & Guy’s
Hospital, London

Anthony has held posts and lectured in several London Hospitals, including holding the post of Reader, Dept of Immunology, Imperial
College London and Honorary Consultant, Division of Medicine, Hammersmith Hospital from 2005- 2009.He is currently a Member of
Faculty on the International Advisory Committee for the World Transplant Congress and is also Co-chair for Innate Immunity; Chemokines,
Cytokines Abstract Review Committee, World Transplant Congress

Anthony has been involved in obtaining major Research Grants for over 20 years.
The latest two are:
• NIHR/MRC EME Programme Grant. 1/4/13 – 31/3/13 - Optimized TacrolimuS and MMF for HLA Antibodies after Renal Transplantation
(The OuTSMART study) A randomized controlled clinical trial to determine if a combined screening/treatment programme can prevent
premature failure of renal transplants due to chronic rejection in patients with HLA antibodies
• Wellcome Trust Translation Award 30/4/13 – 29/05/15. Development of a cytotopically-modified antithrombotic agent for prevention
of acute intra-graft thrombosis in transplantation
Anthony has published extensively.

Gavin Dreyer
Renal SpR, Royal Free Hospital, London

Gavin was awarded an Amgen Bursary in 2008 and a British Renal Society Grant Award in 2009 for research
into the effect of vitamin D on the microcirculation of patients with chronic kidney disease.

He has published extensively and has been awarded several significant grants including two funded by the
Southern African Consortium for Research Excellence (SACORE).

He has written Book chapters Renal Disease in Africa from Medicine in Africa (Edited by E. Parry) – chapter
co-author The Clinical book. Medical handbook, department of medicine, QECH, Malawi – chapter author for Kidney Disease

15
 Richard Fluck
National Clinical Director (Renal), NHS England and Consultant Nephrologist, Royal Derby Hospital

Richard Fluck trained at Trinity Hall, Cambridge and the London Hospital Medical College, qualifying in 1985.
Early training was undertaken in the East London area before moving into research at St Bartholomew's
Hospital. He was appointed a British Heart Foundation fellow whilst exploring the link between
cardiovascular disease, calcium signalling and abnormalities of calcium metabolism in chronic kidney
disease. He returned to the Royal London Hospital as Lecturer and honorary Senior Registrar in Nephrology.
In 1996 he took up post at Derby City Hospital as a single handed nephrologist. Over the next decade, the
department expanded and developed a strong clinical research and safety programme. As a whole, the
department has interests in cardiovascular consequences of CKD and dialysis, infection and vascular
access. As part of the team, he is involved in the coordination of two cohort studies looking at chronic kidney
disease in primary care (RRID) and the short and long term consequences of acute kidney injury (ARID). More recent projects include
the development of PROMs for renal patients and enhancing home therapies for patients on dialysis.

Within the acute trust he has been clinical lead for renal disease for 15 years and clinical director for medicine. He has been the clinical
lead for the East Midlands Renal Network and worked with the DH and HPA on infection in renal disease. He was also the clinical lead
for the KidneyCare National audit on vascular access and transport in the haemodialysis population. In April 2013 he was appointed as
National Clinical Director (renal) at NHS England.

Until September 2013 he was President of the British Renal Society and chair of the Kidney Alliance. He sits on the UK Renal Registry
Board, is the UK country co-investigator for the Dialysis Outcomes and Practice Patterns Study (DOPPS) and is on the editorial board
of Nephron. In 2007, he led the renal team at Derby that won the Renal Team of the year award, given by Hospital Doctor and the
following year received the Health and Social care award for safety in patient care.

Samuel "Sam" Galbraith

Samuel "Sam" Galbraith was born in Clitheroe, Lancashire. He attended Greenock High School and then
Glasgow University, where he received honours in medicine. He is married, the father of three daughters. In
prior years he was an avid mountaineer. As a consultant neurosurgeon, Mr Galbraith was recognised as a
world-class surgeon, he left his role as a surgeon and embarked on a political career. At the 1987 general
election, he was returned as Member of Parliament for the Strathkelvin and Bearsden constituency, and
held the seat until standing down at the 2001 general election. He announced his resignation on 20 March
2001 due to reasons of health.

As Minister for Health in the Scottish Office (1997 – 1999) Mr Galbraith used his personal insight as both a
doctor and as a patient, to shape radical change in the NHS. He served as Minister for Children and
Education in the Scottish Executive under Donald Dewar from 1999 to 2000 and then, as Minister for Environment, Sport and Culture
under Henry McLeish.

“Sam Galbraith has served patients for thirty years, first as a respected neurosurgeon then as an MP, an MSP and a Minister. Sam was
driven by his passion for social justice and his great contribution will be the recognition that ill-health and poverty go hand in hand.
Before Sam took office, Government had resisted recognising that well-understood link. Its acceptance will, in time, prove to be a pivotal
moment in the battle to improve Scotland’s health.” Dr John Garner, Chairman of BMA Scottish Council.

Sam received a lung transplant, in 1990 (age 45), due to fibrosing alveolitis (the same condition affected his sister who died a year after
she’d had a transplant). He is believed to be the world’s longest-surviving lung transplant patient.
Since 2006 he has been an energetic chairman of the Scottish Maritime Museum

Maria Da Silva-Gane, MSc

Lead Clinical Counsellor; Visiting Research Fellow University of Hertfordshire
East & North Herts Trust, Lister Hospital, Stevenage, Hertfordshire

Maria is the Lead Clinical Counsellor and she has worked in the renal team since 1991. During this time she has contributed to various
developments, including the development of the psychosocial team, supportive care pathways and research.

She has been involved with BRS over many years in different roles and currently is a Research for Renal committee member.
Maria will be presenting the prestigious Donna Lamping MDT Researcher Lecture on Thursday at 16.00.

Tim Goodship
Professor of Renal Medicine at Newcastle University and Consultant Nephrologist, Newcastle upon
Tyne Hospitals NHS Foundation Trust.

Tim has a long-standing interest in complement and renal disease. With his wife, Professor Judith Goodship,
he was the first to identify genetic abnormalities in complement in atypical haemolytic uraemic syndrome
(aHUS) in the 1990s.

Subsequently their team has gone on to discover other inherited and acquired abnormalities in complement
in individuals with this disease.

Tim is the Director of the interim NHS England national service for aHUS and Chairman of the Board of Trustees of Kidney Research UK.

16
 Dr Roger Greenwood
Consultant Nephrologist, Lister Hospital, Stevenage

Following a first career in aeronautical engineering Roger graduated in medicine from Bristol, UK, in 1976.
After training in Manchester and London (Barts) he moved to Stevenage in 1988 to establish a new renal unit
(Lister) where he was Clinical Director of Renal Services for 20 years. He continues as Consultant
Nephrologist in the NHS.

His main areas of interest in clinical research and service development include HDF, self-care home HD,
non-dialytic conservative management and end-of-life issues.

Dr Greenwood was President of the British Renal Society (1997-2000), Chairman of the Kidney Alliance (2003-2007) and a member of
the External Reference Group of the Renal National Service Framework (2001-2004).
He is currently a member of the national Clinical Reference Group (dialysis) advising NHS England on the transition of Specialised
Services Commissioning into new NHS structures.

Sharlene Greenwood
Sharlene Greenwood is the Lead Renal Physiotherapist and a National Institute of Health Research (NIHR)
doctoral research fellow at King’s College Hospital, London, U.K, the chair of the British Renal Society
Rehabilitation Network, and the U.K representative on the Canadian Renal Rehabilitation Network.

Sharlene is currently pursuing a PhD exploring the role of renal rehabilitation for patients with Chronic Kidney
Disease across the disease trajectory, and through her role at the BRS, is supporting and encouraging the
national implementation of exercise services for patients with Chronic Kidney Disease.

Kathryn E Griffith
GP principal with Unity Health in York and a GP specialist in Cardiology at York Teaching Hospital FT.

Kathryn completed her GPSI training in Bradford and is now a senior clinical tutor on the Cardiovascular
Diploma course.

She achieved her Masters in Postgraduate Cardiology with a dissertation on the links between CVD and CKD
in primary care and became a member of the Renal Advisory Group at the Department of Health.

She was a member of the Consensus Panel of the Royal College of Physicians in Edinburgh developing the
Consensus Statements on Early Chronic Kidney Disease in 2007, which proposed the division of CKD stage 3 into 2 sub groups. She
was a member of the KDIGO Guideline Development Group for the Update of the CKD Guideline, which was published in 2012 focusing
particularly on the section on CKD and CVD.

She is now a member of the NICE CKD and Anaemia in Kidney Disease Guideline Update Groups. In 2013 she was appointed the RCGP
Clinical Champion for Kidney Care and is tasked with improving the understanding and management of CKD and AKI in the community.
Kathryn is the chair of the HQIP National CKD Audit Project Board and a member of the National AKI Work stream.

Matthew Hall
Consultant Nephrologist and Honorary Lecturer, School of Biomedical Sciences, Nottingham
University

Matthew gained his BA in Physiology, BA of Medicine and MA at Cambridge University and Doctor of
Medicine at the University of Leicester. He has received numerous awards including an Abstract award at
the Renal Association Annual Conference, Manchester in 2010. He is a member of several Societies, a Fellow
of the Higher Education Academy and Member of the Royal College of Physicians. Matthew has published
extensively on Renal Disease in pregnancy and lectured in Europe and the USA. He runs competitively,
having completed five marathons and eighteen half marathons, and is an accomplished musician

Thomas Francois Hiemstra

NIHR Research Fellow, Cambridge Clinical Trials Unit and Honorary Consultant Nephrologist,
Addenbrooke’s Hospital

Thomas trained in Nephrology at Edinburgh Royal Infirmary and Addenbrooke’s Hospital, Cambridge.
In 2011 Thomas was awarded Best Abstract, British Renal Association and First prize for Graduate Research
at the Graduate School of Life Sciences Symposium.

He was a Clinical lecturer in translational medicine and therapeutics from January 2012- October 2013
In 2014, he has been awarded the prestigious AE Raine Award.
Thomas has published extensively.

17
 Keith Hodkinson
Chairman, Lay Advisory Committee, Kidney Research UK

Keith is the Chairman of the Scottish Kidney Federation and retired in 2004 as a Director after almost 40 years
in Banking. His career in Banking encompassed Branches, Audit, International, Credit and Retail Banking.

He has been a Renal patient for some 15 years with polycystic kidneys and after a period on dialysis received
a kidney transplant in 2008.

Peter Hohenstein
Group Leader, Roslin Institute, University of Edinburgh

Postdoctoral fellow MRC Human Genetics Unit, Edinburgh from 2001- 2007 and then until 2012, a Senior
Investigative Scientist.
Peter was awarded his PHD at Leiden University Medical Center in the Netherlands.

The research of his group within the laboratory of Professor Nick Hastie has focused on the role of Wt1 in
kidney development, Wilms’ tumours and breast cancer. Peter has shown that Wt1 has different roles in
different stages of kidney development.

He has published extensively and contributed to several books including Geller, J.I. and Hohenstein, P. Molecular Targeted Therapy for
Pediatric Renal Tumors, which is expected this year

Dr Helen Hopkinson
Consultant in general medicine and diabetes and endocrinology, Victoria Infirmary Glasgow.

She has an interest in patient education that led to her involvement with the national UK DAFNE (dose adjustment for normal eating)
organisation that provides training for healthcare professional and people with type 1 diabetes in intensive insulin self-management.

Helen became the chair of the Executive Board of UK DAFNE in 2011. The DAFNE Collaborative has extensive experience in the national
administration of a quality assured, peer-reviewed and audited education programme. DAFNE is recognised by NHS England as a highly
cost effective intervention by QIPP (the quality innovation productivity and prevention collection on the NHS evidence database).

Stephen Hughes
Specialist Clinical Pharmacist, Central Manchester Foundation Trust, Manchester

Stephen’s main clinical and educational interests lie within autoimmune kidney diseases, transplant
immunology, pharmacokinetics in renal dysfunction and antimicrobial therapies.

He has completed his clinical research masters on de novo DSA production in long-term transplant recipients
and how maintenance anti-suppressant therapies affect graft outcomes.

He had published on SLE management in the past and contributed to textbooks on this subject. Other
publications interests include gout management and anticoagulation in ESRD.

Publications include: Systemic lupus erythematosus; Clinical features and diagnosis. N Brown, S Hughes.
Clinical Pharmacist 2012;7:74. Systemic lupus erythematosus; Management. S Hughes, N Brown, M Vincent. Clinical Pharmacist
2012;7:79

Professor Chris Isles

Consultant Physician and Nephrologist (semi-retired), Dumfries Infirmary, Scotland

Chris has been a Consultant Physician for 25 years and has a keen interest in teaching and Clinical research.

He has published numerous papers including WOSCOPS, one of the early trials on statins.

18
 Kitty Jager
Associate Professor and Principle Investigator in the Academic Medical Center, Amsterdam.

As a clinical epidemiologist she has been the Director of the ERA-EDTA Registry for 14 years, has
participated as project leader in a number of EU funded projects and has published 200 papers in the area
of nephrology.

Kitty is the Editorial Board of Nephrology Dialysis Transplantation and she is responsible for an educational
paper series on the subject of Clinical Epidemiology in Nephrology.

Professor Vivekanand Jha (MBBS, MD, DM, PhD, FRCP, FAMS)

Executive Director, George Center for Global Health India, and a Professor of Nephrology at University
of Oxford.

He has been a Professor of Nephrology and Head of the Department of Translational Regenerative Medicine
at the Postgraduate Institute of Medical Education and Research in Chandigarh.

Vivekanand Jha graduated from Patna Medical College, did his postgraduate training in Medicine and
Nephrology from the Postgraduate Institute of Medical Education and Research (PGI), Chandigarh, India
and a basic science research Fellowship at the Beth Israel Deaconess Medical Center, Boston.

He is currently Secretary of the Indian Society of Nephrology, Councilor of International Society of Nephrology, Councilor of the
Transplantation Society, Executive Committee member of the Asian Pacific Society of Nephrology and Asian Forum of Chronic Kidney
Disease Initiative.

He is a past member of Board of Directors of the Kidney Disease Improving Global Outcomes and a member of KDIGO Guideline
Development groups for management of kidney transplant recipients and patients with glomerulonephritis, member of several Task
Forces and Expert Committees of the Department of Biotechnology and Indian Council of Medical Research and Review panel of
international funding organizations.

He has over 220 publications in peer-reviewed journals and 30 chapters in major textbooks. Dr Jha has been elected a Fellow of the Royal
college of Physicians (London) and the National Academy of Medical Sciences (India).

Lina Johansson
NIHR Clinical Lecturer/ Renal Dietetic Lead, Imperial College Healthcare NHS Trust

Lina is the Renal Dietetic lead for Imperial College Healthcare NHS Trust. She has recently been awarded
an NIHR Clinical Lectureship to investigate improving outcomes (nutritional, medical and patient focused)
in older people who are approaching end stage renal disease.

Lina was awarded a PhD by Imperial College London in July 2012. The body of work was entitled
“Broadening Options for Long-term Dialysis in the Elderly (BOLDE)” and was supported by Kidney Research
UK. This focused on quality of life, nutrition, cognitive function and dialysis modality decision-making in older
people.

Recent publications are in the fields of renal nutrition in older people; quality of life on dialysis and shared decision making in dialysis
modality decisions.

Dr. Elaine Christina Jolly

Clinical Research Fellow and Specialist Registrar in Nephrology and Transplantation, Addenbrooke’s Hospital, Cambridge

Elaine is the Clinical supervisor and OSCE Examiner for medical students at the Clinical School, University of Cambridge.
She gained her MBChB (Hons) University of Glasgow and BSc. Hons (First Class) at University College London.
In 2009 she was awarded an Evelyn Trust Fellowship to investigate “Transcriptional changes associated with Graft Dysfunction in Renal
Transplant Patients

In 2012 she was the Athena SWAN champion for the Department of Medicine, Cambridge.
Elaine has presented worldwide and has published extensively.

19
 Professor Philip Kalra
Consultant Nephrologist, Salford Royal NHS Foundation Trust and Honorary Professor at the
University of Manchester.

Professor Philip Kalra graduated from Cambridge University and is lead of the renal research team at Salford
with major research interests in atherosclerotic renovascular disease and cardiovascular disease in CKD.

He is chair of the National Renal speciality group of the NIHR clinical trials network. He has been involved
in development of several large UK clinical trials in nephrology and cardiology and has played a role in
amalgamating Cardio-Renal education and research within the UK.

He has been involved in Postgraduate Nephrology education for over 2 decades and is editor of a popular
textbook used in preparing for the MRCP.

Dr Liz Lightstone
Reader in Renal Medicine, Imperial College London
And Honorary Consultant Physician, Imperial College Healthcare NHS Trust Renal and Transplant
Centre, Hammersmith Hospital

Liz has a long standing interest in renal disease and pregnancy. She established the Renal Obstetric clinic
in 1996 and now has her practice embedded in the high-risk obstetric medical service at Queen Charlottes
and has managed >600 women over the last 16 years. She was a founder member of the Collaborative
Obstetric Renal Database group (The CORD group) which has now matured into the national Pregnancy and
Chronic Kidney Disease Rare Disease group, of which Liz is the inaugural National Coordinator. She has
published on preparation for and management of women with kidney disease, is undertaking research into
identifying novel prognostic marker in such pregnancies and evaluating novel therapeutic strategies.

Her other main interest is in lupus nephritis – together with Renal and Rheumatology colleagues she manages a cohort of over 300
patients with lupus nephritis at the Imperial College Lupus Centre. She is chief investigator of the RITUXILUP randomised controlled
trial evaluating a rituximab based oral steroid-free treatment regimen, and has published on biomarkers, outcomes and novel therapeutic
approaches. She is on the peer review panel of LUPUS UK, and on the EU executive of the Lupus Nephritis Trials Network.

Elizabeth Lindley
Elizabeth is a Specialist Clinical Scientist working in the Department of Renal Medicine at the Leeds Teaching
Hospitals NHS Trust and a facilitator for the UK Renal Technology course in Bradford. She has PhD Physics
and a Postgraduate Diploma in Health Research and has worked in the field of Nephrology for 15 years.

She is currently moderator of the RenalPro e-mail discussion forum for renal care professionals and a
member of the ERA’s European Renal Best Practice Advisory Board and the UK Renal Association’s Clinical
Practice Guidelines committee.

Dr Melvin Lobo
Consultant Physician and Clinical Hypertension Specialist, Barts Health Trust. Hon Senior Lecturer,
NIHR Barts CV BRU, William Harvey Research Institute, Queen Mary University, London

Dr Lobo is the Director of the internationally renowned Bart's and The London Hypertension Clinic which has
been recognised as a Hypertension Centre of Excellence by the European Society of Hypertension and
receives referrals of complex hypertensive patients on a national and international basis. The clinic is allied
to the world renowned William Harvey Research Institute and has participated in several landmark studies
in hypertension. Since October 2011 he has co-hosted and chaired the annual UK Symposia on Renal
Denervation at the Royal College of Physicians with a distinguished panel of international authorities in
hypertension medicine and interventionists.

Dr Lobo has been awarded a significant grant (from the Barts and The London Charitable Foundation) to study the effects of renal
denervation on blood pressure and autonomic function in patients with chronic kidney disease and patients who are intolerant of anti-
hypertensive medications. He has published extensively.

20
 Fiona Loud
Fiona Loud is Policy Director of The British Kidney Patient Association, a national charity which supports
people and their families affected by kidney disease with advice, grant aid, research and funding for multi-
disciplinary healthcare professionals. It is the biggest source of grant aid in the UK for kidney patients.

She is co-author of Kidney Health: Delivering Excellence on behalf of 7 national charities, which has
developed a series of ambitions to improve kidney care. She was Director, and previously Chair of the former
Kidney Alliance and has worked closely with all the main patient and professional kidney organisations in
the UK.

She works to promote prevention and early identification of kidney disease, and high quality treatment for
all patients at risk from or identified with kidney failure. She meets and works with policymakers and Parliamentarians to inform and
influence the development and implementation of Government policy relating to kidney care. She has been and is on a number of NICE
Guideline Development and Topic Expert Groups.

Fiona is lay chair of the local Organ Donation Committee for West Hertfordshire. She is also chair of her local Kidney Patient Association.
She works to promote kidney health and awareness wherever possible including in the media and in educational DVDs. She uses her
experience of kidney disease to inform her work. Fiona spent 5 years on dialysis after her kidneys failed before receiving a transplant
from her husband seven years ago. Her background is in IT management, software support and development and project management;
it includes IT training and e-learning. She has a degree in English.

Kidney Health: Delivering Excellence is on http://britishrenal.org/kidney-health.aspx

Neil MacGowan
Head of Operations, Scottish Qualifications Authority

Neil is an Honours graduate in Business Studies from Napier University, Edinburgh. He was a member of
the SQA Board between 2002 and 2005 and has spent his entire career in educational administration.

At the creation of the Scottish Vocational Education Council (SCOTVEC), Neil was appointed Committee
Secretary, responsible for the operations of the Board and senior committees and providing support to the
Chief Executive and Chairman, eventually becoming Head of Administrative Services. At the formation of
SQA in 1997, Neil took on the role of Head of Higher Still Implementation and was responsible for all aspects
of the implementation of the new National Qualifications system. Neil then moved into the post of Head of
Customer Relations and Marketing and then on to become the Head of the Chief Executive Department.

Neil is currently now Head of Operations with responsibility for all logistics and customer engagement to support the introduction of
Scotland’s new qualifications system.

Helen MacLaughlin
Lead Renal Dietitian, King’s College Hospital

Helen gained her B Health Sc (Nutrition and Dietetics) (Hons IIA) at the Queensland University of Technology
in Australia. From 2009-2013, she was a Doctoral Research Fellow at King’s College London gaining her
PhD with her Thesis topic: “Weight loss interventions in obese patients with chronic kidney disease”.

In 2012, she won the King’s College London School of Medicine Postgraduate Research Showcase Poster
Prize and also the British Dietetic Association General Education Trust Award of a Travel Bursary to attend
the 16th International Congress of Dietetics in Sydney, Australia.

She has been awarded numerous Grants including the most recent, King’s Health Partners Challenge as co-
investigator in “Obesity in patients with chronic kidney disease: feasibility of intra-gastric balloon treatment”.
She has published extensively and presented at the American Society of Nephrology Kidney Week, 2013.

Patrick B Mark
Patrick Is an academic Nephrologist, with the focus of his work on the cardiovascular complications of chronic kidney disease and novel
applications of imaging in renal disease and hypertension. He was appointed as a Clinical Senior Lecturer at the University of Glasgow
in 2011.

Patrick is undertaking a number of clinical studies examining renin-angiotensin-aldosterone system regulation and oxidative stress in CKD
as well as running a large epidemiological study looking at risk factors for diabetic kidney disease.

He also leads the West of Scotland Academic Foundation Programme and his work is funded by the British Heart Foundation and Kidney
Research UK
Patrick has been in the field of Nephrology for 11 years and has published extensively.

21
 Philip David Mason
Consultant Nephrologist and Renal Clinical lead, Oxford Kidney Unit, Churchill Hospital, Oxford.

Philip qualified from Guy’s Hospital in 1979 and after several junior posts trained in immunology, nephrology
and transplantation at the Hammersmith Hospital in London and was appointed senior lecturer in 1994.

He moved to Oxford as consultant nephrologist in 1995. His particular interests are lupus, vasculitis and
transplantation and he established the ABO and HLA antibody incompatible transplant programme in Oxford.

Philip is a member of the Clinical Reference Group for transplantation and sits on the Kidney Advisory Board
of NHSBT ODT.

Dr David V Milford
Consultant Paediatric Nephrologist, The Children's Hospital, Birmingham and Honorary Senior Clinical Lecturer, University of
Birmingham.
Elected Fellow of the Royal College of Physicians 1st May 1997 and Fellow of the Royal College of Paediatrics and Child Health.
David has been Chair of BAPN Clinical Guidelines and Standards Committee from Oct 2009 – Oct 2013 and is also currently Chair of
the West Midlands Renal Network.
Some of the other posts he has held:
Regional Representative on RCPCH Council June 1997-April 2000
Clinical Director – Orthopaedics, General Surgery, Plastic Surgery, Burns, Urology, Nephrology. 1st July 2003 – 30th June 2005
Clinical Director Orthopaedics, General Surgery, Plastic Surgery, Burns, Urology, Nephrology, ENT, Ophthalmology, Dental, Maxillofacial,
Cleft lip and palate 1st July 2005 – June 2006
David has published over 100 original publications and letters in peer reviewed journals and is author of four invited chapters in textbooks.
He has presented over 90 lectures at local, national or international meetings.

Professor Donal O’Donoghue, BSc, MBChB, FRCP

Consultant Renal Physician, Salford
Royal Foundation Trust, Honorary Professor in Renal Medicine, University of Manchester

Donal has been a Consultant Renal Physician at Salford Royal since 1992 and is also Professor of Renal
Medicine at the University of Manchester. He was inaugural President of the multiprofessional British Renal
Society, Treasurer then President elect of the Renal Association and became the first National Clinical
Director of Kidney Care at the Department of Health from 2007 – 2013.
Donal is a practicing kidney doctor, active researcher and in addition to his work for people with kidney
disease is Medical Director of the Greater Manchester Academic Health Science Network, Chair of the
Greater Manchester, Lancashire and South Cumbria Clinical Senate and a Governing Body Member of
Liverpool Clinical Commissioning Group.
With his colleagues, Donal provides a comprehensive kidney care service for a catchment population of 1.5 million from Salford Royal
and their six sister hospitals. During that time the service has grown from a satellite local service to one of the highest profile kidney
services in the UK, with a reputation for multi-professional working, measuring quality and modernising care.

Patricia Lynn Painter

Research Associate Professor, Department of Physical Therapy, University of Utah and Adjunct Faculty, School of Medicine,
Division of Nephrology, University of Utah, USA
The focus of Patricia’s research career has been in the application of exercise physiology in clinical populations, specifically in patients
with end-stage renal disease (ESRD) – both dialysis and transplant.
Her research studies have used various outcome measurements including measurement of oxygen uptake, physical performance testing
and health-related quality of life that includes self-reported physical functioning.
She has been a fellow and a member of the Board of the American College of Sports Medicine and received the distinguished service
award from the National Kidney Federation.
She is currently leading in two major research projects:
• Physical Activity and Functioning in Home Dialysis Patients
• Exercise Training to Reduce Claudication: Arm Ergometry vs. Treadmill Walking
Patricia has published extensively on Patient exercise and Physical activity.

Dr Hugh Rayner
Consultant Nephrologist, Dept of Renal Medicine, Birmingham Heartlands Hospital.
Between 2000 and 2009, Hugh was Medical Director for the Trust. After that he was appointed Clinical
Director for Birmingham East and North Primary Care Trust until 2012. He has returned to full time clinical
nephrology practice, focusing on improving outcomes for patients with CKD and on haemodialysis.
Hugh is UK Country Investigator for the Dialysis Outcomes and Practice Patterns Study and has published
a number of papers based upon analyses of DOPPS data. He is the author of the chapter about starting
dialysis in Comprehensive Clinical Nephrology.
He has published extensively and most recently: ‘Recovery time, Quality of Life and Mortality in
Haemodialysis Patients’ (DOPPS Study)
22
 Dan Ridgway
Dan completed undergraduate and postgraduate study at the University of Leicester Medical School; from
where he was award his Doctorate for research into apoptosis during pancreatic preservation and islet cell
isolation.

He has undertaken basic training in general surgery in the East Midlands and higher training in general
surgery and transplantation in Yorkshire.
He has completed fellowships in both surgical endocrinology and live donor nephrectomy in the Sheffield,
Manchester and Newcastle units.

Dan was appointed as consultant surgeon in 2012 at the Sir Peter Medawar Transplant Unit, Liverpool with
an interest in live donor transplantation, complex vascular access surgery and endocrine surgery.

Caroline Savage
Caroline is Head of the Experimental Medicine Unit within the ImmunoInflammation Therapy Area. She joined
GSK in July 2010 following a one year secondment from The University of Birmingham where she was
Professor of Nephrology and Director of the Wellcome Trust Clinical Research Facility.

She has a long-standing interest in pathogenic mechanisms of autoimmune and inflammatory diseases.
The strategic aim of the Experimental Medicine Unit is to expedite innovative approaches to early medicines
development through implementation of small studies that demonstrate whether a compound is safe, active
on its target and can lead to meaningful efficacy in patients.

Dr Rebecca Jo Suckling
Consultant Nephrologist, Epsom & St Helier NHS Trust

She was appointed to the above post in March 2011 and was awarded her PhD in November 2011.
Previously as an SpR in Renal Medicine, she has worked in Guys’ and St Thomas’ and Kings College, London and carried out independent
research into blood pressure, also carrying out recruitment and screening for Premium and ASTRAL studies.

Dr Suckling has received numerous grant awards including a Hypertension Trust Research Fellowship.
She is currently a Specialist advisor for the Blood Pressure Association and has published extensively.

Professor Charles Swanepoel

Assoc Prof, Senior Lecturer and a full-time Consultant Nephrologist in the Division of Nephrology and
Hypertension, Dept of Medicine, the University of Cape Town and Groote Schuur Hospital.

He graduated from UCT in 1973 and was awarded his MRCP (UK) in 1978. His FRCP (Edin) award came in
1994. He spent 2 years learning Nephrology while working as a renal registrar at the Leeds General Infirmary
under Dr Frank Parsons.

He returned to Cape Town and did a short spell as a Medical Registrar in Groote Schuur Hospital before
formally joining the team in the Renal Unit in 1981. He has remained there ever since involved in clinical
research, under-and postgraduate teaching and clinical work mainly in Nephrology but does stints in General
Medicine.

He is a member of the ISN and EDTA and a member of the ISN-ACCT (advisory committee on clinical trials, in developing and developed
countries). He has been an Editor of the SA Medicines Formulary and has co-authored chapters in books and has published in most of
the reputable nephrology journals. He is a subject Editor for Nephrology (Carlton) and has acted as a reviewer for various nephrology
journals.

Maarten W. Taal
Lead Clinician of the Renal Unit, Royal Derby Hospital and Professor in Medicine in the Division of
Medical Sciences and Graduate Entry Medicine, University of Nottingham.

Maarten has a career-long interest in Chronic Kidney Disease (CKD) and co-authored the Renal Association’s
Clinical Practice Guidelines for CKD. His current research is focused on the Renal Risk in Derby (RRID) study
which is investigating long-term outcomes in a large cohort of people with CKD in primary care.

He is Lead Editor for the 9th Edition of “Brenner and Rector’s The Kidney”, Section Editor for “Current
Opinions in Nephrology and Hypertension” and Deputy Editor of “Nephron Clinical Practice”.

Maarten’s other research interests include CKD progression, cardiovascular disease in CKD, CKD-MBD and
diabetic nephropathy.

23
 Professor Richard Thomson
Professor of Epidemiology and Public Health, Newcastle University

Professor Thomson leads the Decision Making and Organisation of Care Research Group within the Institute
of Health and Society at Newcastle University.

He is a Professor of Epidemiology and Public Health in IHS and Associate Dean for Patient and Public
Engagement for the Faculty of Medical Sciences.

His primary research interests are in shared decision making (SDM), patient safety and patient involvement.
Richard has been PI on many studies, most recently in development and evaluation of decision support, and
co-led two NIHR programme grants, one including SDM and hyperacute stroke, the other on involvement
of patients in patient safety.

He co-led the large programme on implementation of SDM (MAGIC – Making Good Decisions in Collaboration) with Glyn Elwyn in Cardiff,
supported by the Health Foundation. He has also acted as an advisor to the UK Renal Registry project on “Measuring Shared Decision-
Making in Chronic Kidney Care”.

Dr Laurie Tomlinson
Wellcome intermediate Clinical Fellow, London School of Hygiene and Tropical Medicine and honorary Consultant Nephrologist
at Brighton and Sussex University Hospitals NHS Trust.

Laurie lectured at Cambridge University for four years and is a Member of the steering group for the Renal Clinical Research Skills Forum,
Associate Editor of PLoS Medicine and Expert advisor to the Scientific Advisory Group, European Medicines Agency.

She is currently working on a project called “drug-associated acute kidney injury, who gets it, when and why?”

Her research focuses on the epidemiology of acute kidney injury in large population databases, and the role that infections and
medications play in its development. The aim is to develop primary care interventions to modify prescribing and to reduce the risk of this
important and serious condition.

Her other research interests concern the crossover between chronic kidney disease and cardiovascular disease. She has been involved
in many observational studies of arterial disease including setting up and running a cohort of people with CKD, examining the role that
measures of arterial health play in the development of renal disease progression and mortality.
Laurie has published extensively.

Charlie Tomson
Charlie has been a Consultant Kidney Specialist since 1991.
He has a strong interest in ways of improving the safety, effectiveness, and efficiency of care pathways for
kidney patients.

He has worked on clinical practice guidelines (for the Renal Association, Kidney Disease Improving Global
Outcomes, and European Renal Best Practice), quality improvement (as a Health Foundation Quality
Improvement Fellow at the Institute for Healthcare Improvement) and on measurement and reporting of the
quality of shared decision-making (at the UK Renal Registry).

Charlie was Chair of the UK Renal Registry in 2007-2010 and President of the Renal Association in 2010-
2012.

Professor Neil Turner

Professor of Nephrology, University of Edinburgh,
Hon Consultant in Renal Medicine, Edinburgh Royal Infirmary

Neil Turner has been Professor of Nephrology at the University of Edinburgh since 1998. After broad
experience of general medicine he worked in renal units in Oxford, Hammersmith and Aberdeen before
moving to Edinburgh. His first research was on autoimmunity and basement membrane biochemistry, more
recently proteinuria, and now his major research and clinical interests are in genetic diseases of the
glomerular basement membrane, and in paediatric-adult transition.

He has led the PatientView project, which gives 30,000 patients online access to live test results and
information about their disease and treatment, since its initiation in 2004. In the new Radar initiative it is
providing a platform for rare kidney disease registries, and he leads the UK Alport group.

He recently took up a lead role in undergraduate medical education in Edinburgh. In 2011 he founded an online postgraduate Masters
course in Internal Medicine in collaboration with the Royal College of Physicians of Edinburgh.

He is an author for Davidson’s Textbook of Medicine, and senior editor of the forthcoming 4th edition of the Oxford Textbook of Clinical
Nephrology.

24
 Wim Van Biesen
Professor of Nephrology at the Ghent University Hospital, Belgium.

He is author and co-author of more than 200 articles dealing with a wide variety of topics in nephrology
(peritoneal dialysis, haemodialysis, chronic kidney disease management), intensive care nephrology.

He is the actual chair of ERBP. He is also Subject Editor for dialysis for Nephrology, Dialysis and
Transplantation and is member of the editorial board of different other journals.

Wim is a regular reviewer of scientific papers for different journals on nephrology, intensive care and
epidemiology.

Adrian S Woolf
Professor of Paediatric Science, Institute of Human Development, Faculty of Medical and Human
Sciences, University of Manchester; Honorary Consultant, Royal Manchester Children’s Hospital and
Honorary Professor, University College London.

Adrian was a Trustee and Honorary Secretary of The Renal Association (2000-2004) and was Research
Secretary of the British Association for Paediatric Nephrology (2000-2002). He served on the Kidney
Research UK grants committee (1997-2002), and joined their Board of Trustees and Research Strategy
Group in 2012 and has academic responsibility for their Alumni programme.

Adrian is a clinician-scientist with a focus on finding out why some people are born with kidney and urinary
tract malformations. He runs a Renal Genetics clinic in the Royal Manchester Children’s Hospital. Making a
specific genetic diagnosis can provide a family with an answer to their often long-sought question “why was our child born with kidney
disease”. He takes part in a similar clinic, seeing Adults with genetic kidney problems, in the St. Mary’s Hospital.

He has supervised clinical and science students leading to 12 PhD, three MD, one MPhil and two MSc awarded theses.

Adrian has been awarded numerous grants, the two latest being Medical Research Council project Molecular bases of congenital bladder
diseases and Medical Research Council equipment grant In-vivo Imaging technologies to assess the efficacy and safety of regenerative
medicine therapies.

$ $
He has published over 120 original research publications and written numerous articles and chapters

$ $
BRS 2015$ $ $$
$$ $ $ $$
$ Save
$ $the$ dates:$ $ $$
Tuesday 30th
$ June - $Thursday $ 2nd
$ July$ $
Join the BRS at Leeds University for
multi professional education, research & service developments

25
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
Clinical Poster Abstracts by Category
AKI: Cause (Wednesday 30th April 13.30 – 14.30) moderated by Bisher Kawar
P1 AN AUDIT OF 21 YEARS OF INTERSTITIAL NEPHRITIS IN ONE CENTRE
Bray V1, Mathavakkannan S2, Warwicker P2,1,
1 P13
CMT, Luton and Dunstable Hospital FT ²Lister Renal Units, East and North Hertfordshire NHS
Trust
P2 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME ASSOCIATED WITH A CD46
MUTATION UNMASKED BY A SHIGELLA DIARRHOEAL ILLNESS
Brocklebank V1, Wong E2, Ward R3, Fielding R1, Goodship T1, 2, Kavanaugh D1,2
1 Cheshire S1, Williamson S1, Bentall A1,3, Clare S2, Al-Baaj F2, 3
Renal Services Centre, Freeman Hospital, Newcastle upon Tyne, 2The Institute of Genetic
Medicine, Newcastle University, Newcastle upon Tyne, 3Department of Immunology, Newcastle
upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
P3 REVIEW OF CONTRAST-INDUCED ACUTE KIDNEY INJURY (CI-AKI) PREVENTION
PROTOCOL IN AN OUTPATIENT COHORT AT OUR INSTITUTION
Chan V, Gibson M, Mohteshamzadeh M
Renal Unit and Radiology Department, Royal Berkshire NHS Foundation Trust, Reading
P4 AUDIT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AT A NORTH WEST OF ENGLAND
TERTIARY HOSPITAL
Frost H, Nipah R, Department of Acute Medicine, Salford Royal Hospital
P5 ACUTE RENAL FAILURE DUE TO PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA:
A CASE REPORT AND REVIEW OF THE LITERATURE
Graham J, McKeveney P, Department of Renal Medicine, Daisy Hill Hospital, Newry
26
P6 HOSPITAL ACQUIRED ACUTE KIDNEY INJURY OF PATIENTS WITH FRACTURE OF NECK OF
FEMUR AT THE HULL ROYAL INFIRMARY: RESULTS FROM A SINGLE CENTRE
RETROSPECTIVE CROSS-SECTIONAL STUDY
Jackson R, Mafi P, Hull York Medical School, Hull Royal Infirmary
P7 RENAL ARCUATE VEIN MICROTHOMBI – A NEW CLINICO-PATHOLOGICAL ENTITY CAUSING
ACUTE KIDNEY INJURY IN YOUNG ADULTS
Mamoud H1, Redfern A1, McCulloch T2, Shardlow A1, Hall M3, Byrne C3, Selby N1,4
1
Department of Renal Medicine, Royal Derby Hospital, 2Departments of Histopathology and
3 P19
Renal Medicine, Nottingham University Hospitals, 4Division of Medical Sciences and
Graduate Entry Medicine, University of Nottingham
P8 DEVELOPING AN INTERACTIVE PATIENT INFORMATION BOOKLET FOR ACUTE KIDNEY
INJURY
Moreland J, Phiri E, Selby N, Department of Renal Medicine, Royal Derby Hospital
P9 ACUTE KIDNEY INJURY REQUIRING INTERMITTENT HAEMODIALYSIS: A PILOT STUDY TO
INFORM DEVELOPMENT OF A NATIONAL AUDIT DATASET
Shaw C1, Braddon F1, S Shaw1, Medcalf J2 on behalf of the UK Renal Registry and the audit pilot
sites
1 1
UK Renal Registry, Bristol; 2Department of Renal Medicine, University Hospital of Leicester
Department of Renal Medicine
P10 RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ACUTE KIDNEY INJURY
FOLLOWING ELECTIVE CORONARY ARTERY BYPASS GRAFTING (CABG): A SINGLE CENTRE
RETROSPECTIVE OBSERVATIONAL STUDY
Wang J1, Ahmed N2, Alexander N3, Deshpande R3, Jayawardene S1
1
Department of Renal Medicine, King’s College Hospital, 2King’s College London School of
Medicine,3Department of Cardiothoracic Surgery, King’s College Hospital
AKI Recognition (Thurdsay 1st May 12.45 - 13.45) moderated by Nitin Kolhe
P11 ACUTE KIDNEY INJURY: DOES THE PTWR CONTRIBUTE TO THE DIAGNOSIS?
Carter B, Murphy SNT; Dept of Medicine Princess Royal Hospital, Haywards Heath
P12 BIOLOGICAL VARIATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL)
AND KIDNEY INJURY MOLECULE 1 (KIM-1) IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS
Carter JL1, Stevens PE2, Knight S2, Eaglestone G2, Farmer CKT2, Lamb EJ1
1
Clinical Biochemistry and 2Kent and Kidney Care Centre, East Kent Hospitals University NHS
Foundation Trust, Canterbury, Kent
ACUTE KIDNEY INJURY RECOGNITION AND MANAGEMENT IN THE ACUTE MEDICAL UNIT
– WHY ARE PATIENTS STILL SUFFERING?
Chamberlin N, Tedd H, Hartley T, Moore I,
Renal Unit, City Hospitals Sunderland
P14 INSULTED AT THE FRONT DOOR? DOES IDENTIFICATION OF AKI IMPACT CLINICAL CARE?
¹University of Birmingham, Medical School, ²Sandwell and West Birmingham Hospitals NHS
Trust, ³Queen Elizabeth Hospital Birmingham
P15 URINE MICROSCOPY SCORE COMBINED WITH ALBUMIN CREATININE RATIO SCORE
IMPROVES PREDICTION OF FUTURE ACUTE KIDNEY INJURY (AKI) AND WORSENING AKI
Dixon J,J1,2,3, Lane K1,2, Fleming-Nouri W2, Hussain, C2, Walker P2, MacPhee I,A,M2,3, Philips B,J1,2
1
General Intensive Care Unit, St. George’s Hospital, London, 2St. George’s, University of London
3
Renal Medicine, St. George’s Hospital, London
P16 MORTALITY AND THE CLASSIFICATION OF POST-ADMISSION AKI BY PROPORTIONATE OR
ABSOLUTE CHANGES IN SERUM CREATININE
Jurawan N, Pankhurst T, Borrows R, Ray D, Coleman JJ, Rosser D and Ball S
University Hospital Birmingham
P17 SURVEY OF GENERAL AWARENESS OF RISK ASSESSMENT, IDENTIFICATION AND
MANAGEMENT OF ACUTE KIDNEY INJURY (AKI) AMONG JUNIOR DOCTORS IN A DISTRICT
GENERAL HOSPITAL IN THE NORTH OF ENGLAND
Kazmi I1, Briggs V2, Kawar B2,
¹Barnsley Hospital NHS Foundation Trust, Barnsley, ²Sheffield Kidney Institute, Sheffield Teaching
Hospitals NHS Foundation Trust, Sheffield
P18 ACUTE KIDNEY INJURY; IN HOSPITAL ARE WE MISSING THE BIGGER PICTURE?
Meran S*, Wonnacott A*, Amphlett B and Phillips A
Institute of Nephrology, University Hospital of Wales, Cardiff
AKI ALERTS ARE AN IMPORTANT AND EARLY BIOMARKER FOR CRITICAL CARE:
POTENTIAL FOR SIGNIFICANTLY IMPROVING AKI OUTCOMES
Prendecki M1, Blacker E2, Sadeghi-Alavijeh O1, Edwards R1, Montgomery H2, Gillis S2, Harber M3
1
Department of Nephrology, 2Department of Intensive Care, Whittington Hospital, 3Department of
Nephrology, Royal Free Hospital
AKI: Risk and Outcome (Friday 2nd May 13.00-14.00) moderated by Andy Lewington
P20 INVESTIGATING THE INFLUENCE OF ACUTE KIDNEY INJURY ON LONGITUDINAL eGFR
MEASUREMENTS
Asar O1, Ritchie J2, Diggle P1, 3, Kalra P2, Alderson H2, O’Donoghue D2
Lancaster Medical School, Lancaster University, 2Vascular Research Group, Manchester Academic
Health Sciences Centre, University of Manchester, Salford Royal NHS Foundation Trust, 3Institute of
Infection and Global Health, University of Liverpool
P21 AVOIDABLE DIALYSIS- REQUIRING ACUTE KIDNEY INJURY: 6 MONTH EXPERIENCE
Ferreira CC, Mason J, Ramadoss S, Diwakar R
Department of Renal Medicine, Shrewsbury and Telford Hospital NHS Trust (SATH)
P22 RISK FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF CHRONIC KIDNEY
DISEASE FOLLOWING ACUTE KIDNEY INJURY
Horne K1, Packington R1, Hinchliffe S1, Monaghan J2, Reilly T3, Kolhe NV1, Fluck RJ1,
McIntyre CW1,4, Selby NM1,4
1Department of Renal Medicine, 2Department of Clinical Biochemistry, 3Department of Informatics,
Royal Derby Hospital, 4 Division of Medical Sciences and Graduate Entry Medicine, University of
Nottingham
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P23 AKI IS ASSOCIATED WITH SIGNIFICANT DETERIORATION IN RENAL FUNCTION AND
PROTEINURIA WHICH PERSISTS TO AT LEAST ONE YEAR: RESULTS OF A PROSPECTIVE
CASE CONTROL STUDY
Horne K1, Packington R1, Hinchliffe S1, Monaghan J2, Reilly T3, Kolhe NV1, Fluck RJ1,
McIntyre CW1,4, Selby NM1,4
1
Department of Renal Medicine, 2Department of Clinical Biochemistry, 3Department of Informatics,
Royal Derby Hospital, 4Division of Medical Sciences and Graduate Entry Medicine, University of
Nottingham
P24 RISK FACTORS FOR CONTRAST INDUCED NEPHROPATHY IN ADULT INTENSIVE CARE: A
RETROSPECTIVE SINGLE CENTRE OBSERVATIONAL STUDY
Lewis D1, Manoras A2, Alderson S1, Papanikitas J3, Pillai S4, and McKechnie S2
1
Acute General Medicine, 2Intensive Care Unit, 3Department of Radiology, Oxford University
Hospitals NHS Trust, Oxford, 4Intensive Treatment Unit, Morriston Hospital, Swansea
P25 ACUTE KIDNEY INJURY STAGE 3 OUTCOMES FOLLOWING INTENSIVE CARE ADMISSION. A
SINGLE CENTRE REPORT
Raman M1, Chinnadurai R1, Niteh S1, Nipha R1, Ferris P2
Department of Renal Medicine1 and Intensive Care Medicine2, Salford Royal NHS Foundation Trust
P26 THE UTILITY OF PRE-PROCEDURE RENAL MAGNETIC RESONANCE ANGIOGRAPHY IN
PATIENTS AWAITING CARDIOTHORACIC PROCEDURES: A SINGLE CENTRE EXPERIENCE
Talbot B, Kong R1, Hutchinson 1, Trivedi U1, Forsyth A1, Gayfer J1, Kingdon EJ
Sussex Kidney Unit + Sussex Cardiac Centre1, Brighton +Sussex University Hospitals Trust
P27 NEWS DOES NOT ACCURATELY PREDICT AKI
Williams A, Ramasamy V, Davies D, Williams G, Thomas, B
Wrexham Maelor Hospital, Betsi Cadwaladr University Health Board
AKI: Primary Care (Wednesday 30th April 13.30-14.30) moderated by Jonathan Fox
27
P28 THE MISSING LINK: HOSPITAL DISCHARGE LETTERS FOLLOWING ACUTE KIDNEY INJURY
Allen JC, Harrison LEA, Bisset L
Department of Renal Medicine, Nottingham University Hospitals
P29 COMMUNITY ACQUIRED ACUTE KIDNEY INJURY (CAKI): INCIDENCE AND OUTCOMES
Coupe A, Barton AL*, Mallard AS*, Dickinson S, Johnston P, Stratton J, and Parry RG
Clinical Chemistry Department* and Renal Unit Royal Cornwall Hospitals Trust, Truro
P30 INCIDENCE OF COMMUNITY- ACQUIRED VS HOSPITAL- ACQUIRED ACUTE KIDNEY INJURY
IN A DISTRICT GENERAL HOSPITAL
Diwakar R, Yomi-Adeleke A, Gohar A, Richmond K
Shrewsbury and Telford Hospitals NHS Trust
P31 DIAGNOSIS OF COMMUNITY ACQUIRED ACUTE KIDNEY INJURY IN PATIENTS ADMITTED
TO GENERAL INTERNAL MEDICINE IN A TERTIARY REFERRAL CENTRE
Egan A, Dodd P, Loucaidou M,
Hammersmith Hospital, London
P32 PATIENT ADVICE REGARDING PRESCRIBED MEDICATIONS DURING INTERCURRENT
ILLNESS TO PREVENT ACUTE KIDNEY INJURY
Lloyd O, McGuinness J, Hind J, Muniraju T
Renal Unit, Dumfries & Galloway Royal Infirmary
P33 IMPAKT EVOLVE – AN INFORMATICS SOLUTION TO IDENTIFY AKI IN PRIMARY CARE:
UNDERSTANDING DEMOGRAPHICS, PREDICTING RISK AND DEFINING OUTCOMES
Player P, Shepherd D, Brunskill N
Dept of Nephrology, Leicester General Hospital; Dept of Health Sciences, University of Leicester;
Dept of Infection, Immunity and Inflammation, University of Leicester
P34 EPIDEMIOLOGY AND OUTCOME OF COMMUNITY ACQUIRED ACUTE KIDNEY INJURY
Talabani B, Zouwail S*, Pyart RD, Meran S, Riley SG and Phillips AO.
Insititute of Nephrology, Cardiff University School of Medicine, Cardiff
*Department of Biochemistry and Immunology, Cardiff and Vale University Health Board, University
Hospital of Wales, Cardiff and Department of Medical Biochemistry, School of Medicine, Alexandria
University, Egypt
P35 KNOWLEDGE OF ACUTE KIDNEY INJURY AMONGST PRIMARY CARE PROFESSIONALS
Xu G1, Wheatcroft S2, Asrar M2, Fyall A2, Jackson D2, Riaz S3, Westacott R1, Baines R1, Parry R4,
Selby N3,5, Carr S1.
1
John Walls Renal Unit, University Hospitals of Leicester: 2Primary care partners, East Midlands
Region. 3Department of Renal Medicine, Royal Derby Hospital: 4Renal Medicines, Royal Cornwall
Hospital. 5Divisions of Medical Sciences and Graduate Entry Medicine, University of Nottingham
AKI: Treatment (Friday 2nd May 13.00-14.00) moderated by Simon Ball
P36 HOW TO IMPROVE ACUTE KIDNEY INJURY (AKI) MANAGEMENT
Karimi S¹, Cserep G¹, Gannon D2, Sinnamon K¹
¹Renal Unit and 2Emergency Assessment Unit, Colchester Hospital University NHS Foundation
Trust
P37 ACUTE KIDNEY INJURY - IMPROVEMENT IN RECOGNITION AND MANAGEMENT OF AKI IN
ACUTE MEDICAL ADMISSIONS
Kathuria P, Trehan A, Nipah R, Salford Royal Foundation Trust
P38 MICRONUTRIENT LOSS DURING RENAL REPLACEMENT THERAPY FOR ACUTE KIDNEY
INJURY
Oh WC1,4, Rigby M4, Mafrici B4, Sharman A1, Harvey D1, Welham S3, Mahajan R1, Gardner D2,
Devonald M1,4
Division of Anaesthesia, School of Clinical Sciences1, School of Veterinary Medicine and Science2
and School of Biosciences3, University of Nottingham, Renal and Transplant Unit, Nottingham
University Hospitals NHS Trust4
P39 SEVERE HYPERKALAEMIA: DEMOGRAPHICS AND OUTCOME
Phillips BM, Milner S, Zouwail S*, Roberts G#, Cowan M, Riley SG and Phillips AO
Insititute of Nephrology, Cardiff University School of Medicine, Cardiff
*Department of Biochemistry and Immunology, Cardiff and Vale University Health Board, University
Hospital of Wales, Cardiff and Department of Medical Biochemistry, School of Medicine, Alexandria
University, Egypt.
#Department of Nephrology and Transplantation, Cardiff and Vale University Health Board,
University Hospital of Wales, Cardiff
P40 ACUTE KIDNEY INJURY: EXPERIENCE OF NURSE LED INTERVENTION BY EARLY
IDENTIFICATION AND INTERVENTION FOR INPATIENTS DEVELOPING AKI USING E-ALERT
SYSTEM
Subbegowda PH, Hutchison AJ, Challiner R, Heatley S, Hurst H, Henney R, Butterworth C.
Department of Renal Medicine and Critical care, Manchester Royal Infirmary, Manchester Academic
Health Science Centre
P41 RECOGNITION AND TREATMENT OF HYPERKALAEMIA IN THE SECONDARY CARE SETTING
Waugh FR, Phelps RG, Goddard J, Vernon MA
Department of Renal Medicine, Royal Infirmary of Edinburgh
Cardiovascular (Wednesday 30th April 13.30-14.30) moderated by Martin Chanayireh
P42 ENOS POLYMORPHISM PREDICTS CARDIAC MR SYSTOLIC PARAMETERS IN NON-HEART
FAILURE PRE-DIALYSIS CKD
Chand S1, Chue CD2, Edwards NC2, Simmonds MJ3, Hamilton A3, Gough SC3, Steeds RP2,
Townend JN2, Ferro CJ1, Borrows R1
1
Renal Department, Queen Elizabeth Hospital Birmingham, 2Cardiology Department, Queen
Elizabeth Hospital Birmingham, 3OCDEM, University of Oxford.
P43 DIURNAL VARIATION IN BLOOD PRESSURE AND ARTERIAL STIFFNESS IN CKD – THE ROLE
OF ENDOTHELIN1
Dhaun N, Moorhouse R, MacIntyre I, Melville V, Kimmitt R, Brown K, Kennedy E, Goddard J,
Webb D,B,H,F, Centre of Research Excellence, University of Edinburgh
P44 LONG-TERM PROGNOSTIC IMPLICATIONS OF BRAIN IMAGING FINDINGS IN PATIENTS WITH END
STAGE RENAL FAILURE
Findlay MD, Dawson J, Patel RK, Jardine AG, Thomson PC, Mark PB
Renal and Transplant Unit, Western Infirmary, Glasgow
Institute of Cardiovascular and Medical Sciences, University of Glasgow
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P45 CHANGES IN CARDIAC STRUCTURE AND FUNCTION AFTER REVASCULARISATION VERSUS P69
MEDICAL THERAPY FOR RENAL ARTERY STENOSIS: THE ASTRAL HEART
ECHOCARDIOGRAPHY SUB-STUDY
Green D1, Handley K2, Wheatley K2, Chrysochou T1, Hegarty J1, Wright J3, Moss J4, Patel R4,
Deighan C5, Webster J6, Crichton W6, Rowe P7, Carr S8, Cross J9, O’Driscoll J10, Ives N2, Kalra P1
1 P70
Salford Royal Hospital, 2University of Birmingham, 3Central Manchester Foundation Trust, 4Western
Infirmary, Glasgow, 5Glasgow Royal Infirmary, 6Aberdeen Royal Infirmary 7Derriford Hospital,
Plymouth, 8Leicester Royal Infirmary, 9Royal Free Hospital, London, 10St George’s Hospital, London
P46 CLINICAL SIGNIFICANCE OF TROPONIN T VALUES IN CHRONIC KIDNEY DISEASE
PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME
Venugopal N, Pandya B, Aintree University Hospital
P71
P47 OUTCOME OF CONTEMPORARY PERCUTANEOUS INTERVENTION (PCI) IN PATIENTS WITH
CHRONIC KIDNEY DISEASE (CKD): THE HOSPITAL CKD -PCI REGISTRY
Voukalis C, Laing C and Rakhit R, Royal Free Hospital, London
P72
Cardiovascular Risk (Thursday 1st May 12.45-13.45) moderated by Maarten Taal
P48 PROGNOSTIC VALUE OF MYOCARDIAL PERFUSION IMAGING IN PATIENTS REFERRED FOR
RENAL TRANSPLANT ASSESSMENT
Bhandari S, Tweddel A, Eadington D, Clark A, Wright G, Papodopolous M P73
Hull and East Yorkshire NHS Trust
P49 CONVENTIONAL CARDIOVASCULAR RISK FACTORS, SERUM ALBUMIN AND PHOSPHATE
PREDICT REDUCED SURVIVAL AND CARDIOVASCULAR EVENTS FOLLOWING RENAL
TRANSPLANT ASSESSMENT
Campbell N1, Patel RK1,2, Stevens KK1,2, Johnston N1, Gillis K1,2, Taylor AHM1,2, Kingsmore DB2,
Clancy MJ2, Jardine AG1,2, Mark PB1,2
METALLOSIS AND CHRONIC KIDNEY DISEASE: CONSIDERATIONS FOR A NEPHROLOGIST
Balasubramaniam G*, Khang S*, Lusty P#, Greer S#, Almond M*
*Department of Renal Medicine, Southend General Hospital
#Department of Orthopaedics, Southend General Hospital
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY: TWO NOVEL GENETIC
MUTATIONS AND UNITED KINGDOM EXPERIENCE
Balasubramaniam G1, Fairbanks L2, Marinaki A2, Arenas M2, Escuredo E2, Mapplebeck S1,
Sheaff M1, Almond M1
1
Southend University Hospital, Southend, Essex
2
Purine Research Laboratory, Guy's and St Thomas' NHS Trust, London
CIRCULATING FETUIN IS INDEPENDENTLY ASSOCIATED WITH PROTECTION FROM THE
PROGRESSION OF CHRONIC KIDNEY DISEASE
Caplin B, Ketteler M, Jahnen-Dechent W, Cunningham J, Wheeler D
UCL Medical School and Klinikum Coburg, Germany
SKIN AUTOFLUORESCENCE IS AN INDEPENDENT DETERMINANT OF ALL-CAUSE
MORTALITY IN PEOPLE WITH CKD STAGE 3
Fraser SDS1, Roderick PJ1, McIntyre NJ2, Harris S1, McIntyre CW2, Fluck RJ2, Taal MW2
Southampton General Hospital1, Royal Derby Hospital2
THE eGFR-C STUDY. ACCURACY OF GLOMERULAR FILTRATION RATE (GFR) ESTIMATION
USING CREATININE AND CYSTATIN C AND ALBUMINURIA FOR MONITORING DISEASE
PROGRESSION IN PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE: PROSPECTIVE
LONGITUDINAL STUDY IN A MULTIETHNIC POPULATION (STUDY REGISTRATION NUMBER
ISRCTN42955626)
Lamb EJ,* Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Harris K, Higgins T, Kalra PA, Khunti K,
Loud F, Ottridge RS, Sitch AJ, Sharp CC, Stevens PE, Sutton AJ, Taal M on behalf of the eGFR-C
study group. *corresponding author, Clinical Biochemistry, East Kent Hospitals University NHS

28
¹Institute of Cardiovascular and Medical Sciences, University of Glasgow
²Glasgow Renal and Transplant Unit, Western Infirmary, Glasgow
P50 HYPERURICAEMIA IS ASSOCIATED WITH CARDIOVASCULAR MORTALITY IN CHRONIC
KIDNEY DISEASE
Chiu D, Ritchie J, Green D, Sinha S, Kalra PA
Salford Vascular Research Group, University of Manchester, MAHSC, Manchester
P51 OPTIMISING POST-TRANSPLANT CARDIAC OUTCOMES: USE OF RISK STRATIFICATION TO
GUIDE APPROPRIATE WORKUP
Edwards, H, Venturi, S, Budzbon, D, Wheeler, R, Griffin, S, University Hospital, Wales
P52 THE ASSOCIATION OF PULSE WAVE ANALYSIS AND CARDIOVASCULAR MORTALITY IN
PATIENTS WITH CHRONIC KIDNEY DISEASE
Green D, Sinha R, Ritchie J, Eddington H, Lane B, O’Donoghue D, Middleton R, Kalra P, Sinha S
Department of Renal Medicine, Salford Royal Hospital
CKD (Friday 2nd May 13.00 - 14.00) moderated by Karen Jenkins & Maarten Taal
P67 ASSOCIATION BETWEEN OSTEOPROTEGERIN, BASELINE AND CHANGE IN ARTERIAL
STIFFNESS IN CKD
Alderson H, Ritchie J Kalra P, Salford Royal NHS Foundation Trust
P68 EXTERNAL VALIDATION OF THE BERLIN EQUATIONS FOR ESTIMATION OF GFR IN THE
ELDERLY
Alshaer IM, 1, Kilbride HS,1 Stevens PE,1, Eaglestone G,1, Knight S,1, Carter JL,3, Delaney MP,1,
Farmer CKT,1, Irving J,1, O’Riordan SE,2, Dalton RN,4, Lamb EJ,3
The Kent Kidney Care Centre,1, Health Care of the Older Person2 and Clinical Biochemistry,3 East
Kent Hospitals University NHS Foundation Trust, Canterbury, Kent and The Wellchild Laboratory,4,
Evelina Childrens Hospital, London
Foundation Trust, Canterbury, Kent
P74 RETINAL VESSEL CALIBRE - A POTENTIAL BIOMARKER FOR CHRONIC KIDNEY DISEASE
McGowan A,1, Patterson CC,1, Silvestri V,2, Silvestri G,2, Moore E,2, Maxwell AP,1, McKay GJ,1,
Centre for Public Health, Queen's University Belfast1
Centre for Experimental Medicine, Queen's University Belfast2
P75 ELEVATED MINERALOCORTICOID LEVELS ARE ASSOCIATED WITH INCREASED RISK OF
REQUIRING RENAL REPLACEMENT THERAPY
McQuarrie E¹,², Mark P¹,², Freel EM¹, Taylor A¹,²Fraser R¹, Connell J³, Jardine A¹,²
Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre,
University of Glasgow¹
The Glasgow Renal & Transplant Unit, Western Infirmary, Glasgow²
School of Medicine, University of Dundee, Dundee³
P76 MICRONUTRIENT STATUS IN CHILDREN WITH CHRONIC KIDNEY DISEASE (CKD)
Yadav P, Waller S, Evelina Childrens Hospital, London
CKD Management (Thursday 1st May 12.45 - 13.45) moderated by Robert Lewis
P77 ANALYSIS OF HYPERPARATHYROIDISM AND ITS TREATMENT IN PATIENTS WITH NON-
DIALYSIS CHRONIC KIDNEY DISEASE
Abeygunaratne T, Green D, Chiu D, Kalra PA
Salford Vascular Research Group, University of Manchester
P78 VARIATIONS IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE ACROSS THE UK:
RESULTS OF A NATIONAL SURVEY (CKMAPPS)
Arnold J, Baharani J, Rayner H
Department of Renal Medicine, Birmingham Heartlands Hospital
P79 DEVELOPMENT OF AN INTEGRATED CARE SERVICE IN THE MANAGEMENT OF CKD IN
THE COMMUNITY: WHAT HAVE WE LEARNT SO FAR?
Burke S1, Johnston, S2, Connolly, J2,
¹Therapies Directorate ²Department of Nephrology, Royal Free London NHS Foundation Trust
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P80 FACTORS ASSOCIATED WITH PROGRESSION TO RENAL REPLACEMENT THERAPY IN P92 RATES AND PREDICTORS OF ADMISSION IN A REFERRED CKD POPULATION
ELDERLY VERSUS YOUNGER PATIENTS AND IN DIFFERENT CAUSES OF Ritchie J1, Asar O2, Green D1, Alderson H1, Chiu D1, Middleton R1, Diggle P2, O’Donoghue D1,
CHRONIC KIDNEY DISEASE Kalra, P1
Chiu D, Kalra PA, Green D, Institute of Population Health, University of Manchester ¹Salford Royal NHS Foundation Trust Department of Renal Medicine, Stott Lane, Salford
²Faculty of Health and Medicine, Lancaster University
P81 MORE QUESTIONS THAN ANSWERS - AN AUDIT OF LIPID LEVELS IN A LOW
CLEARANCE POPULATION P93 RENAL DIAGNOSES AND OUTCOMES IN WOMEN WITH DISEASE IDENTIFIED DURING
Curwell J, Glover S, Hirst G. PREGNANCY COMPARED WITH NON-PREGNANT CONTROLS: A 2 CENTRE COHORT STUDY OF 1406
Department of Dietetics, Manchester Royal Infirmary Central Manchester Healthcare Trust WOMEN
Webster P1, Bramham K2, Webster L2, Cook H1, Horsfield C2, Lydon I2, Homsy M2, Vaz R1,
P82 CKD NURSE LED SERVICE: A NEW DEVLEOPMENT FOR PRIMARY CARE Santos C1 & Lightstone L1
1
D’Souza, P, Department of Renal Medicine, Royal Devon & Exeter Foundation Trust Imperial College Healthcare NHS Trust Renal & Transplant Centre, Hammersmith Hospital
2
Maternal and Fetal Research Unit, King’s College London
P83 CHRONIC KIDNEY DISEASE - BRIDGING THE GAP BETWEEN PRIMARY AND SECONDARY
CARE Conservative Care (Thursday 1st May 12.45 – 13.45) moderated by Aine Burns
Guitton C; Jones J; Griffiths S, Renal and Diabetic Unit, Wrexham Maelor Hospital, North Wales
P63 DEVELOPING THE IMPLEMENTATION OF ADVANCE CARE PLANNING: THE PSYCHOSOCIAL
P84 MANAGING PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE IN PRIMARY CARE: A CONTRIBUTION
QUALITATIVE STUDY WITH GENERAL PRACTITIONERS Eyre M, Rowan H, Riedel B, York Hospital Renal Team
n
Tonkin-Crine, S1, Santer, M1, Leydon, G1, Murtagh, F2, Farrington, K3, Caskey, F4, Rayner, H5,
draw
Roderick, P1 on behalf of the CKMAPPS group
h P64 END OF LIFE CARE. FINDING A WAY FORWARD?
wit Hartnett H, Goulden J, Queen Alexandra Hospital, Portsmouth
Primary Care and Population Sciences, University of Southampton1
Department of Palliative Care, Policy and Rehabilitation, King’s College London2
P65 "THE LESSER OF TWO EVILS" - DECISION-MAKING IN END STAGE KIDNEY DISEASE: A
P85 DEVELOPMENT OF A CKD PATIENT PATHWAY TO ENSURE ACCESS TO THE RIGHT RENAL QUALITATIVE SYNTHESIS
REPLACEMENT THERAPY (RRT) AT THE RIGHT TIME Hussain JA1, Flemming K2, Johnson MJ3
Worley B, Anson R, Palmer D, Dallyn P, Buckfield Dialysis Unit, Royal Sussex County Hospital, Leeds Teaching Hospitals NHS Trust1, University of York2, University of Hull3
Ansell T, Baxter Healthcare.
P66 EMBEDDING ADVANCE CARE PLANNING IN DAILY PRACTICE (RENAL SPECIFIC)

29
CKD Risk & Outcome (Wednesday 30th April 13.30 - 14.30) moderated by Nigel Brunskill Latchford J, Hallatt J, Davison P, Green L, Jones C

P86 DIFFERENCES IN AUGMENTATION INDEX BETWEEN DIFFERENT AETIOLOGIES OF CHRONIC
KIDNEY DISEASE
Abeygunaratne T, Green D, Ritchie J, Chiu D, Kalra P
Salford Vascular Research Group, University of Manchester
P87 HYPONATRAEMIA IS ASSOCIATED WITH ALL-CAUSE MORTALITY IN CHRONIC KIDNEY
DISEASE
Chiu D, Green D, Ritchie J, Sinha S, Kalra PA
Salford Vascular Research Group, University of Manchester, MAHSC, Manchester
Depression & Dialysis (Friday 2nd May 13.00 - 14.00) moderated by Ann Murdoch
P101 DEPRESSIVE SYMPTOMS PREDICT POST DIALYSIS RECOVERY TIME
Friedli K1, Guirguis A1, 2, Almond M3, Day C4, Davenport A5, Fineberg NA1,6, Da Silva- Gane M2,
Chilcot J7, Wellsted D1, Farrington K1, 2
1
University of Hertfordshire, 2East and North Hertfordshire NHS Trust, 3Southend University
Hospital NHS Foundation Trust, 4University Hospitals Birmingham NHS Foundation Trust, 5Royal
Free London NHS Foundation Trust, 6Hertfordshire Partnership University NHS Foundation Trust,
7
King’s College London

P88 THE CHALLENGES OF MANAGING TRADITIONAL CARDIOVASCULAR RISK FACTORS IN
PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE III AND IV ACROSS THE NORTH WEST
– A RE-AUDIT 2013
Goldsmith C, Aintree Hospital, Liverpool
Gulcicek G, Powell, T, Manchester Royal Infirmary, Department of Renal Medicine
P89 EARLY DETECTION OF RISK FACTORS FOR FOOT ULCERATION IN PRE-DIALYSIS
POPULATION
Jones NJ¹, Phillips A.O, MD1, Mathieson I², Morris K², Riley S.G, MD¹
¹ Cardiff & Vale University Health Board ² Cardiff Metropolitan University
P90 ADMISSIONS TO HOSPITAL IN THOSE WITH CHRONIC KIDNEY DISEASE: DIFFERENCES
FROM THOSE WITH NORMAL RENAL FUNCTION
Marks A, Black C, Clark L, Prescott G, Robertson L, Simpson W & Fluck N
Chronic Disease Research Group & Department of Renal Medicine, University of Aberdeen & NHS
Grampian
P91 FRACTURE RISK IN CHRONIC KIDNEY DISEASE
Marks A, Nguyen H, Fluck N, Prescott G, Robertson L & Black C
Chronic Disease Research Group & Department of Renal Medicine, University of Aberdeen & NHS
Grampian
P102 COMPARISON OF PATIENT HEALTH QUESTIONNAIRE 9 AND BECK DEPRESSION
INVENTORY VERSION II FOR DEPRESSION SCREENING IN HAEMODIALYSIS PATIENTS
Friedli K.1, Guirguis A.1,2, Almond M.3, Day C.4, Davenport A.5, Fineberg N.A.1,6, Da Silva- Gane M.2,
Chilcot J.7, Wellsted D.1, Farrington, K.1,2
1
University of Hertfordshire, 2East and North Hertfordshire NHS Trust, 3Southend University Hospital NHS
Foundation Trust, 4University Hospitals Birmingham NHS Foundation Trust, 5Royal Free
London NHS Foundation Trust, 6Hertfordshire Partnership University NHS Foundation Trust, 7King’s
College London
P103 STRONG ASSOCIATION OF FATIGUE AND DEPRESSIVE SYMPTOMS IN HAEMODIALYSIS
PATIENTS
Guirguis A1,2, Friedli K2, Almond M.3, Day C.4, Davenport A.5, Fineberg, NA 2,6, Da Silva- Gane M2,
Chilcot J.7, Wellsted D.2, Farrington K.1, 2
1
East and North Hertfordshire NHS Trust, 2University of Hertfordshire, 3Southend University Hospital NHS
Foundation Trust, 4University Hospitals Birmingham NHS Foundation Trust, 5Royal Free
London NHS Foundation Trust, 6Hertfordshire Partnership University NHS Foundation Trust, 7King’s
College London
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P104 DEPRESSIVE SYMPTOMS ARE COMMON IN HAEMODIALYSIS PATIENTS DESPITE
ANTIDEPRESSANT PHARMACOTHERAPY
Guirguis A1, 2, Friedli K2, Almond M3, Day C.4, Davenport A5, Fineberg NA2,6, Da Silva- Gane M2,
Chilcot J7, Wellsted D2, Farrington K1,2
1
East and North Hertfordshire NHS Trust, 2University of Hertfordshire, 3Southend University Hospital
NHS Foundation Trust, 4University Hospitals Birmingham NHS Foundation Trust, 5Royal Free
London NHS Foundation Trust, 6Hertfordshire Partnership University NHS Foundation Trust, 7King’s
College London
P105 GRIEVING AND BEREAVEMENT IN THE DIALYSIS UNIT- RE-DEFINING THE WHITE ELEPHANT
IN THE ROOM
Laukam, C and Baharani, J
Department of Renal Medicine, Birmingham Heartlands Hospital
P106 IMPROVING DEPRESSION MANAGEMENT WITHIN THE HAEMODIALYSIS POPULATION
McCloskey MC1, Harron C1, Mullan R1, Cunningham R1, Young M2
1
Antrim Renal Unit, Antrim Area Hospital, 2Old Age Psychiatry, Northern Health and Social Care
Trust
Dialysis complications (Friday 2nd May 13.00 - 14.00) moderated by Ken Farrimgton
P164 IMPROVING THE QUALITY OF FOOT CARE OF DIABETIC RENAL PATIENTS- ‘PREVENTING
THE PREVENTABLE PROBLEM’
Chatterjee D, Davies S.J, Wessels J, Walker A, Barlow H, Bourne E, Tomlinson K.C,
Kidney Unit, University Hospital of North Staffordshire, NHS Trust
P165 LONG TERM MORTALITY RATES IN END-STAGE RENAL DISEASE PATIENTS AFTER LOWER
LIMB AMPUTATIONS
Elsayed I, Khwaja A, Sheffield Teaching Hospitals
30
P166 THE EFFECT OF EVOLVING ANAEMIA MANAGEMENT ON TRANSFUSION RATES IN
HAEMODIALYSIS PATIENTS
Forbes SH, Ashman N
Department of Nephrology and Transplantation, Royal London Hospital, Whitechapel
P167 CURRENT MANAGEMENT ON CKD-MBD IN WALES - NOT SO NICE?
Ghalli F1, Ibakkanavar R1, Chess J3, Roberts G,2,4, Riley S,4, on behalf of Welsh Association of Renal
Physicians
1
Department of Nephrology and Transplant, University Hospital of Wales
2
Royal Gwent Hospital, Newport, 3Morriston Hospital, Swansea, 4Institute of Nephrology, Cardiff
University
P168 ASSESSMENT AND MANAGEMENT OF BONE MINERAL DISORDER IN DIALYSIS PATIENTS
ACROSS THE NORTH WEST OF ENGLAND- RE-AUDIT 2013
Goldsmith C, Raza, H, Aintree Hospital, Liverpool
Rasheeda K, Manchester Royal Infirmary, Department of Renal Medicine, North West Region
P169 PLASMA HYDROGEN SULPHIDE (H2S) LEVELS IN CKD PATIENTS
John S¹, Garle M², Owen P¹, Ralevic V², O'Sullivan S², McIntyre C¹,²,
¹Department of Renal Medicine, Royal Derby Hospital, Derby ²Graduate Entry Medicine and Health,
University of Nottingham, Derby
P170 THE IMPACT OF HAEMOGLOBIN ON SURVIVAL OF HAEMODIALYSIS PATIENTS
McCrink LM1, Marshall AH1, Cairns KJ1, Fogarty D2
1
Centre of Statistical Science & Operational Research, Queen’s University Belfast
2 1
Belfast Health and Social Care Trust, Belfast
P171 COST ANALYSIS OF SWITCHING FROM SEVELAMER CARBONATE TO LANTHANUM
CARBONATE MONOTHERAPY IN THE UK
Morison B,1, Wilson RJ,2, Keith MS,3, Copley JB3
1 Marks A, Fluck N, Prescott G, Robertson L, Smith WCS & Black C
Shire Pharmaceuticals, Basingstoke, 2Spica Consultants, Marlborough, 3Shire, Wayne PA, USA
P172 ANAEMIA IN HEMODIALYSIS PATIENTS: AN AUDIT OF HEMOGLOBIN TARGETS AND
ERYTHROPOIESIS-STIMULATING AGENTS USE
Owen S, Hull York Medical School, Hazara A and Bhandari S, Hull and East Yorkshire Hospitals
NHS Trust
P173 ALLOGRAFT DYSFUNCTION AND NEPHROCALCINOSIS FOLLOWING
PARATHYROIDECTOMY: AN UNDER ESTIMATED COMPLICATION
Raman M1, Chinnadurai R1, Wood G1, Choudhury J2, Kalra P1, Middleton R1
Department of Renal Medicine1 and Pathology2, Salford Royal NHS Foundation Trust
Education (Friday 2nd May 13.00 – 14.00) moderated by Sue Carr
P53 DO MEDICAL TRAINEES RECEIVE ADEQUATE TRAINING IN UNDERSTANDING, MANAGING
AND TREATING CHRONIC KIDNEY DISEASE AND ITS COMPLICATIONS?
Ali M, Renal Medicine, York Teaching Hospitals Foundation NHS Trust, York
P54 SAGE & THYME TRAINING®: CAN WE TRAIN RENAL STAFF TO FEEL MORE CONFIDENT TO
RESPOND TO DISTRESSED PATIENTS?
Brand S, Tomlin M, Rigby M, & Coyne E
Renal Unit, Nottingham University Hospitals NHS Trust
P55 HAEMODIALYSIS PATIENTS’ UNDERSTANDING, PHOSPHATE LEVELS AND NUTRITIONAL
STATUS, BEFORE AND AFTER A NEW APPROACH TO DIETARY PHOSPHATE MANAGEMENT
Hannah J, Wells LM, Brenchley V, Jones, CH,
Department of Renal Medicine, York Hospital NHS Foundation Trust
P56 SUPPORTING STAFF INFORMATION NEEDS USING A LITERATURE SEARCHING SERVICE:
THE ROLE OF A RENAL CLINICAL LIBRARIAN
James C1, Johnson C2
Library and Knowledge Service1 and Department of Renal Medicine2, Royal Derby Hospital
P57 USING SIMULATION TO DEVELOP HAEMODIALYSIS SKILLS FOR NEPHROLOGY SPECIALTY
TRAINEES
Molyneux R1, Harrison T2, Taylor A3, Welberry-Smith M3, Jones C1, Stoves J2 and Roberts R2
1 3
York District Hospital, 2Bradford Royal Infirmary, Leeds Teaching Hospitals
P58 IMPROVING THE INPATIENT EXPERIENCE OF HAEMODIALYSIS PATIENTS
THROUGH STAFF EDUCATION
Peake M and McLaughlin D, Antrim Area Hospital Renal Unit and Ward C7
Epidemiology (Thursday 1st May 12.45 – 13.45) moderated by Fergus Caskey
P94 JOINT ANALYSIS OF LONGITUDINAL eGFR MEASUREMENTS AND TIME TO RENAL
REPLACEMENT THERAPY AND DEATH IN A CKD COHORT
Asar O1, Ritchie J2, Kalra P2, Diggle P¹,³
1
Lancaster Medical School, Lancaster University, 2Vascular Research Group, Manchester Academic
Health Sciences Centre, University of Manchester, Salford Royal NHS Foundation Trust
3
Institute of Infection and Global Health, University of Liverpool
P95 CAUSES OF DEATH IN ELDERLY VERSUS YOUNGER PATIENTS WITH CHRONIC KIDNEY
DISEASE
Chiu D, Abeygunarathne T, Ritchie J, Alderson H, Sinha S, Kalra PA, Green D
Institute of Population Health, University of Manchester
P96 THE INFLUENCE OF WEATHER ON HOSPITAL ADMISSION RATES FOR ACUTE KIDNEY
INJURY AND URINE TRACT INFECTION
Green D1,2, Kalra P1,2, Ritchie J1,2
Institute of Population Health, University of Manchester, 2Salford Royal Hospital, Manchester
Academic Health Sciences Centre
P97 COMORBIDITY: DIFFERENCES BETWEEN THOSE WITH CHRONIC KIDNEY DISEASE AND
NORMAL RENAL FUNCTION
Chronic Disease Research Group & Department of Renal Medicine, University of Aberdeen & NHS
Grampian
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P98 UNDERSTANDING PREDICTORS OF MORTALITY IN END STAGE RENAL DISEASE PATIENTS
ON DIALYSIS: A RETROSPECTIVE OBSERVATIONAL STUDY
Murphy E1,2,5, Germain M4, Cairns H3, Higginson I2, Murtagh F2,
1
NIHR GSTFT/KCL Biomedical Research Centre, Guy’s and St Thomas’ NHS Foundation Trust,
London, 2King’s College London, Department of Palliative Care, Policy and Rehabilitation, Cicely
Saunders Institute London, 3Kings College Hospital NHS Foundation Trust London
4 1
Baystate Medical Center and Tufts University School of Medicine, Springfield, USA,
5
University of Southampton
P99 RENAL REPLACEMENT THERAPY FOR THOSE AGED OVER 80: A BASELINE COMPARISON
BASED UPON SURVIVAL
Palfrey JC1, Wroe AC2
1 Alford H1, Franklin G1, De Silva-Gane M1, Roberts D2, Enric V1, Farrington K1
Freeman Hospital, Newcastle-Upon-Tyne
2 Department of Renal Medicine, Lister Hospital Stevenage, 2University of Hertfordshire
James Cook University Hospital, Middlesbrough
P100 HYPONATRAEMIA PRIOR TO DISCHARGE FROM HOSPITAL AFTER A GENERAL MEDICAL
ADMISSION IS ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF READMISSION
WITHIN 28 DAYS
Solanki P, Whitelaw B, Miell J, Alywin S
Endocrine Department, King’s College Hospital
Haemodialysis (Thursday 1st May 12.45 – 13.45) moderated by Alison Brown and Stephen Kardasz
P107 EXPOSURE TO IONISING RADIATION IN PATIENTS ON HAEMODIALYSIS
Hazara AM, Cathcart T, Saunderson J, Moore C and Bhandari S
Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust
P108 IMPLEMENTATION OF BODY COMPOSITION MONITORING IN A SATELLITE HAEMODIALYSIS
UNIT: BENEFITS REALISED AND LESSONS LEARNED
31
Lindley E1,2, Baines E3, Coughlan E4, Hull S4, Jowsey C4, Keane D1,2 and Roberts R4
1
Renal Medicine & Medical Physics, Leeds Teaching Hospitals NHS Trust; 2NIHR Devices for Dignity
Healthcare Technology Co-operative; 3NHS Technology Adoption Centre, Manchester; 4Renal
Medicine, Bradford Teaching Hospitals NHS Foundation Trust
P109 BLOOD PRESSURE CONTROL AND INTERDIALYTIC WEIGHT GAIN IN HAEMODIAFILTRATION
AND HAEMODIALYSIS COHORTS, A SINGLE CENTRE EXPERIENCE
Mahdi K, Elkossi M, Department of Renal Medicine, Doncaster Royal Infirmary
P110 PRIMED AND READY TO GO
Molyneux R1, Harrison T2, Harrison L3, & Roberts R2
1 Reston J¹, Wilson P2, Bieraugel R3, Wellsted D1, Offredy M2, Da Silva-Gane M3, Farrington K3
York District Hospital, 2Bradford Royal Infirmary, 3Royal Derby Hospital
P111 NATIONAL SURVEY OF STAFF OPINIONS TO EXTENDED TREATMENT TIME ON
HAEMODIALYSIS
Singh S, Power A, Pusey C, Choi P, Duncan N, Brown E
Imperial College Renal & Transplant Centre, London
P112 BASELINE HIGH SENSITIVITY TROPONIN T LEVELS REMAIN STABLE IN HAEMODIALYSIS
PATIENTS
Summers L1, Williams J1, D’Souza R1, McDonald T2, Moore J1
1 of Hertfordshire
The Kidney Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter
2
Department of Biochemistry, Royal Devon and Exeter NHS Foundation Trust, Exeter
P113 BIOCHEMICAL EFFECTS OF CHANGING FROM HIGH FLUX HAEMODIALYSIS TO ONLINE
HAEMODIAFILTRATION IN HAEMODIALYSIS PATIENTS
Syed A, Bhandari S
Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust
P114 A STUDY INTO THE PREVELANCE OF INTRADIALYTIC HYPERTENSION IN A UK
HAEMODIALYSIS POPULATION
Talbot B, Goodache R, Ford M, Lawman S, Royal Sussex Kidney Unit, Brighton
P115 BODY COMPOSITION AND DIALYSIS DOSE
Vilar E1,2, Machado A1, Farrington K1,2
1
Lister Renal Unit, Stevenage, 2Department of Postgraduate Medicine, University of Hertfordshire
P116 PREVALENCE OF UNEXPLAINED INFLAMMATION IN HAEMODIALYSIS PATIENTS
Wong J1, Sridharan S1, Vilar E1,2 & Farrington K1,2
Lister Hospital, 2University of Hertfordshire
Home HD/Shared Care (Friday 2nd May 13.00 – 14.00) moderated by Sandip Mitra
P117 SCOPING EXERCISE TO INVESTIGATE BARRIERS AND ENABLERS TO NUTRITIONAL SELF-
MANAGEMENT IN ADULTS REQUIRING HAEMODIALYSIS
1
P118 UPTAKE OF FULL SELF-CARE IN A COHORT OF HAEMODIALYSIS PATIENTS
Baharani J, Hatton C and Rayner H
Department of Renal Medicine, Heart of England NHS Foundation Trust
P119 A 12 MONTH PILOT STUDY USING NXSTAGE SYSTEM ONE NOCTURNAL HOME
HAEMODIALYSIS (NHHD)
Borman N, Huggins S, Hignell L, Humphrey S and Mason J
Wessex Renal and Transplant Service, Queen Alexandra Hospital, Portsmouth
P120 RESULTS OF A BASELINE SURVEY OF IN-CENTRE HAEMODIALYSIS PATIENTS REGARDING
GREATER INVOLVEMENT IN THEIR DIALYSIS
Ferraro A, Corbett A, Coyne E, Dring B, Kinchin A
Renal and Transplant Unit, Nottingham University Hospitals NHS Trust
P121 THE DESIGN AND DEVELOPMENT OF A HOME HAEMODIALYSIS WEBSITE
Holmes T, Swan C, Rhodes C, Fluck R, Department of Renal Medicine, Royal Derby Hospital
P122 DISCONNECT BETWEEN THE ANTICIPATED AND THE LIVED EXPERIENCE:
ADDRESSING THE PERSPECTIVE GAP IN HOME HAEMODIALYSIS
Majeed-Ariss R1, Jayanti A1, Wearden A2 and Mitra S1
1
Department of Renal Research, Central Manchester Foundation Trust
2
University of Manchester, Manchester Centre for Health Psychology
P123 JOURNEY TO CULTURAL CHANGE: EXPERIENCES OF FACILITATING SELF-MANAGEMENT IN
AN IN-CENTRE HAEMODIALYSIS SETTING
¹Centre for Lifespan and Chronic Illness Research, University of Hertfordshire
2
Centre for Research in Primary and Community Care, University of Hertfordshire
3
Lister Hospital, East & North Hertfordshire NHS Trust
P124 THE POTENTIAL FOR INCREASED SELF-MANAGEMENT IN PATIENTS ON IN-CENTRE
HAEMODIALYSIS
Reston J¹, Bieraugel R2, Wilson P3, Wellsted D1, Offredy M3, Da Silva-Gane M2, Farrington K2
¹Centre for Lifespan and Chronic Illness Research, University of Hertfordshire, 2Lister Hospital, East
& North Hertfordshire NHS Trust, 3Centre for Research in Primary and Community Care, University
P125 ONLY A SKYPE AWAY
Swan C, Holmes T, Rhodes C, Fluck R, Department of Renal Medicine, Royal Derby Hospital
P126 KNOWLEDGE AND PERCEPTION OF HOME THERAPIES IN A COHORT OF IN-CENTRE
HAEMODIALYSIS PATIENTS
Thomas P, Ramadoss S, and Baharani J
Department of Renal Medicine, Birmingham Heartlands Hospital
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
Hypertension (Wednesday 30th April 13.30 – 14.30) moderated by Martin Wilkie
P59 TIMING OF BLOOD PRESSURE MEASUREMENT IN THE TRANSPLANT CLINIC AND ITS
EFFECT ON AUDIT OR REGISTRY OUTCOMES
Jones MT, Farrell F, Moro-Azuela F, Hughes G, Almond MK, Harnett PR
Renal Unit, Southend University Hospital NHS Trust
P60 HISTOPATHOLOGICAL DIAGNOSES IN PATIENTS PRESENTING WITH HYPERTENSIVE
KIDNEY DISEASE
Joslin J, Yalamarti T, Wood S, Suckling R, Swift P
Department of Renal Medicine, Epsom and St Helier University Hospitals NHS Trust
P61 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING: ACCEPTED GOLD STANDARD BY NICE, P141 AN EXPLORATORY STUDY OF THE EFFECT OF LIPID APHERESIS USING THE THERASORB™
NOT NECESSARILY ACCEPTED BY PATIENTS RESULTS FROM A TRUST-WIDE
INITIATIVE
Kung T, Ahmed S, Rooks K, Moore I
Renal Unit, City Hospitals Sunderland
P62 SUCCESSFUL TREATMENT OF EARLY ANTENATAL SEVERE RESISTANT HYPERTENSION BY
BILATERAL RENAL ANGIOPLASTY
Sarween N1, Karim A1, Day C1, Knox E4, McCafferty I2, Temperton, D3 and Lipkin G1
University Hospital Birmingham NHS Foundation Trust, Department of Renal Medicine1Radiology2
and RRPS3 Birmingham Women’s NHS Foundation Trust, Department of Obstetrics4
Infection (Friday 2nd May 13.00 – 14.00) moderated by Alison Brown
P178 HAEMODIALYSIS ACCESS ASSOCIATED INFECTIONS – THE NEED FOR A UNIFORM
DEFINITION
Makanjuola D1, Steele M1, Clark J2
32
Renal Unit1, Department of Microbiology2, St. Helier Hospital, Carshalton, Surrey
P179 ANTI-MICROBIAL LOCKS FOR HAEMODIALYSIS CATHETERS:
A SAFER EXPERIENCE FOR ALL
Murray A, Ayard B¹, Woodman A, Renal Unit, Ulster Hospital, Dundonald, Belfast
P180 REDUCING HAEMODIALYSIS BACTERAEMIA RATES
Murray EC, Deighan C, Geddes C, Thomson PC
Renal Unit, Western Infirmary, Dumbarton Road, Glasgow, G11 6NT
P181 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND METHICILLIN-
SENSITIVE STAPHYLOCOCCUS AUREUS (MSSA) IN HAEMODIALYSIS PATIENTS: CARRIAGE,
DEMOGRAPHICS AND SHORT TERM OUTCOMES
Price A, Sarween N, Powers S, Allen C, Holland M, Gupta I, Baharani J
Birmingham Heartlands Hospital
P182 ONGOING EFFICACY OF THE CATHETER CARE BUNDLE IN MINIMISING DEVICE
INFECTIONS IN HAEMODIALYSIS
Spooner H, Nicholas J, Newcross Hospital, Wolverhampton
P183 USE OF CEFUROXIME IN TREATMENT OF METHICILLIN SENSITIVE STAPHYLOCOCCUS
AUREUS IN HAEMODIALYSIS PATIENT – A SINGLE CENTRE EXPERIENCE
Thanaraj V, Dhaygude A, Renal Department, Royal Preston Hospital
Innovation (Friday 2nd May 13.00 – 14.00) moderated by Jane Macdonald
P138 PATIENT INVOLVEMENT IN THE IMPROVEMENT OF DIALYSIS SERVICES IN LEICESTERSHIRE
Boral I1*, Murray CJ1*, Baines RJ2, Burton JO2
1
Department of Medical and Social Care Education, University of Leicester, Leicester
2
Department of Renal Medicine, University Hospitals of Leicester NHS Trust, Leicester
P139 WHICH CODING DIAGNOSES ARE MISSING FROM DIALYSIS PATIENTS’ NOTES IN A LONDON
HOSPITAL? A RETROSPECTIVE RECORDS-BASED STUDY OF ALL PATIENTS ATTENDING A
DIALYSIS UNIT
Candfield S, Agrawala T, Game DS
Guy’s & St Thomas’ NHS Foundation Trust
P140 PREVALENCE AND CHARACTERISTICS OF RENAL HIGH DEPENDENCY UNITS IN THE UK:
RESULTS FROM A NATIONWIDE SURVEY
Chrastek D1, Inaba A2, Karim M1,2
1
Norwich Medical School, University of East Anglia
2
Department of Renal Medicine, Norfolk and Norwich University Hospital
ADSORBER ON LOW DENSITY LIPOPROTEIN (LDL) LEVELS AND PATIENTS’ SATISFACTION
WITH THEIR TREATMENT
Duncan C, University Hospital Birmingham NHS Foundation Trust
P142 E-PHOTO REFERRAL: “A PICTURE CAN SPEAK A THOUSAND WORDS” AN ELECTRONIC
REFERRAL INCORPORATING SERIAL PHOTOGRAPHS IMPROVES RESPONSE TIME FOR
VASCULAR ASSESSMENT. RESULTS FROM A SINGLE - CENTRE PILOT STUDY
Gordon I, Layard B, Smyth J, Woodman A, Marshall W, Leonard N
Renal Unit, Ulster Hospital, Belfast
P143 PROMOTING GREEN NEPHROLOGY: IS IT TIME TO SWITCH OFF PAPER REPORTING OF
PATHOLOGY AND RADIOLOGY RESULTS?
Hazar AM, Boyalla V, Wallace K, Bhandari S
Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust
P144 THE IMPACT OF SOCIAL MEDIA TO INCREASE PATIENT INFORMATION PROVISION,
NETWORKING AND COMMUNICATION - KIDNEY INFORMATION NETWORK (KIN)
Vasilica C, and Ormandy P, University of Salford; Powell S and Pennington K.
Hope Hospitals Kidney Patients Association
Medicines Management (Friday 2nd May 13.00 – 14.00) moderated by Aileen Dunleavy
P262 DALTEPARIN VENOUS THROMBO EMBOLISM PROPHYLAXIS IN PATIENTS WITH RENAL
IMPAIRMENT
Ali MN1, Allan KL1, Lines SW1, Ackroyd S2, Stoves J1
¹Department of Renal Medicine, Bradford Royal Infirmary (BRI)
²Department of Haematology, Bradford Royal Infirmary (BRI)
P263 PRIMARY INTRAVENOUS (IV) FLUID PRESCRIBING AND MONITORING AUDIT
Biggs M, Sabin E, Thomson C, Whybra N, University Hospitals Leicester
P264 PRESCRIBING PATTERNS OF CARDIOPROTECTIVE MEDICATIONS IN CHRONIC KIDNEY
DISEASE AND END STAGE KIDNEY DISEASE
Chiu D, Abeygunarathne T, Ritchie J, Alderson H, Sinha S, Kalra PA, Green D
Institute of Population Health, University of Manchester
P265 CROSS-SECTIONAL STUDY OF HYPONATRAEMIA ASSOCIATED WITH PRESCRIBED
MEDICATIONS IN CHRONIC KIDNEY DISEASE
Chiu D, Green D, Sinha S, Kalra PA
Salford Vascular Research Group, University of Manchester, MAHSC, Manchester
P266 TIME TO CLEAR OUT THE BATHROOM CABINET! AN AUDIT OF UNUSED MEDICATIONS AT A
HAEMODIALYSIS UNIT
Flint J, Patel K and Connolly J, Renal Unit, Royal Free London NHS Foundation Trust
P267 LOW DOSE TINZAPARIN AS VENOUS THROMBOEMBOLISM PROPHYLAXIS IN CHRONIC
KIDNEY DISEASE – A SINGLE CENTRE STUDY
Forbes SH, Ali I, Zaman A, Ashman N
Department of Nephrology and Transplantation, Royal London Hospital
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P268 USE OF ENOXAPARIN AND ANTI-FACTOR XA MONITORING IN A RENAL OBSTETRIC
COHORT
Sarween N1, Probert L1, Webster J2, Lester W2, Knox E3, Lipkin G1 and Day C1
University Hospital Birmingham NHS Foundation Trust, Department of Renal Medicine1
Birmingham Women’s NHS Foundation Trust, Department of Haematology2 and Obstetrics3
Nephritis (Friday 2nd May 13.00 – 14.00) moderated by Liz Lightstone
P222 LONG-TERM OUTCOME OF NEPHROTIC SYNDROME SECONDARY TO PRIMARY FOCAL
SEGMENTAL GLOMERULOSCLEROSIS TREATED WITH TACROLIMUS MONO-THERAPY
Connor T, Levy J, Tarzi R, Pusey C, Galliford J, Cairns T, Griffith M
West London Renal & Transplant Centre, Hammersmith Hospital, London
P223 COMPARING ANTI-DOUBLE STRANDED DNA ANTIBODY ASSAYSTO MONITOR PATIENTS
WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Egan A1, Agama J2, Pantelidis P3, Dodd P1, Kelleher P3, Lightstone L1, Botto M2
Department of Renal Medicine1, Centre for Complement and Inflammation Research2, Department
of Infection and Inflammation3, Hammersmith Hospital, Imperial College London
P224 OUTCOMES OF PATIENTS WITH ACUTE TUBULOINTERSTITIAL NEPHRITIS AT THE OXFORD
KIDNEY UNIT
Judge PK, Dasgupta T, Roberts I, Winearls CG, Oxford Kidney Unit, Churchill Hospital, Oxford
P225 RENAL DISEASE IN PATIENTS TREATED WITH ALEMTUZUMAB FOR MULTIPLE SCLEROSIS
Phelps RG
Renal Autoimmunity Group, Queen’s Medical Research Institute, University of Edinburgh
P226 THE USE OF A LOW-DOSE PREDNISOLONE REGIMEN TO TREAT A RELAPSE OF STEROID
SENSITIVE NEPHROTIC SYNDROME IN CHILDREN
Raja K, Hothi D, Webb H, Great Ormond Street Hospital, London
33
P227 A RETROSPECTIVE ANALYSIS OF PATIENTS WITH IDIOPATHIC MEMBRANOUS
NEPHROPATHY TREATED WITH STEROIDS AND INTRAVENOUS CYCLOPHOSPHAMIDE
Ramphul R1, Kamal R1, Makanjuola D1, Suckling R1, Harris F1, Sood B1
1
Renal Unit, St. Helier Hospital, Carshalton, Surrey
P228 LONG TERM TREATMENT OF LUPUS NEPHRITIS WITH MYCOPHENOLATE MOFETIL (MMF) IS
ASSOCIATED WITH AS GOOD LONG TERM OUTCOMES AS MAINTENANCE TREATMENT
WITH MMF AFTER CYCLOPHOSPHAMIDE (CYP)
Rodriguez-Cubillo B, Panagoutsos S, Juega J, Griffith M, Cairns T and Lightstone L
Imperial College Healthcare NHS Trust Lupus Centre, Hammersmith Hospital, London
P229 THE USE OF CYCLOPHOSPHAMIDE OR MYCOPHENOLATE MOFETIL AS INDUCTION
THERAPY FOR LUPUS NEPHRITIS IN A LARGE NEPHROLOGY CENTRE
Salter T, Burton H, Suckling R, Makanjuola D, Harris F, St Helier Hospital, Carshalton, Surrey
Nutrition: Role of the Dietitian/Intervention (Thursday 1st May 12.45 – 13.45)
moderated by Jan Flint
P145 PATIENT EXPERIENCE OF THE RENAL DIETETIC SERVICE IN PRE-DIALYSIS CLINIC
Campbell R, Central Manchester University Hospitals NHS Foundation Trust
P146 ACCURACY OF BODY MASS INDEX USED IN RENAL ASSOCIATION GUIDELINES FOR
UNDERNUTRITION: THE IMPORTANCE OF PATIENT HEIGHT MEASUREMENT
Charter C, Renal Dietetic Department, Kent Kidney Care Centre, East Kent Hospitals University NHS
Foundation Trust
P147 AUDIT OF CHANGES IN NUTRITIONAL STATUS IN LOW CLEARANCE CLINICS OVER A 1
YEAR PERIOD: OVER VERSUS UNDER NUTRITION
Hannah J, Wells LM, Brenchley V, Jones CH,
Department of Renal Medicine, York Hospital NHS Foundation Trust
P148 THE EVER DEVELOPING ROLE OF THE RENAL DIETETIC PRACTITIONER AT THE HEART OF
ENGLAND FOUNDATION TRUST
Hines B & Renal Dietetic Team, Heart of England Foundation Trust
P149 A QUESTIONNAIRE TO DETERMINE THE RENAL DIETARY KNOWLEDGE OF CLINICAL STAFF
WORKING WITHIN THE RENAL MULTIDISCIPLINARY TEAM
MacAskill E. Dietetic Department and Department of Renal Medicine, Manchester Royal Infirmary
P150 SAFETY AND EFFICACY OF BARIATRIC SURGERY IN OBESE PATIENTS WITH CKD: THE
LONDON RENAL OBESITY NETWORK (LonRON) EXPERIENCE
MacLaughlin HL1, Macdougall IC1, Ahmed AR2, Patel AG1, Chang A1, Burns A3, Finer N4, Chalal H2,
Tharakan G2, Pucci A4, Tam FWK2, Johansson L2, Flint J3, Frankel AH2
1
King’s College Hospital, London, 2Imperial College Healthcare, London ³Royal Free London,
4
University College London Hospitals
P151 PREVALENT NATIVE VITAMIN D LEVELS WITHIN A NORTHERN IRISH CHRONIC KIDNEY
DISEASE POPULATION
McKee J, Hutchinson N, Bradley L, McManus M, Cunningham R, Mullan R, Quinn M, Harron C.
Renal Unit, Antrim Area Hospital, Northern Ireland
P152 BARIATRIC SURGERY IN END STAGE RENAL FAILURE, A SCOPING EXERCISE TO REVIEW
CURRENT PRACTICE OF NUTRITIONAL MANAGEMENT
Ramsey Z, Franklin G,, Department of Renal Medicine, Lister Hospital
P153 IMPROVING REGIONAL PAEDIATRIC DIETETIC CARE FOR CHILDREN WITH CHRONIC
KIDNEY DISEASE
Trace S, Inward C, Bristol Royal Hospital for Children
Nutrition in Dialysis (Wednesday 30th April 13.30 – 14.30)
moderated by Deepa Kariyawasam
P154 NUTRITION IMPACT SYMPTOMS (NIS): IS NIS ALONE EFFECTIVE AS A SCREENING TOOL TO
PREDICT MALNUTRITION IN PATIENTS ON A RENAL UNIT?
Blain S1, Yacoob S1, MacLaughlin H2
1
London Metropolitan University, 2King’s College Hospital London
P155 EXAMINING CHANGES IN HAND GRIP STRENGTH, BODY MASS INDEX AND SUBJECTIVE
GLOBAL ASSESSMENT IN PERITONEAL DIALYSIS
Clackson H, Kariyawasam D, Blacklock R, MacLaughlin HL
King’s College Hospital NHS Foundation Trust
P156 EVALUATION OF FOOD INTAKE DURING HAEMODIALYSIS – AN AUDIT OF SIX SATELLITE
UNITS IN NORTH CENTRAL LONDON
Desaim M1, Hollis T2, Flint J1
1
Department of Renal Dietetics, Royal Free London NHS Foundation Trust, 2London Metropolitan
University
P157 IS APPETITE OR KNOWLEDGE ASSOCIATED WITH HYPO- OR HYPERPHOSPHATEMIA IN
OUR HAEMODIALYSIS POPULATION?
Fletcher SJ1,2, Willingham FC1,2, Leung JC2, Taal MW2
1
Nutrition and Dietetic Department, Royal Derby Hospital, Derby, 2Department of Renal Medicine,
Royal Derby Hospital, Derby
P158 DIETETIC ADVICE FOR HOME HAEMODIALYSIS PATIENTS: IS THERE AN UNMET NEED?
Glover S¹, Mitra S²
¹Department of Nutrition and Dietetics, Manchester Royal Infirmary (MRI), ²Department of Renal
Medicine, Manchester Royal Infirmary
P159 NOURISH: NUTRITIONAL OUTCOMES FROM A RANDOMISED INVESTIGATION OF
INTRADIALYTIC ORAL NUTRITIONAL SUPPLEMENTS IN PATIENTS RECEIVING
HAEMODIALYSIS. A PILOT RANDOMISED CONTROLLED TRIAL
Jackson L¹, Sully B², Cohen J², and Julious S²
1
Northern General Hospital, 2Sheffield teaching Hospitals NHS Foundation Trust, Sheffield Introduction
P160 AN AUDIT OF WATER SOLUBLE VITAMIN SUPPLEMENTATION IN RENAL DIALYSIS PATIENTS
Jackson R¹, Williams H¹, Vardhan A², Hughes S²,
¹Department of Nutrition and Dietetics, Manchester Royal Infirmary, ²Department of Renal Medicine,
Manchester Royal Infirmary
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P161 IMPROVEMENT IN NUTRITIONAL STATUS OF A HAEMODIALYSIS PATIENT WITH SEVERE
ANXIETY ACHIEVED BY EFFECTIVE MULTIDISCIPLINARY TEAM WORKING – A CASE REPORT
King M, Department of Nutrition and Dietetics, Salford Royal NHS Foundation Trust
P162 AUDITING THE NUTRITIONAL STATUS AND BONE MANAGEMENT OF A HOME
HAEMODIALYSIS POPULATION AGAINST THE RENAL ASSOCIATION STANDARDS FOR
NUTRITION
Peacock V1, Mafrici B1, Porter C.J2, Bebb C2, Roe S2
1
Dietetic and Nutrition Department, Therapy Services, Nottingham University Hospital NHS Trust
2
Renal and Transplant Unit, Nottingham University Hospital NHS Trust
P163 OBESITY IN THE SCOTTISH HAEMODIALYSIS POPULATION: A GROWING PROBLEM?
Reed S1, Ferenbach H1, Traynor JP2, Metcalfe W2 on behalf of the Scottish Renal Registry
1
Dietetic Department, Renal Unit, Royal Infirmary of Edinburgh, 2Scottish Renal Registry
Patient Experience (Thursday 1st May 12.45 – 13.45) moderated by Helen Hurst
P269 DIALYSIS PATIENTS’ REPORTED SYMPTOMS – THE UNMET NEED FOR PAIN CONTROL
Afuwape S.A, Cross J, Alston H, Nitsch, D, Davenport, A, Royal Free London NHS Foundation Trust
P270 IMPROVING THE PATIENT EXPERIENCE IN A SATELLITE DIALYSIS UNIT
Andersen J¹, Babu V¹, Cox B¹, Duncan N², Edwards C², Myung J¹, Ho X¹, Patell R, Rahman R¹ and
Taube D²
¹Imperial College Business School, London, ²Imperial College Renal and Transplant Centre
P271 ABO INCOMPATIBLE KIDNEY TRANSPLANTATION (ABOIKTX) – BEGINNING TO ASSESS THE
PATIENT EXPERIENCE
Bentall A, Jandu S, Sharif A, Inston N, Ball S
Department of Renal Medicine and Surgery, Queen Elizabeth Hospital Birmingham
34
P272 A CROSS-SECTIONAL QUALITY OF LIFE SURVEY IN A COHORT OF HEMODIALYSIS
PATIENTS
Elliott M, Devine P, Hanko J.
Regional Nephrology Unit, Belfast City Hospital, Belfast, Northern Ireland
P273 QUALITY OF LIFE MEASUREMENT IN PATIENTS ON RENAL REPLACEMENT THERAPY (RRT):
THREE YEARS EXPERIENCE
Kleszcz E*, Sherwood E*, Natarajan B, Dickinson S, Johnston P, Stratton J, and Parry R.G
Peninsula Medical School* and Renal Unit, Royal Cornwall Hospital (RCHT), Truro
P274 WITH ONLINE NOTES AND INCREASINGLY COMPUTER-BASED CLINICS, ARE WE LOSING
IMPORTANT PATIENT-DOCTOR INTERACTION?
Murray A, McHugh M, Moore I, Renal Unit, City Hospitals Sunderland
P275 IMPROVING PATIENTS EXPERIENCE OF DIALYSIS TREATMENT THROUGH TRANSFORMING
CARE
Navarro J, Thorne M, Clark T. Renal Nurses, Main Dialysis Unit, Cardiff and Vale UHB
P276 EVALUATING PATIENT EXPERIENCE AND UNDERSTANDING OF ACUTE KIDNEY INJURY: A
FEASIBILITY STUDY
Wilson H, Chandrasekera H, Bowen E, Jayawardene S, Elias R, Wang J, King’s College Hospital
Peritoneal Dialysis (Wednesday 30th April 13.30 – 14.30) moderated by Graham Woodrow
P127 DIAGNOSING TUBERCULOUS PERITONITIS EARLY: A CASE REPORT ON USING XPERT
MTB/RIF ASSAY
Edwards S1, David M2 and Kamesh L1
1
Renal Unit, 2Department of Microbiology, Queen Elizabeth Hospital, Birmingham
P128 A BREAK FROM DAILY PERITONEAL DIALYSIS ENHANCES PATIENT EXPERIENCE
Haddoub S, McGrory J, Hisole N, Clemenger, M, Brown, E
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
P129 FRAIL ELDERLY PATIENT OUTCOMES ON DIALYSIS (FEPOD) PART 1: DESCRIPTIVE
ANALYSIS OF SECONDARY OUTCOMES
Iyasere O, Johansson L, Smee J, Huson L, Brown E.A, and FEPOD 1 Investigators
Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust; Renal units
SE England and Northern Ireland
P130 A 6 YEAR RETROSPECTIVE REVIEW OF NURSE LED PATIENT PATHWAY FOR INSERTION OF
PERITONEAL DIALYSIS CATHETERS
Knaggs A, Martin J, Lewis D, Department of Renal Medicine Salford Royal Foundation Trust, Hannay
H, Baxter Healthcare, Lappin L, University of Salford
P131 EXTRAPERITONEAL PERCUTANEOUS PHYSICIAN INSERTED PERITONEAL DIALYSIS
CATHETER: AN UNUSUAL COMPLICATION
Lewis D, New D, Dhaygude A, Green A, Halpin J
Departments of Renal Medicine, Salford Royal and Preston Hospitals
P132 A DIFFERENT DIRECTION OF TRAVEL? 4 YEAR RETROSPECTIVE SINGLE CENTRE REVIEW
OF PATIENT TRANSFER FROM HAEMODIALYSIS TO PERITONEAL DIALYSIS
Lewis D¹, Carney A¹, Lappin L²
Department of Renal Medicine, Salford Royal Foundation Trust¹ and University of Salford²
P133 ASSISTED PD FOR NORTHERN IRELAND
Mawhinney S, Belfast City Hospital
P134 IT’S IN THE BAG
McMullan G, Belfast City Hospital
P135 DIAGNOSTIC AND PROGNOSTIC ROLE OF PERITONEAL CA 125 IN PERITONITIS
EPISODES IN PD PATIENTS: A BRIEF REPORT
Panorchan K, Davenport A, UCL Center for Nephrology, Royal Free Hospital
P136 THE DEVELOPMENT OF A PATIENT EDUCATION PACKAGE FOR ADULT PATIENTS ON
PERITONEAL DIALYSIS: TO IMPROVE KNOWLEDGE AND UNDERSTANDING OF DIALYSIS
RELATED INFECTIONS
Ward K, Worsey L, Hagan S, Hamm H, Swainson-Corby P, Taal M, Fluck R
Peritoneal Dialysis Team, Royal Derby Hospital
P137 SODIUM CROMOGLYCATE IN EOSINOPHILIC PERITONITIS –RESULTS FROM A SINGLE
CENTRE PAEDIATRIC STUDY
Yadav P, Kumaraswamy M, Shroff R, Ledermann S, Great Ormond Street Hospital
Quality Improvement (Wednesday 30th April 13.30 – 14.30) moderated by Hugh Gallagher
P184 HAEMODIALYSIS TRIGGER TOOL: OUR EXPERIENCE AFTER ONE YEAR OF
IMPLEMENTATION
Fielding C, Rhodes C, Chesterton L, Fluck R, Lambe G, Inacay G and Taal M
Department of Renal Medicine, Derby Hospitals NHS Foundation Trust
P185 IMPROVING TIMELY LISTING FOR TRANSPLANT USING COMMISSIONING FOR QUALITY
AND INNOVATION (CQUIN) FRAMEWORK
Gair R, Boorer L, Ash N, Plymouth Hospitals NHS Trust
P186 LAUNCHING A QUALITY IMPROVEMENT DEVELOPMENT GROUP FOR KIDNEY CARE
Gallagher H1,2, Loud F2, Tomson C3, Wilkie M4, on behalf of the QI Development Group for Kidney
Care
1
SW Thames Renal Unit, St. Helier Hospital, Surrey; 2Kidney Health Team; 3Southmead Hospital,
North Bristol NHS Trust; 4Sheffield Teaching Hospitals NHS Foundation Trust
P187 WHAT CONTEXTUAL FACTORS IMPACT ON QUALITY IMPROVEMENT SUSTAINABILITY AT
THE CLINICAL FRONT-LINE?
Lappin LP and Ormandy P, The University of Salford
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P188 DAY CASE RENAL BIOPSY IS SAFE AND EFFECTIVE IRRESPECTIVE OF RENAL FUNCTION:
RESULTS FROM A SINGLE-CENTER EXPERIENCE
Muthuppalaniappan V, Byrne C, Sheaff M, Rajakariar R & Blunden M
Department of Renal Medicine, The Royal London Hospital
P189 REAL TIME MONITORING OF PROGRESSION TOWARDS RENAL FAILURE IN PRIMARY CARE
PATIENTS
Peter D1,2, Ines S3, Ozgur A1
1
Lancaster Medical School, Lancaster University, 2Institute of Infection and Global Health, University of
Liverpool, 3Department of Mathematics and Applications, University of Minho, Portugal
P190 MOVING FORWARD WITH CHANGES IN PRACTICE THROUGH A MULTIDISCIPLINARY RENAL
DEVELOPMENTS MEETING
Ridley L and Wells L on behalf of the Multidisciplinary Renal Team (MDT), York Hospital NHS
Foundation Trust, York
P191 PRIORITIES FOR QUALITY IMPROVEMENT IN HAEMODIALYSIS: A BRS/UKRR NATIONAL
SURVEY
Shaw S1, Casula A1, Cullen R1, Fluck R2, Tomson C3
1
Renal Registry, 2Royal Derby Hospitals, 3Southmead Hospital
P192 NOT JUST ABOUT THE NUMBERS: USING QUALITY IMPROVEMENT METHODOLOGY TO
IMPROVE STAFF ENGAGEMENT AND PATIENT CARE
Youssouf S, Adamson S, Hegarty J
On behalf of the Collaborative in Kidney Replacement Therapies, Department of Renal Medicine
Salford Royal NHS Foundation Trust
Rehabilitation & Exercise (Thursday 1st May 12.45 – 13.45)
moderated by Sharlene Greenwood
35
P208 ETHNIC VARIATIONS IN SELF-REPORTED FUNCTIONAL CAPACITY IN CHRONIC KIDNEY
DISEASE
Aukland M, Clarke AL, Hull K, Burton JO, Smith AC
Leicester Kidney Exercise Team, John Walls Renal Unit, University Hospitals of Leicester, and
Department of Infection, Immunity and Inflammation, University of Leicester
P209 THE PREVALENCE, PREDICTORS AND IMPACT OF REDUCED CARDIORESPIRATORY
FITNESS IN PREVALENT KIDNEY TRANSPLANT RECIPIENTS
Chan W1,2, Jones D3, Phillips A2, Bosch J2, McTernan P4, Inston N1, Moore S1, Kaur O1,
McClean A1, Harper L1, Borrows R1,2
1 Shared Decision Making (Wednesday 30th April 13.30 – 14.30)
QEH, Birmingham, 2University of Birmingham, 3Manchester Metropolitan University, 4University of
Warwick
P210 PHYSICAL ACTIVITY LEVELS IN KIDNEY TRANSPLANT RECIPIENTS
Clark R1, O'Connor E1, Lindup H1, Mercer T2, Hendry B3, Macdougall I4 and Greenwood S1
Department of Physiotherapy, King’s College Hospital, London1, Queen Margaret University,
Edinburgh2, King’s College London3, Department of Renal Medicine King’s College Hospital,
London4
P211 EXERCISE AND PHYSICAL ACTIVITY BEHAVIOUR IN CHRONIC KIDNEY DISEASE: PATIENT
PERSPECTIVES AND READINESS TO CHANGE
Clarke AL,1, Young HML,1, Hull KL,1, Hudson N,2, Burton JO,1, Smith AC1
1
Leicester Kidney Exercise Team, Dept of Renal Medicine, University Hospitals of Leicester and
Dept of Infection, Immunity and Inflammation, University of Leicester, 2School of Applied Social
Sciences, De Montfort University
P212 PHYSICAL CAPACITY AND EXERCISE PATTERNS IN CHRONIC KIDNEY DISEASE VARY
DEPENDING ON PRESENCE OR ABSENCE OF MEDICAL CO-MORBIDITY
Graham-Brown MPM1, Clarke AL1,2, Hull KL1,2, John, SG3, Smith AC1,2, Burton JO,1,2
1
Leicester Kidney Exercise Team, John Walls’ Renal Unit, University Hospitals of Leicester NHS
Trust, Leicester, 2Department of Infection, Immunity & Inflammation, University of Leicester,
Leicester, 3Department of Renal Medicine, Royal Derby Hospital, Derby
P213 EXERCISE COUNSELLING PRACTISES FOR PATIENTS WITH CHRONIC KIDNEY DISEASE IN
THE U.K: A RENAL MULTIDISCIPLINARY TEAM PERSPECTIVE
Greenwood S1, Koufaki P2, Rush R2, Macdougall I1, O’Connor, E1, Mercer T2
1
King’s College Hospital, London, 2Queen Margaret University, Edinburgh
On behalf of the British Renal Society Rehabilitation Network
P214 PHYSICAL ACTIVITY BEHAVIOUR IN KIDNEY TRANSPLANT RECIPIENTS
Lloyd-Davies LH, Clarke AL, Brown SA, Hull KL, Burton JO, Smith AC,
Leicester Kidney Exercise Team, John Walls Renal Unit, University Hospitals Leicester and
Department of Infection, Immunity and Inflammation, University of Leicester
P215 EVALUATION OF DIFFERENT APPROACHES TO EXERCISE PRESCRIPTION IN OBESE
PATIENTS WITH CHRONIC KIDNEY DISEASE ATTENDING A RENAL WEIGHT MANAGEMENT
PROGRAMME
O’Connor E1, Blacklock R2, Clark R1, Lindup H1, Macdougall I3 & Greenwood S1
Departments of Physiotherapy1, Nutrition and Dietetics2 and Renal Medicine3, King’s College
Hospital, London
Research Method (Thursday 1st May 12.45 – 13.45) moderated by Paula Ormandy
P174 PUBLIC AWARENESS OF RESEARCH ACTIVITY AT AN NHS FOUNDATION TRUST RENAL
DEPARTMENT - ‘A TRIGGER FOR IMPROVEMENT’
Chiu D, Summersgill C, Cox J, Kershaw M, Wilson C, Lane B, Blood J, Dimza D, Kalra PA
Vascular Research Group, Department of Renal Medicine, Salford Royal NHS Foundation Trust,
Salford
P175 THE IMPACT OF A DIRECTORATE RESEARCH CO-ORDINATOR TO INCREASE CLINICAL
RESEARCH ACTIVITY
Dunn L, Wilkie M, on behalf of the Renal Directorate, Sheffield Teaching Hospitals
P176 PATIENT INVOLVEMENT WITHIN RENAL RESEARCH DEPARTMENT HULL AND EAST
YORKSHIRE NHS TRUST
Hull S, Broddle J, Hazara A, James K, Bhandari S, Hull & East Yorkshire Hospitals NHS Trust
P177 FIRST PATIENT RECRUITED IN LESS THAN 70 DAYS? – A SOLUTION TO YOUR PROBLEM -
CONSENT 4 CONSENT (C4C)
Ullah A1, Howse M1, Burgess L2, Ganguli A2, Fitzgerald R2 and Henry C,3,
Nephrology1, Clinical Pharmacology2, Research and Development3 Department Royal Liverpool and
Broadgreen University Hospitals NHS Trust, Liverpool
moderated by Kate McCarthy
P277 NO DECISION ABOUT ME, WITHOUT ME EMBEDDING SUSTAINABLE SHARED DECISION
MAKING
Ash N, Gair R, Tse W, Watkins C, Derriford Hospital, Plymouth
P278 SHARED DECISION MAKING: A STEP IN THE RIGHT DIRECTION
Collier J, Dean J, Middleton R, Salford Royal NHS Foundation Trust
P279 UNTIL TEMPERED BY SHARED DECISION MAKING, PROFESSIONAL ENTHUSIASM FOR
HOME DIALYSIS THERAPIES CAN RESULT IN EXCEPTIONAL RATES OF PD-CHOICES
AMONGST PRE-DIALYSIS PATIENTS, BUT DOES NOT APPEAR ASSOCIATED WITH
INCREASED LEVELS OF DECISIONAL CONFLICT
Ferraro A, Fish M, Yeoh S-A, Coyne E
Renal and Transplant Unit. Nottingham University Hospitals NHS Trust
P280 SERVICE USERS PRE-DIALYSIS AND TREATMENT DECISION-MAKING EXPERIENCE: A SELF-
EFFICACY THEORY-BASED EDUCATION INTERVENTION
McCarthy K, Renal Services, University Hospitals Coventry & Warwickshire NHS Trust
P281 EMBEDDING SHARED DECISION MAKING IN CLINICAL PRACTICE: PATIENTS’ EXPERIENCES
Ofori-Ansah S, Anson R, Lawman S, Brighton and Sussex University Hospitals NHS Trust
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P282 OUTCOMES OF A COHORT OF PATIENTS STARTING DIALYSIS FROM CHOICE OF
TREATMENT -TO MODALITY OUTCOME- A RETROSPECTIVE OBSERVATIONAL STUDY TO
ASSESS SERVICE PROVISION
Richardson C, Barrett M, Dodds A, Ferris B, Baharani J
Department of Renal Medicine, Birmingham Heartlands Hospital
P283 PRAGMATIC OR AGEIST? SELECTION FOR CKD PATIENT GROUP EDUCATION BY AGE: ONE
UNIT’S EXPERIENCE
Wood E1, Israel L2,
1
Renal Unit, Royal Free Hospital, 2Renal Unit, Kings College Hospital
P284 A SIMPLE PACKAGE OF INTERVENTIONS CAN SIGNIFICANTLY INCREASE CLINICIAN
ENGAGEMENT WITH PEER SUPPORT SERVICES
Wood E, Department of Renal Medicine,The Royal Free Hospital
P285 PATIENT INVOLVEMENT IN DECISION-MAKING TO DRIVE QUALITY IN KIDNEY CARE:
SETTING THE AGENDA AND REDESIGNING THEIR SERVICE
Youssouf S, Pennington K, Poynton V, Hegarty J
Department of Renal Medicine, Salford Royal NHS Foundation Trust
Transplantation: Histopathology & Antibodies (Wednesday 30th April 13.30 – 14.30)
moderated by Will McKane
P230 CLINICOPATHOLOGICAL CORRELATION OF TRANSPLANT ASSOCIATED THROMBOTIC
MICROANGIOPATHY
Berry M1, Bardsley V2, Griffiths M2, Thiru S2, Torpey N1, Broecker V2
1
Transplant Unit, 2Department of Histopathology, Addenbrooke’s Hospital, Cambridge
P231 RENAL BIOPSY IN POTENTIAL DONORS WITH NON-VISIBLE HAEMATURIA:
36
A SINGLE CENTRE EXPERIENCE
Blunden M1, O'lone E1, Lee A2, Sheaff M2, Rajakariar R1, Thurasingham R1
1 3
Renal Unit Royal London Hospital, 2Histopathology Royal London Hospital
P232 IMPACT OF PRE-FORMED AND DE-NOVO MICA ANTIBODIES ON RENAL ALLOGRAFT
OUTCOMES IN TRANSPLANT RECIPIENTS SENSITISED BY PRE-FORMED, DONOR-SPECIFIC
HLA ANTIBODY
Dodd P, Willicombe M, Brookes P, Santos-Nunez E, Gunby N, Koutrousos K, Goodall D, Clarke C,
Charif R, Galliford J, McLean A, Taube D
Imperial College Renal & Transplant Centre, London
P233 CLASS I HLA-IGM DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH ANTIBODY
MEDIATED REJECTION AFTER RENAL TRANSPLANTATION
Dodd P, Willicombe M, Brookes P, Roufosse C, Santos-Nunez E, Goodall D, Moutzouris D, Clarke C, Charif
R, Galliford J, McLean A, Taube D
Imperial College Renal & Transplant Centre, London
P234 EARLY ALLOGRAFT BIOPSY FOLLOWING RENAL TRANSPLANTATION IN CHILDREN
Gurreebun BF, Lee CY, Roberts D, Plant ND, Webb NJ, Shenoy M.
Department of Paediatric Nephrology, Royal Manchester Children’s Hospital
P235 ALLOGRAFT SURVIVAL AFTER TRANSPLANTATION FOR IGA NEPHROPATHY OR FOCAL
SEGMENTAL GLOMERULOSCLEROSIS: RISKS OF RECURRENCE
Karim A, Bentall A, Metsini A, Neil D, Chatzitolios A, Hewins P, Lipkin G
Department of Renal Medicine, Queen Elizabeth Hospital Birmingham
Department of Pathology, Queen Elizabeth Hospital Birmingham
P236 FEATURES OF ANTIBODY MEDIATED REJECTION ARE ASSOCIATED WITH LATE RENAL
TRANSPLANT FAILURE- A SINGLE CENTRE STUDY
Patel R1,2*,Stevens K1,2, Kipgen D3, Stevenson K1, Clancy M1, Geddes C1
1 1
Glasgow Renal and Transplant Unit, Western Infirmary, Glasgow, 2Renal Research Group,
BHFGCRC, University of Glasgow, 3Department of Pathology, Southern General Hospital, Glasgow
P237 IMMUNOGENICITY OF DQ7 HLA ANTIGENS IN RENAL TRANSPLANTATION
Willicombe M, Brookes P, Santos E, Blow M, McLean A, Taube D
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
P238 SIGNIFICANCE OF TUBULORETICULAR INCLUSIONS IN RENAL ALLOGRAFTS
Willicombe M, Roufosse C, Moran L, Moss J, Taube D and Cook T
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
Transplantation: Viruses & Therapeutics (Thursday 1st May 12.45 – 13.45)
P239 HISTORY OF TACROLIMUS-INDUCED HYPOMAGNESAEMIA. RISK FACTORS AND
TREATMENT
Addulnabi K, Moberly J, Skaltsa N, Sharma A, Mehra S, Ridgway D, Howse M, Hammad A
The Royal Liverpool Hospital
P240 ECULIZUMAB TREATMENT FOR SEVERE ACUTE ANTIBODY-MEDIATED REJECTION (AMR) IN
ABO INCOMPATIBLE RENAL TRANSPLANTATION
Arunachalam C¹, Brown A¹, Talbot D¹, Sheerin N¹, Baines L¹, Carter V2, Watson E¹, Scuffell C¹
¹Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, 2Histocompatibility and
Immunogenetics, NHSBT Newcastle
P241 COMBINATION PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN THE TREATMENT OF
HEPATITIS C IN END STAGE RENAL FAILURE PATIENTS PRIOR TO TRANSPLANTATION: A
SINGLE CENTRE EXPERIENCE
Duraisingham SK1, Blunden M1, Marley R2, Thuraisingham, R1
Departments of Nephrology and Transplantation1 and Hepatology2, Barts Health NHS Trust, London
P242 CMV PROPHYLAXIS IN RENAL TRANSPLANT PATIENTS WITHIN THE NORTHERN REGION
DURING 2011 AND 2012
Davison R1,3, Dowen F1, Palfrey J2, Montgomery E4, Dallas F4, Reaich D2, Valappil M1 & Jones K1
1
Freeman Hospital, Newcastle upon Tyne, 2James Cook University Hospital, Middlesbrough,
Sunderland Royal Hospital, Sunderland, 4Cumberland Infirmary, Carlisle
P243 POST-TRANSPLANT GLOMERULONEPHRITIS FOLLOWING ALEMTUZUMAB INDUCTION IN
KIDNEY TRANSPLANTATION
Koutroutsos K¹, Loucaidou M¹, Roufosse C², Willicombe M¹, Charif R¹, Cook T², Taube D¹
¹Imperial College Kidney and Transplant Centre, London
²Department of Histopathology, Imperial Healthcare NHS Trust, London
P244 DE-NOVO ADVAGRAF IMMUNOSUPPRESSION IN CATEGORY III DCD KIDNEY
TRANSPLANTATION – A SINGLE CENTRE EXPERIENCE
Thanaraj V, Randhawa N, Knight A, Rigg KM, McHaffie G, Byrne C, Bhattacharjya S
Department of Renal Medicine and Renal Transplant Unit, Nottingham University Hospital
P245 ALLOGRAFT FAILURE AFTER ALEMTUZUMAB INDUCTION IN RENAL TRANSPLANTATION
Willicombe M, Goodall D, Charif R, Galliford J, McLean A and Taube D
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
Transplantation: Diabetes & Donation (Friday 2nd May 13.00 – 14.00)
moderated by Lisa Burnapp
P246 TOTAL 25-HYDROXYVITAMIN D LEVELS AND POST TRANSPLANT HYPERGLYCAEMIA
Chand S1, Shabir S1, Chan W2, Cramb R3, Borrows R1
1
Department of Nephrology, Queen Elizabeth Hospital Birmingham, 2Department of Nutrition &
Dietetics, Queen Elizabeth Hospital Birmingham, 3Department of Biochemistry, Queen Elizabeth
Hospital Birmingham
P247 β CELL GLUCOTOXIC-ASSOCIATED SNPS IN IMPAIRED GLUCOSE TOLERANCE AND NODAT
Chand S1, Shabir S1, Chan W1, McCaughan J2, McKnight AJ2, Maxwell AP2, Borrows R1
Renal Department, Queen Elizabeth Hospital Birmingham, 2Regional Genetics Unit, Belfast City
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P248 VARIATION OF GFR MEASUREMENTS IN POTENTIAL LIVE KIDNEY DONORS
Montgomery E1, Wroe C1, Richardson M2, Hedley S2
1
Renal Department, 2Nuclear Physics Department, James Cook University Hospital, Middlesbrough
P249 NEW ONSET DIABETES AFTER KIDNEY TRANSPLANTATION DESPITE THE USE OF A
STEROID-SPARING REGIME IS ASSOCIATED WITH A HIGHER MORTALITY FROM CARDIAC
CAUSES
Moutzouris DA, Baker C, Kumar N, Willicombe M, Duncan N, Corbett R, Galliford J, McLean A,
Taube, D
Imperial College Renal and Transplant Centre Hammersmith Hospital, London
P250 NEW ONSET DIABETES AFTER KIDNEY TRANSPLANTATION [NODAT] DESPITE THE USE OF
A STEROID-SPARING REGIME
Moutzouris DA, Baker C, Kumar N, Willicombe M, Duncan N, Corbett R, Galliford J, McLean A,
Taube D
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London
P251 INCREASING SOUTH ASIAN ORGAN DONATION THROUGH STRATEGIC INTERVENTION
Pradeep A, University of Salford, & Central Manchester Foundation Trust, Ormandy P, University of
Salford; Augustine T, Central Manchester Foundation Trust
P252 DIAGNOSTIC GENETIC TESTING IN ADPKD MAY INCREASE LIVING RELATED KIDNEY
TRANSPLANTATION
Simms RJ1, Travis D2, Durkie M2, Ong ACM3
1
Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN; 2Sheffield Diagnostic Genetics
Service, Sheffield Children’s NHS Foundation Trust, S10 2TH; 3Kidney Genetics Group, Academic
Unit of Nephrology, University of Sheffield, S10 2RX
P253 LIVE KIDNEY DONOR WORK UP – WHAT LIES BENEATH THE TIP OF THE ICEBERG
Thanaraj V, Theakstone A, Stopper K, Evans L, Ferraro A, Devonald M, Williams A
37
Bhattacharjya S, Renal Transplant Unit, Nottingham University Hospital NHS Trust
Transplantation/Miscellaneous (Wednesday 30th April 13.30 – 14.30)
moderated by Sian Griffin
P254 THE EFFECT OF AMILORIDE ON TACROLIMUS-INDUCED HYPOMAGNESAEMIA
Abdulnabi K, Moberly J, El-Bakry A, Mehra S, Sharma A, Ridgway D, Hammad A, Howse M
Department of Kidney Transplantation, The Royal Liverpool Hospital
P255 THE ROLE OF MYOCARDIAL PERFUSION IMAGING IN DETERMINING SUITABILITY FOR
RENAL TRANSPLANTATION
Callan P, Bhandari S, Tweddel A, Eadington D, Clark A, Wright G, Papodopolous M
Hull and East Yorkshire NHS Trust
P256 CHANGE IN BMI FOLLOWING EARLY STEROID WITHDRAWAL IN PAEDIATRIC RENAL
TRANSPLANT RECIPIENTS
Hussain U, Webb N, Shenoy M, Department of Paediatric Nephrology, Royal Manchester Children’s
Hospital
P257 LOW INCIDENCE OF CARDIAC DEATH AFTER RENAL TRANSPLANTATION IN PATIENTS
UNDERGOING PRE-EMPTIVE CORONARY ANGIOGRAPHY AND REVASCULARISATION
Moutzouris DA, Baker C, Kumar N, Willicombe M, Duncan N, Corbett R, Galliford J, McLean A,
Taube D
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London
P258 DETERIORATING RENAL FUNCTION IN LONG-TERM RENAL ALLOGRAFTS: DOES
ALLOGRAFT BIOPSY PROVIDE EFFECTIVE SOLUTIONS EVEN AT A LATE STAGE?
Nagaraja P¹, Rees D.O¹, Shrivastava R¹, Howarth S², Parker C¹, Aithal V.S¹
¹Renal Unit and ²Department of Pathology, Morriston Hospital, Swansea
P259 OUTCOME, GROWTH AND BODY COMPOSITION MONITORING IN PAEDIATRIC RENAL
TRANSPLANT RECIPIENTS IN LEEDS OVER THE LAST 5 YEARS
Norton D, Tyerman K, Lindley E, Ahmad N
Department of Paediatric Nephrology, Leeds Teaching Hospitals NHS Trust
P260 RENAL FUNCTION, SERUM PHOSPHATE, SERUM ADJUSTED CALCIUM AND BLOOD
PRESSURE FOLLOWING LIVE DONOR NEPHRECTOMY
Reid DJJ, Stevens KK, Clancy M, Geddes CC.
Glasgow Renal & Transplant Unit, Western Infirmary, Glasgow
P261 PREGNANCY OUTCOMES IN RENAL TRANSPLANT RECIPIENTS: A SINGLE-CENTRE STUDY
Stoumpos S1, McNeill S1, McPherson K2, Gorrie M1, Brennand J2, Geddes C1, Deighan C1
1
Glasgow Renal and Transplant Unit, 2Maternity Unit, Southern General Hospital
Vascular Access Outcomes (Thursday 1st May 12.45 – 13.45)
moderated by Graham Warwick
P193 A RETROSPECTIVE STUDY OF FIRST PERMANENT VASCULAR ACCESS OUTCOMES IN
INCIDENT HAEMODIALYSIS PATIENTS
Alexander C, Joss N, Raigmore Hospital, Inverness
P194 HAEMODIALYSIS VASCULAR ACCESS: PATIENT VALUES AND FISTULA REFUSAL
Ashby D, Johansson L, Duncan N, Crane J
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
P195 HAEMODIALYSIS VASCULAR ACCESS: PATIENT REASONING, SOURCES OF INFLUENCE AND
FISTULA REFUSAL
Ashby D, Johansson L, Duncan N, Crane J
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London
P196 DEVELOPMENT OF A TRAINING PACKAGE TO ASSIST SENIOR HAEMODIALYSIS NURSING
STAFF TO UTILISE ULTRASOUND IMAGES TO ASSESS ARTERIO-VENOUS FISTULAE
Fielding CA, Owen P, Chesteron L, Fluck RJ and Pitt H
Department of Renal Medicine, Derby Hospitals NHS Foundation Trust
P197 30-DAY MORTALITY FOR HAEMODIALYSIS VASCULAR ACCESS SURGERY INCREASES WITH
MODE OF ANAESTHESIA AND TYPE OF ACCESS; RESULTS FROM A 5-YEAR SINGLE
CENTRE STUDY
Jorna T, Bushnell J, Ravanan R, Mouton R, Weale A
Richard Bright Renal Unit, Southmead Hospital, Bristol
P198 EFFECT OF ANTI-THROMBOTIC MEDICATION ON PRIMARY FAILURE RATE AND SURVIVAL
OF SIMPLE ARTERIOVENOUS FISTULAE
Murley A, Wijewardane A, Powers S, Allen C, Hollingsworth L, Baharani J, Wilmink T
Departments of Renal Medicine and Vascular Surgery, Heart of England Foundation Trust,
Birmingham
P199 NATIVE VALVE ENDOCARDITIS IN HAEMODIALYSIS PATIENTS USING BUTTON HOLE
CANNULATION
Williams JK, Bingham C, D’Souza RJ, Oakaby L
Exeter Kidney Unit, Royal Devon and Exeter Hospital
Vascular Access: Salvaging Access (Friday 2nd May 13.00 – 14.00)
moderated by Nick Fardon
P200 ARTERIOVENOUS FISTULA (AVF) THROMBOSIS: RISK FACTORS AND ROLE OF
ANTIPLATELET THERAPY, WARFARINISATION AND THOMBOPHILIA SCREEN
Abdulnabi K1, Morcos M1, Denham N1, Ullah A1, Khalil A1, Howse M1, Anijeet H1, Alexander J1,
Pai P1, Rylands I4, Powell S2, Ridgway D3
Nephrology Department1, Radiology Department2, Renal Transplant Department3, The Royal
Liverpool University Hospital, Edge Hill University4
P201 DISTAL ARTERIOVENOUS FISTULA (AVF) FAILURE: RISK FACTORS
Abdulnabi K1, Lyon P1, Denham N1,Khalil A1, Howse M1, Anijeet H1, Rylands I2, Alexander J1,
Pai P1, Powell S1, Ridgway D1
1
The Royal Liverpool Hospital, 2Edge Hill University
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
P202 FAILURE OF VASCULAR ACCESS IN HAEMODIALYSIS PATIENTS; IS EARLY INTERVENTION
BENEFICIAL?
El-Damanawi R, Kershaw S, Petchey W, Campbell G
Renal Unit, Norfolk and Norwich University Hospital
P203 DYSFUNCTIONAL LINES AND NO DEFINITIVE ACCESS OPTIONS: YOU NEED A HERO
(HAEMODIALYSIS RELIABLE OUTFLOW DEVICE)
Inston NG, Tullett K, Jones R, Day C, Queen Elizabeth Hospital, Birmingham
P204 EVALUATION OF THE ANGIOJET RHEOLYTIC DEVICE IN MANAGING THROMBOSED
HAEMODIALYSIS ACCESS
Nicholas J, Collins M, Dyer J, Rangarajan B, Sandhu K, Newcross Hospital, Wolverhampton
P205 A RETROSPECTIVE ANALYSIS OF TUNNELLED FEMORAL VEIN CATHETER OUTCOMES IN
HAEMODIALYSIS PATIENTS
Ramphul R1, Kamal R1, Suckling R1, Swift P1
1
Renal Unit, St. Helier Hospital, Carshalton, Surrey
P206 THE FIRST USE OF A REVERSE –TUNNELLED HAEMODIALYSIS CATHETER REPAIR KIT AT
OUR HAEMODIALYSIS UNIT. A CASE STUDY
Stott A, Powell S, Anijeet H, The Royal Liverpool Hospital
P207 THE EFFECT OF ETHNICITY, SOCIOECONOMIC FACTORS AND COMORBIDITIES ON
PRIMARY FAILURE RATE AND SURVIVAL OF SIMPLE ARTERIOVENOUS FISTULAE
Wijewardane A, Murley A, Powers S, Allen C, Baharani J, Wilmink T
Departments of Renal Medicine and Vascular Surgery, Heart of England Foundation Trust,
Birmingham
Vasculitis (Wednesday 30th April 13.30 – 14.30) moderated by Jeremy Levy
38
P216 DISCONTINUATION OF IMMUNOSUPPRESSION IN ANCA ASSOCIATED VASCULITIS
Mason A1, Harper L2, Morgan M2
1 2
Sandwell and West Birmingham Hospitals, 2Queen Elizabeth Hospital Birmingham
P217 USE OF A FULLY HUMANIZED ANTI-CD20 MONOCLONAL ANTIBODY FOR B CELL
DEPLETION THERAPY IN ANCA-ASSOCIATED VASCULITIS
McAdoo SP, Bedi R, Griffiths M, Tarzi R, Pusey CD, Cairns T
Imperial College London and Imperial College Healthcare NHS Trust
P218 SECONDARY IMMUNODEFICIENCY IS ASSOCIATED WITH INCREASED RISK OF INFECTION,
POOR VACCINE RESPONSES AND INCREASED MORTALITY IN ANTI-NEUTROPHIL
CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS
Morgan M1, Richter A1, Flint J1, Yiannakis C1, Drayson M1, Goldblatt D2, Harper L1
1
University of Birmingham, Birmingham, 2Institute of Child Health, University College London,
London
P219 A RATIONALE FOR THE WIDER USE OF PLASMA EXCHANGE IN THE MANAGEMENT OF
ANCA VASCULITIS
Saunders A, Dhaun N, Kluth D, Royal Infirmary of Edinburgh
P220 BENEFITS OF A SPECIALISED CLINIC FOR THE MANAGEMENT OF ANCA-ASSOCIATED
SYSTEMIC VASCULITIS
Saunders A, Dhaun N. Kluth D, Royal Infirmary of Edinburgh
P221 UNITED KINGDOM & IRELAND VASCULITIS REGISTRY (UKIVAS) – CROSS-SECTIONAL DATA
ON THE FIRST 654 PATIENTS
Sznajd J1,2, Salama A3, Jayne D4, Chaudhry A4, Robson M5, Rosa J1, Barrett J1, Basu N6,
Moran S7, Venning M8, Harper J9, Luqmani R1, Watts R10, Little M11
1
NDORMS, University of Oxford, 2Medical College of Jagiellonian University, Poland, 3UCL Centre
for Nephrology, Royal Free, 4Department of Medicine, Addenbrooke’s Hospital, University of
Cambridge, 5King’s College London, 6Department of Epidemiology, University of Aberdeen, 7Cork
University Hospital, 8Manchester Royal Infirmary, 9Royal Liverpool University Hospital, 10Department
of Rheumatology, Ipswich Hospital NHS Trust, 11Trinity Health Kidney Centre, Trinity College Dublin,
Ireland
Young People (Thursday 1st May 12.45 – 13.45) moderated by Heather Maxwell
P286 PEG RELATED PROBLEMS IN CHILDREN WITH CYSTINOSIS
Arslan Z, Richards C, Waller S, Evelina London Childrens Hospital
P287 GETTING IT RIGHT TOGETHER- SUPPORTING YOUNG PERSONS WITH RENAL DISEASE AS
THEY MOVE INTO THE ADULT RENAL SERVICE
Collinson H, Kent M, Kirkham C, Renal Department, Hull and East Yorkshire Hospitals NHS Trust,
and McNicholas K, City Health Care Partnership (Community Interest Company), Hull
P288 A SINGLE-CENTRE EXPERIENCE OF A YOUNG ADULT NEPHROLOGY CLINIC
Hamilton AJ, Lewis V, Inward CD, Bingham C
Department of Renal Medicine, Royal Devon and Exeter Hospital
P289 IMPROVING STANDARDS OF CARE THROUGH EMEESY: A PAEDIATRIC NEPHROLOGY
NETWORK
Jepson S, Christian M, Children’s Renal and Urology Unit, Nottingham Children’s Hospital
P290 EXPLORING DEATHS IN YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE
Lentell L1, Shah P2, Lambert H1, Baines L1
1
BKPA ‘Supporting Young Adults’ Service, Newcastle upon Tyne NHS Foundation Trust,
Newcastle University
P291 AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN CHILDHOOD, WHAT ARE WE
DOING?
Richardson ARW1, Polubothu S1, Sinha MD2, Kerecuk L3, Winyard PJD1
1
Nephro-Urology Unit, UCL Institute of Child Health, 30 Guilford Street, London
2
Department of Paediatric Nephrology, Evelina Children's Hospital, London
3
Department of Nephrology, Birmingham Children's Hospital, Birmingham
P292 TWIN TO TWIN TRANSFUSION SYNDROME – THE LOST KIDNEY
Yadav P, Raychaudari R, Shroff R, Ledermann S,
Great Ormond Street Hospital, London
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
Science Poster Abstracts by Moderated Poster Group SP10 USE OF URINARY PEPTIDOMICS IN EXPERIMENTAL DIABETIC NEPHROPATHY TO
IDENTIFY CANDIDATE BIOMARKERS OF RENAL INJURY
1 3 2 2 2 1 2 2
Glomerular Nephritis & Vasculitis (Wednesday 30th April 13.30 – 14.30) Betz B , Cronshaw A , Cairns C , Manning J , Dunbar D , Hughes J , Mullins J , Conway B
1 2
moderated by Alan Salama & Lorraine Harper MRC Centre for Inflammation Research British Heart Foundation/Centre for Cardiovascular
3
Science, Proteomics Facility/Institute of Cell Biology, School of Biological Sciences, University of
SP1 LUPUS PODOCYTOPATHY: LUPUS RELATED OR MERE COINCIDENCE? Edinburgh
1 1,2 1 1,2
Antonelou M , Cook T , Cairns T , Lightstone L
1
Imperial College Healthcare NHS Trust Lupus Centre SP11 VASCULAR ENDOTHELIAL GROWTH FACTOR ENHANCES PODOCYTE PRODUCTION OF
2
Department of Medicine, Imperial College London PROTECTIVE COMPLEMENT PROTEINS
Keir LS¹, 2, Firth R¹, Welsh GI¹, Richards A³, Saleem MA¹
SP2 CHARACTERISING A POPULATION WITH SEROLOGICAL FEATURES OF ¹Academic renal unit, School of Clinical Sciences, University of Bristol ²Cell and Molecular Biology, the
ANCA-ASSOCIATED VASCULITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS Scripps Research Institute, La Jolla California ³Queens Medical Research Institute, University
Belcher J, Lochlainn MD, Burns A, Yang R, Salama A of Edinburgh
Department of Medical Sciences, University College London SP12 AN IN VITRO INVESTIGATION OF FACTORS THAT MODULATE PODOCYTE INSULIN
Department of Nephrology, Royal Free Hospital SENSITIVITY
Lay A, Welsh G & Coward R, Academic Renal Unit, University of Bristol
SP3 GENOME WIDE DNA METHYLATION PATTERNS IN ANCA ASSOCIATED VASCULITIS
1 2 2 1 1
Brown N , Williams S , O’Sullivan J , Venning M , Brenchley P SP13 THE EFFECTS OF XTRACELLULAR MATRIX COMPONENTS ON PODOCYTE PHENOTYPE
¹Renal Unit, Manchester Royal Infirmary, CMFT ². Genetics Department, St. Mary’s Hospital, CMFT Madne T¹, MacPhee I², Phanish M¹, Dockrell M¹
SP4 SENSING DNA? AIM FOR THE CYTOPLASM IN SYSTEMIC LUPUS ERYTHEMATOSUS ¹SWT Institute for Renal Research, London², St George’s University of London
Egan A¹, Pacyna J², Blagrove M², Jones M² Department of Medicine¹, Genomics Laboratory, MRC
Clinical Sciences Centre² Hammersmith Hospital, Imperial College London SP14 PLCE1 CONTROLS THE TGF-B1 SIGNALLING RESPONSE IN PODOCYTES
May C, Saleem M, Welsh G, Academic Renal Unit, University of Bristol
SP5 GENERATION OF NOVEL SUBCONGENIC BXSB MOUSE MODELS TO INVESTIGATE THE
ROLE OF THE HIN200 GENE FAMILY IN THE DEVELOPMENT OF SYSTEMICLUPUS SP15 THE EFFECTS OF A DIABETIC MILIEU ON CYTOKINES AND FIBROTIC MARKERS USING A
ERYTHEMATOSUS NOVEL HUMAN IN VITRO CO-CULTURE SYSTEM
Egan A¹, Rose J¹, Jones M², Montero RM, Heidebrecht F, Yates S, Makanjuola D, Dockrell MEC
¹Department of Medicine, ²Genomics Laboratory, Hammersmith Hospital, Imperial College London SWT Institute for Renal Research, St Helier Hospital, Wrythe Lane, Carshalton, London

39
SP6 SOLUBLE CD163 LEVEL AS A BIOMARKER OF ACTIVE DISEASE IN SYSTEMIC CKD Progression (Friday 2nd May 13.00 - 14.00) moderated by Claire Sharpe and Jill Norman
VASCULITIS
Kennedy C¹*, Wong L¹*, Elliot L²*, O’Reilly V², Coughlan A¹, O’Hara P¹, Feighery C², Moran S³, SP16 ASSOCIATIONS BETWEEN OSTEOPROTEGERIN, MORTALITY AND PROGRESSION OF CKD
Mellotte G¹, Clarkson M³, Little M¹ Alderson H, Ritchie J, Kalra P, Salford Royal NHS Foundation Trust
1 2
Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Dept of Immunology, Trinity College
3 SP17 THE INFLAMMATORY LIPID- AND PROTE-OME IN CHRONIC KIDNEY DISEASE
Dublin, Cork University Hospital, Cork, (*Joint First Author)
Dias HKI1, Brown C1, Moinuddin1, Ferro C3, Jesky M3, Sharma P2, Dietrich T2, Grant M2,
SP7 GALACTOSYLATION OF ANTI-PROTEINASE 3 ANTIBODIES IN GRANULOMATOSIS WITH Stringer S3, Chapple ILC2, Griffiths H, Cockwell P3
POLYANGIITIS IS ASSOCIATED WITH INCREASED INFLAMMATORY CYTOKINES ¹School of Life and Health Sciences, Aston University² School of Dentistry, University of
2 1 1 1 2 3 Birmingham ³Department of Renal Medicine, Queen Elizabeth Hospitals, University Hospital
Morgan M , Stavenhagen K , Koeleman C , Hipgrave-Ederveen A , Harper L , Jacobs B ,
2 2 1 1 Birmingham
Savage C , Jefferis R , Deelder A , Wuhrer M
1
Biomolecular Mass Spectrometry Unit, Leiden University Medical Center, Leiden, The Netherlands
2 3 SP18 PHARMACOLOGICAL BLOCKADE OF THE ATP-SENSITIVE P2X7 RECEPTOR DOES NOT
School of Immunity and Infection, University of Birmingham, Department of Immunology and
Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The INFLUENCE THE PROGRESSION OF EXPERIMENTAL ARTERIAL CALCIFICATION
Netherlands Fish R¹, Tam F², Gilmour P³, Wheeler D¹, Norman J¹, Unwin R1
¹UCL Centre for Nephrology, Royal Free Campus, London, ²Imperial College Kidney and Transplant
SP8 THE EFFECT OF 5-AZA-2’-DEOXYCYTIDINE (DAC) ON NEPHROTOXIC NEPHRITIS AND DNA Institute, Hammersmith Hospital Campus, London ³AstraZeneca, Mereside, Alderley Park,
CYTOSINE METHYLATION IN MACROPHAGES Cheshire
1, 2 3 2 3 4 2 1
Oates T , McAdoo S , D’Souza Z , Pusey C , Cook T , Aitman T & Petretto E
1 2 3
IGM & PGM Groups, MRC Clinical Sciences Centre; Vascular and Renal Inflammation Section, SP19 THE PREVALENCE OF FAMILIAL KIDNEY DISEASES IN A COHORT OF CKD PATIENTS
4
Division of Medicine and CCIR, Imperial College London Gast C, Rama G
Wessex Renal and Transplant Unit, Queen Alexandra Hospital, Portsmouth and University of
Diabetic Nephropathy & Podocyte Biology (Thursday 1st May 12.45 – 13.45) Southampton
moderated by Amy Jayne McKnight & Bryan Conway
SP20 KLOTHO EXPRESSION IN HUMAN TISSUES
SP9 ALTERED URINARY microRNA PROFILES IN DIABETIC NEPHROPATHY Lim K1, Molostvov G2, Lu T1, Groen A3, Lilley K3, Snead D2, Hsiao L1, Zehnder D2, Hiemstra TF3,4.
1 2 1 1 3 1 1 1
Beltrami C , Clayton A , Jenkins RH , Simpson KA , Satchell SC , Phillips AO , Fraser DJ , Renal Division, Brigham and Women’s Hospital, Harvard Medical School; 2Division of Metabolic
1
Bowen T and Vascular Health, Warwick Medical School; 3Department of Biochemistry and 4Clinical School,
1 2
Institute of Nephrology, Institute of Cancer Genetics, Cardiff University School of Medicine, University of Cambridge.
Heath Park, Cardiff CF14 4XN, UK
3
Academic Renal Unit, University of Bristol, Southmead Hospital, Bristol, BS10 5NB
 Poster Abstracts 2014 by Day of Moderated Session
Authors will be present by their poster for the duration of their moderated session and during lunch on both days
SP21 THE EXPRESSION OF KEY AUTOPHAGY GENES IS REDUCED IN THE HEARTS OF SP32 SECRETION OF ATP ALONG THE LOOP OF HENLE IN RESPONSE TO INCREASED
URAEMIC RATS LUMINAL FLOW RATE: IMPLICATIONS FOR SODIUM TRANSPORT
White W, Kieswich J, Harwood S, Yaqoob M Unwin R¹, Jacquillet G¹, Morla, L²
William Harvey Research Institute, Bart’s & The London, Queen Mary School of Medicine & ¹UCL Centre for Nephrology, Royal Free Campus, University College London ²Centre de recherche des
Dentistry Cordeliers, Université Pierre et Marie Curie, Université Paris-Descartes, Paris, France

Ischaemic Reperfusion & AKI (Wednesday 30th April 13.30 – 14.30)
moderated by Jeremy Hughes & Mark Dockrell
SP22 ORGAN CROSS-TALK AFTER ACUTE KIDNEY INJURY IN A PORCINE MODEL
Gardner D, Dunford L, Welham S, Fallman R, O’Sullivan S, and Devonald M
University of Nottingham, Renal and Transplant Unit, NUH NHS Trust, City Hospital, Nottingham
SP23 THE INTERACTION OF IGM WITH APOPTOTIC CELLS AND DIFFERENTIAL IGM DEPOSITION IN
ISCHAEMIC KIDNEY AND LIVER TISSUE
Hesket E1, Richards J1, Bucsaiova M1, Dockrel M2, Kluth D1 & Hughes J1
1
MRC Centre for Inflammation Research, Queen’s Medical Research Institute, University of
Edinburgh, 2SWT Institute for Renal Research, London
SP24 APOPTOTIC CELL ADMINISTRATION TO MICE MODULATES THROMBIN GENERATION BUT
IS DETRIMENTAL TO RENAL FUNCTION FOLLOWING RENAL ISCHAEMIA REPERFUSION
INJURY
Hesketh E1, Preston R2, Kluth D1, & Hughes J1
1 1
MRC Centre for Inflammation Research, Queen’s Medical Research Institute, University of
Edinburgh, 2Department of Clinical Medicine, Trinity College Dublin
SP25 YAP1 ACTIVITY IN RECOVERY AFTER WOUNDING IN A PROXIMAL TUBULE DERIVED CELL
LINE
Kenwrick K, Gardner D and Welham S, University of Nottingham
Tubular Interstitial Fibrosis (Friday 2nd May 13.00 – 14.00) moderated by Qihe Xu and Steve Harwood
SP33 PROTEINURIA MEDIATED DAMAGE OF PROXIMAL TUBULAR EPITHELIAL CELLS (PTECS)
– A MECHANISM OF RENAL PATHOLOGY IN MULTIPLE MYELOMA INVOLVING MEGALIN
PHOSPHORYLATION
Alammari D, Bevington A, Baines R, Chana R, Brunskill N, Stover C
Department of Infection, Immunity and Inflammation, University of Leicester
Department of Nephrology, Leicester General Hospital, Leicester
SP34 TARGETING ALTERNATIVE SPLICING OF FIBRONECTIN TO BLOCK AN AUTOCRINE LOOP
THAT DRIVES RENAL FIBROSIS
Heidebrecht F1, Rigo F2, Freier S2, Dockrell M1
1
SWT Institute for Renal Research, London, 2ISIS Pharmaceuticals, Carlsbad, CA, USA
SP35 MODULATING ALTERNATIVE SPLICING OF FIBRONECTIN WITH ANTISENSE
OLIGONUCLEOTIDES
Heidebrecht F1, Gnanananthan V1, To B1, Utz N1, Rigo F2, Freier S2, Dockrell M1
SWT Institute for Renal Research, London, 2ISIS Pharmaceuticals, Carlsbad, CA, USA
SP36 A NOVEL ROLE OF CCN3 IN RENAL FIBROSIS
Madne T¹, MacPhee A, Phanish MK¹, Dockrell MEC¹
¹SWTIRR, London, ²St Georges' University of London

40
SP37 CHARACTERISATION OF RENAL FIBROSIS THROUGH MAGNETIC RESONANCE
SP26 HUMAN ACUTE KIDNEY INJURY (AKI) IS ASSOCIATED WITH A PRO INFLAMMATORY IMAGING USING AN ELASTIN SPECIFIC CONTRAST AGENT
PHENOTYPE Saha S1, Newbury L1, Phinikaridou A2, Botnar R2, Hendry B1, Sharpe C1
1
Varrier M, Gauge N, Boardman D, Hernandez-Fuentes M, Ostermann Renal Sciences, King’s College London, 2Imaging Sciences, King’s College London
Guy’s M, and St Thomas’ Hospital and King’s College London
SP38 TARGETING N-RAS GTPASE IN MURINE PROXIMAL TUBULE EPITHELIAL CELLS AND ITS
Cell Signalling (Thursday 1st May 12.45 – 13.45) moderated by Bruce Hendry & Jill Norman POTENTIAL FOR A THERAPEUTIC STRATEGY IN A MURINE MODEL OF
TUBULOINTERSTITIAL FIBROSIS
SP27 SLC35A2 PROVIDES A NOVEL ROLE FOR GLYCOSYLATION IN GLUCOSE UPTAKE Somalanka S*, Sharpe C**, Phanish M* and Dockrell M*
AND CELLULAR METABOLISM *South West Thames Institute for Renal Research, St Helier Hospital, Surrey,
Annear N1, Maxwell P2, Ashcroft M1 and **Department of Renal Medicine, King’s College, London
1
Centre for Cell Signalling and Molecular Genetics, Division of Medicine, The Rayne Building,
University College London, London, 2School of Clinical Medicine, University of Cambridge SP39 MECHANISM DEPENDANT MARKERS OF HUMAN TUBULAR DAMAGE IN VITRO
K-CADHERIN, NGAL AND KIM1 DETECT DIFFERENT TYPES OF TUBULAR INJURY
SP28 ERK5 ACTIVITY IS REQUIRED FOR NORMAL PODOCYTE MOTILITY AND BARRIER Yates S, Davies R, Dockrell MEC, SWT Institute for Renal Research, St Helier Hospital, Carshalton
FUNCTION
Badshah I1, 2, Baines D2, Dockrell M1
1
SWT Institute for Renal Research, Surrey, 2St. George's University of London

SP29 CICLOSPORIN NEPHROTOXICITY IS INDEPENDENT OF TGFβ1

Jain S¹, MacPhee I², Phanish M¹, Dockrell M¹ For further For further
South West Thames Institute for Renal Research, St Helier Hospital, Carshalton¹, St George's
Hospital, London²
information about information about
SP30 ENDOTHELIN-1 DOES NOT ALTER MACROPHAGE PHENOTYPE
Moorhouse R, Dhaun N, Webb D, Kluth D Renal Association British Renal Society
Centre for Cardiovascular Science, QMRI, University of Edinburgh

SP31 THE EFFECT OF FARNESYL THIOSALICYLIC ACID (FTS) ON TRANSFORMING GROWTH

activities activities
FACTOR BETA1 SIGNALLING IN MURINE PROXIMAL TUBULE EPITHELIAL CELLS go to go to
Somalanka S*, Sharpe C**, Phanish M*, Dockrell M*
*South West Thames Institute for Renal Research, St Helier Hospital, Carshalton, Surrey,
**Department of Renal Medicine, King’s College, London
www.renal.org www.britishrenal.org
 EXHIBITOR INFORMATION
The Conference Organisers wish to acknowledge the following companies for their support at UK Kidney Week 2014.
Alexion Pharmaceuticals
Alexion Pharmaceuticals is a global biopharmaceutical company
focused on serving patients with severe and ultra-rare disorders
through the innovation, development and commercialisation
of potentially life-transforming therapeutic products.
Alexion is the global leader in complement inhibition,
and has developed and markets Soliris® (eculizumab)
as a treatment for patients with PNH (Paroxysmal Nocturnal
Haemoglobinuria) and aHUS (Atypical Haemolytic
Uraemic Syndrome).
Prescribing Information is
available at the Alexion stand.
14 Horizon Business Village, 1 Brooklands Road, Weybridge, Surrey,
KT13 0TJ Telephone: 01932 359220 Fax: 01932 349793
Alexion.uk@alxn.com http://www.alxn.com/
Amgen
Amgen, a biotechnology pioneer, discovers, develops and delivers
innovative human therapeutics.
Our medicines have helped millions of patients in the fight against
cancer, kidney disease, rheumatoid arthritis and other serious illnesses.
With a deep and broad pipeline of potential new medicines, we continue
to advance science to serve patients.
Address: 240 Cambridge Science Park Milton Road Cambridge CB4
0WD
Telephone: +44 1223 420305
Fax: +44 1223 426314
Web Site: http://www.amgen.co.uk/
AsahiKASEI Medical
AsahiKASEI Medical provides high performance disposables and high
technology equipment for Haemodialysis, CRRT and Apheresis therapy.
Products which contribute to quality of life for the patient and advance
the progress of blood purification. Used in more than 70 countries
worldwide Asahi continue to pioneer advances in membrane
characteristics and biocompatibility. Our latest developments on show at
the congress include:
Vitamin E interactive Polysulfone membrane – Using patented technology
our VitabranE TM series dialysers are known to offer excellent
antioxidative properties.
CRRT – Asahi's recently launched Kibou CRRT system seeks to push
back the boundaries of CRRT management.
Apheresis – With the Plasauto machine and a wide range of high
performance plasma filters, component separators, and
Immunoadsorption columns, Asahi pursue the possibility of apheresis for
treating autoimmune disorders and other intractable diseases.
Address: AsahiKASEI Medical Europe - UK,
Suite 3, St Mary's Chambers,
Haslingden Road, Rossendale,
Lancashire, BB4 6QX
Telephone: 01706 260815
Fax: 01706 217161
E-mail: info@asahimedical.co.uk
Web site: (Parent site) http://www.asahi-kasei.co.jp/medical/en/
Astellas
Astellas is one of the leading pharmaceutical companies in the world. As
a young, forward thinking company with a rich heritage, Astellas is
dedicated to improving people’s lives through the introduction of
innovative and reliable pharmaceutical products. In everything we do we
are guided by our ethos of CHANGING TOMORROW to create a brighter
future for all our stakeholders – above all for patients.
In Europe, Astellas’ strategic focus and core expertise lie in the therapy
areas of Transplantation, Urology, Anti-Infectives, Pain Management and
Dermatology.
In addition, Astellas is committed to growing a strong presence in the
field of Oncology.
Address: Astellas Pharma Ltd., 2000 Hillswood Drive,
Chertsey, Surrey, KT16 0RS
Tel: 0203 379 8700
Fax: 0203 379 8703
email: marketing@astellas.com
Website: http://www.astellas.eu/
Baxter-Gambro Renal
Baxter enhanced its footprint in renal therapies with the acquisition of
Gambro and now offers a comprehensive portfolio of therapeutic options
across the home, in-centre and intensive care settings.
The portfolio includes innovative technologies
and therapies for peritoneal dialysis, in-centre
and home haemodialysis, continuous renal
replacement therapy, multi-organ
extracorporeal support therapy and
additional dialysis services.
Baxter-Gambro Renal, Wallingford Road,
Compton, Newbury, RG20 7QW
Telephone: +441635 206316 Fax: +441635 206295
http://www.baxterhealthcare.co.uk/
41
B Braun Avitum (UK) Ltd
The B Braun group is one of the world’s fastest growing top healthcare
companies. In the UK B Braun operates from a purpose built head office
and distribution centre at Thorncliffe Park Sheffield providing medical
products and services to all NHS hospitals in the UK B Braun Avitum UK
provides the NHS with a complete solution for Haemodialysis products
and services. Today we operate 11 UK dialysis centres and continue to
work in partnership with Trusts and PCTs to address capacity demands
and patient choice for Haemodialysis in the hospital, satellite unit and
home.
B. Braun Avitum are dedicated to working with NHS trusts to help them
meet government targets in home haemodialysis.
B. Braun Avitum provides effective home haemodialysis (HHD), from
efficient patient management and delivery service, to providing required
clinical and technical support.
With 25 years of experience we are able to offer our HHD programme
which is individualised for each trust specific requirements from home
installation, to clinical and technical training and support.
B. Braun now also offer a new, innovative product managed service
established to meet the needs of your renal units and your patients.
We welcome you to visit the B Braun stand to discover more about the B
Braun Avitum UK products and services.
Address: Christine McCabe, Commercial Manager,
B Braun Avitum UK, Thorncliffe Park,
Sheffield, S35 2PW
Telephone: Tel: +44 (0)114 225 9000
Web site: http://www.bbraun.com/
British Kidney Patient Association
The British Kidney Patient Association supports kidney patients and renal
units around the UK. This well established charity is:
● The largest provider of grants to kidney patients on low income
● A key source of funding for short breaks and holidays for kidney
patients and their families
● Supporter of the British Transplant Games
● Provider of substantial financial aid to renal units every year; funding
staff posts, service developments and improved patient facilities
● Supporter of key national research projects through collaborations
with the British Renal Society and Kidney Research UK
We have recently made some changes
to our hospital grant applications.
Please visit our stand to find out more.
BKPA, 3 The Windmills,
St Mary’s Close, Turk Street,
Alton, GU34 1EF
Tel 01420 541424
www.britishkidney-pa.co.uk
Cambridge Healthcare Supplies Limited
Cambridge Healthcare Supplies Limited is a UK based company that
specialises in marketing a range of pharmaceutical products in the areas
of ophthalmology, urology, dermatology & gastroenterology.
Our products range from prescription only to
over the counter medicines.
Cambridge Healthcare Supplies Limited’s
urology sector includes Effercitrate Tablets
which are used to treat the systems of
cystitis.Visit our stand and our team
will be happy to provide more information.
For further information about the company
& products please see our
website www.effercitrate.co.uk,
contact enquiries@cambridge-healthcare.co.uk
or telephone us on 01953 607856.
Derwent Healthcare Ltd
With an ever increasing number of CKD patients presenting with co
morbid conditions, their management during RRT poses particular
problems. Whether it is managing fluid control and hemodynamic
stability, assessing adequate dialysis dose, or monitoring weight
loss/ gain.
InBody BIA is the most advanced on the market with its patented core
technology which includes -
• Direct Segmental Measurement of each limb and the trunk
• Tetrapolar 8 point tactile electrode system
• Multi-frequency Measurement, allowing measurement of both Intra and
extra cellular compartments
• No use of Empirical estimation This results in an accuracy of 98% and
reproducibility of 99%
InBody outputs include –
1. ICW , ECW – facilitating dry weight calculation
2. Skeletal Muscle Mass and Fat Free Mass – leading
to a more accurate calculation of Kt/V
3. Range of Nutritional parameters, enabling
determination of nutritional status in CKD
patients and the ability to track finite changes
in body composition.
4. Segmental Oedema
5. Resistance, Reactance and Phase Angle measurements
For further information please contact us
on 07970 384 130 or
email to: info@derwenthealthcare.com
Come and see InBody at stand D12
Address: Widdrington House, 35, South Side, Stamfordham,
Newcastle upon Tyne, NE18 0PD
Telephone: 07970 384 130
E-mail: info@derwenthealthcare.com
Web site:http://derwenthealthcare.com/
Diaverum
Diaverum is Europe’s largest independent renal service provider. We
provide a full range of renal therapies for more than 20,000 patients
across 20 countries. As a service provider, and not a manufacturer, our
objectives are fully aligned with our NHS partners. Our mission is to
improve quality of life for renal patients.
In the UK we deliver fully managed satellite renal services from our
growing network of modern facilities. The environment for delivering
renal care is getting tougher, with providers striving to continually
improve quality against a backdrop of stagnant / falling reimbursement.
Diaverum is partnering with a growing number of NHS Trusts to help
them “square the circle”. A truly viable independent sector provider, that
places the patient at the centre, is finally available for Trusts and
commissioners to work with.
Whether you want to learn how we can
help you exceed your quality and cost
targets, or discuss employment
opportunities within our growing
organisation, we extend a warm
welcome to you on stand D30.
Address: Blenheim Gate, 22 -24 Upper Marlborough Road, St Albans,
Hertforshire, AL1 3AL
Telephone: 01727 737680
Fax: 08448 010941
Web site: http://www.diaverum.com/
ELGA Process Water
Purified water is a valuable resource for renal dialysis. Our reliable, high
quality water treatment technologies and services ensure a sustainable
supply of compliant water direct to your dialysis machines. We can
supply new energy efficient products or carry out assessments to identify
potential water savings within your existing Renal Water System.
Our focus on customer service (4hr, 8hr,12hr & 24hr service response
contracts) and continued investment in our people allow us to continually
deliver technical excellence along with innovative products and services
to our customers. Visit our Water Specialists on stand C21 to learn why
purified water is so important to dialysis patients and how we produce
this.
Visit our Stand to:
Find out more about our products’ unique water saving technologies
Book your free water saving assessment, could our water reuse /
recycling products benefit you?
Find out how our Aquamove mobile water treatment systems can help
you in an emergency
Address: Marlow International, Park Way, Marlow, Buckinghamshire, SL7
1YL
Telephone: +44 (0) 1628 897000
Fax: +44 (0) 1628 897001
E-mail: sales.uk@veoliawater.com
Web site: http://www.elgaprocesswater.co.uk/en/
42
Fresenius Medical Care
Fresenius Medical Care are the world’s leading company in the field of
dialysis, combining expertise in the development and production of
technologically-advanced products with comprehensive care for
patients. We offer products and services to optimise the therapy
outcome, inline with the specific needs of the individual patient and
therapy approach. We are also market leaders in the provision of
partnership dialysis unit programmes with nearly 60 clinics in the UK.
Our programmes include: • Haemodialysis/Haemodiafiltration •
Pharmaceuticals • Renal Clinics • Peritoneal dialysis • Home
haemodialysis • Water treatment • Dialysis software
Come and visit us on Stand C20 to learn how Fresenius Medical Care as
your Partnership Provider are:
*Continually driving improvements in Quality and Outcomes.
*Offering Innovative Products and Tailored Solutions to meet your needs.
*Enabling you to make the right decision for Patient Care.
Address: Fresenius Medical Care,
Nunn Brook Road, Huthwaite,
Sutton-in-Ashfield, Nottinghamshire,
NG17 2HU
UK Website: www.freseniusmedicalcare.co.uk
Telephone: 01623 445100 Fax: 01623 550807
E-mail: ukinfo@fmc-ag.com Web site: http://www.fmc-ag.com/
The International Society of Nephrology (ISN)
The International Society of Nephrology (ISN) is a global society
dedicated to improving kidney care and reducing the incidence and
impact of kidney disease worldwide. Through its global network and
programs, ISN brings together the developing and developed world in a
collaborative effort in fighting and treating kidney disease on a global
scale.
With 9,000 professional members from 129 countries,
ISN represents a wide international network.
Since 1960, the ISN has been providing nephrologists
worldwide with highly valuable services,
such as publications, meetings, capacity-building
programs, and has been spearheading concerted
awareness-generating efforts such as
World Kidney Day.
Global Operations Center
Rue des Fabriques 1 | B-1000 Brussels | Belgium
Main: +32 2 808 04 20 | Fax +32 2 808 4454
Email: adelvaux@theisn.org | Web: www.theisn.org
Janssen
Janssen is part of the Johnson & Johnson family of companies, which
comprises of around 250 operating companies throughout the world and
employs approximately 120,000 people in 57 countries, 6,000 of them in
the UK. Janssen is one of the world’s leading research-based
pharmaceutical companies, with operations throughout the world and in
recent years has increasingly moved to the forefront of the biotechnology
revolution.
The company is committed to delivering great
medicines and has introduced a range of
innovative treatments that can make an
important difference to lives of patients
with serious health conditions, such a
kidney failure and anaemia, HIV; and is
able to treat around 1,500 million patients every year.
Address: 50-100 Holmers Farm Way, High Wycombe,
Bucks HP12 4EG UK.
Telephone: 01494 567744 Web site: http://www.janssen.co.uk/
Kidney Research UK
Kidney Research UK is the largest funder dedicated to kidney research
and kidney problems in the UK, with the aim of finding better treatments
and ultimately cures for kidney diseases
Founded in 1961, the charity has been at the forefront of kidney research
for many years and has an international reputation for the pioneering
research it funds.
Every year more than 55,000 people are treated for end stage kidney
failure, 3,000 people die on dialysis, while 350 die waiting for a kidney
transplant and we are dedicated to substantially reducing these numbers
through funding life-saving research.
We have over £10 million invested in research at any one time, awarding
grants to doctors, nurses and researchers across the UK.
Research isn’t the only thing we do. Each year we raise immediate
awareness of kidney-related issues amongst the general public including
people at higher risk. Our patient information service also provides
advice and literature on how best to deal with each type of kidney
condition, helping millions of people better understand the disease.
Even though cases of kidney failure are increasing by four per cent every
year, Kidney Research UK must turn down four out of every five research
proposals it receives due to a lack of funding - proposals which are
aimed at enhancing treatments and ultimately finding a cure for kidney
disease.
To learn more about our work, please visit:
www.kidneyresearchuk.org or
call: 0845 070 7601.
We look forward to seeing you at the
conference and will be happy to answer any questions
you may have on Kidney Research UK and the vital work we do.
KoRa Healthcare (Renacare)
KoRa Healthcare specialises in the research, development and
marketing of niche pharmaceuticals, Food for Special Medical Purposes
and Medical Devices. Within the KoRa Healthcare renal portfolio are a
range of renal disease-specific enteral feeds and nutritional supplements
for the management of hypoproteinaemia, hyperphosphataemia and
malnutrition in CKD patients.
The current Renacare range consists of Renapro®, Renamil®, Renergy®
and Renacet®.
KoRa Healthcare welcomes you to visit Stand D21 and discover more
about the Renacare range.
Telephone: 0845 3038631
Fax: 0845 3038632
E mail:cod@kora-health.com
Web site:http://www.korahealthcare.com/
LINC-Medical
Supplying innovative solutions to the challenges in patient care
management
● UK leader in Plasmapheresis therepies; HF440 offers 10 therapies in
one device
● Y-Tec peritoneal dialysis catheter implantation system
● Joline smoothflow unique long term dialysis catheter
● Complior pulse wave velocity device and Diagnoptics A.G.E reader
● Cytosorb, cytokine and bilirubin absorption column
● Therapy chairs, beds and exercise cycles (for home and hospital
use)
● Sonoclot POC coagulation analyser; User friendly, with lab standard
results
● Toray BK-F dialyser range
● Green nephrology products
Join us at Stand P8 at this year's UK Kidney
Week 2014. See something innovative.
Address: The Green Lane Workshop,
Green Lane, Countesthorpe,
Leicestershire LE8 5QQ
Telephone: 01572 717515 Fax: 01572 717516
E-mail: sales@linc-medical.co.uk
Web site: http://www.linc-medical.co.uk/
Maltron
Maltron is a leading manufacturer of Bio-electrical and Electrical
Impedance Tomography. Its BIA range is used across the world by
leading institutes, clinical centres for assessments of Body, Segmental
and Abdominal Composition.
Maltron pioneered the use of BIA for Dry weight, Interstitial-Fluid, GFR,
Creatinine clearance and established many clinical Biomarkers for ill
health, Malnutrition, Fluid overload and others.
Maltron BioScan 920-II the most advanced analysers is commonly used
in the assessment of Body Composition, Malnutrition, Fluid
management, Dry weight, GFR and Metabolic Syndrome.
Maltron BioScan can provide correct fluid status in Sepsis - ICU/Renal
patients using estimated weight. Weight changes has no profound effect
on BioScan's ability to assess fluid status.
Address: P.O. Box 15 Rayleigh,
Essex SS6 9SN UK
Telephone: +44 (0)1268 778251
Fax: +44(0)1268 745176
E-mail: maltron@msn.com
Web site: http://www.maltronint.com/index.php
Mediqal H.I.
Mediqal H.I. provides dedicated renal and transplant software and
support with its advanced clinical system, eMEDRenal, with a user
friendly interface, standardisation of design and extensive clinical
functionality. eMEDRenal satisfies UK specific requirements such as
automated UK Renal Registry returns, Renal Patient View module and
support of the Renal Association standards.
Our team of experts has extensive domain knowledge in renal disease
and is renowned for its outstanding customer service and support.
Mediqal H.I. is a subsidiary of Health Informatics International
(www.hiiweb.com).
Address: Suite F, Astonbury Business Park, Aston,
Stevenage, SG2 7EG
Telephone: 01438 880190
Fax: 01438 881009
E mail: info@mediqal.com
Web site:http://www.mediqal.com/
43
Mitsubishi Pharma Europe Ltd
Mitsubishi Pharma Europe acts as the European Headquarters, a
consolidated subsidiary of one of Japan’s leading pharmaceutical
companies, Mitsubishi Tanabe Pharma Corporation. Based in London,
the company is dedicated to the clinical development of new drugs for
the European markets and conducts trials in the following therapeutic
areas; cardiovascular, diabetes and renal conditions. Mitsubishi Pharma
Europe is the UK marketing authorisation holder for Tanatril (Imidapril),
Exembol (argatroban) and BindRen® (colestilan) and supports
commercial operations for other in-house products.
For more information go to: http://www.mitsubishi-pharma.eu.com
Visit our Stand D10
• To learn about the new non-calcium, non-metallic,
non-absorbed phosphate binder, BindRen® colestilan
• To learn about new BindRen® granules – a different
way for patients to take phosphate binders,
• For information on patient support material,
to help them adhere to their phosphate
binding therapy
Address: Dashwood House,
69 Old Broad Street,
London EC2M 1QS
Telephone: 020 7065 5000
Fax: 020 7065 5050
E-mail: information@mitsubishi-pharma.eu
National Kidney Federation
Run by Kidney Patients for Kidney Patients
The NKF is the national Kidney Patient charity in the United Kingdom.
The Federation’s aim throughout the UK is to promote both the best
renal medical practice and treatment, and the health of persons
suffering from Chronic Kidney Disease (CKD) or
Established Renal Failure (ERF).
The NKF also supports the related
needs of those relatives and friends
who care for kidney patients.
NKF (National Kidney Federation)
The Point, Coach Road, Shireoaks, Worksop
Nottinghamshire S81 8BW
Tel 01909 544999: Fax 01909 481723 www.kidney.org.uk
Nipro
Nipro is one of the world’s leading producers of disposable medical
equipment for dialysis and dialysis-related treatments. With over 30
years of continuous research and development, we continue to bring
products to market that reflect the needs of its customers with the
highest of quality standards and focus on safety.
Our renal product range includes dialysers, fistula needles, blood tubing
sets, bicarbonate cartridges, haemostatic bandages, Biohole™ kits,
dialysis machines and catheters.
Nipro product innovations include the following:
• Surdial X Online HDF Dialysis Machine
• Surdial 55+ Compact Dialysis Machine
• ECOMix dry acid concentrate system
• Phoenix Water Treatment Systems
• Biohole Buttonhole Needle Systems
• Safetouch & Tulip Safety Needles
• Elisio BPA Free Dialysers
Please visit the Nipro stand D11 in the exhibition, where we will be happy
to update you on the latest product developments.
Address: Nipro Europe NV, 78 York Street,
London, W1H 1DP
Telephone: 020 7692 0742
Fax: 020 7692 0743
E-mail: info@nipro-europe.com
Web site:
http://www.nipro-europe.com/products/product-range/renal-care/
Purite
Purite is a specialist in the design, manufacture and service of reverse
osmosis (RO) systems for haemodialysis. The company has been
established for over 30 years and is accredited to ISO 9001:2008, ISO
14001 and ISO 18001. Purite is part of Degremont Industrial Solutions, a
major water solutions provider backed by the resources of the multi-
national SUEZ group.
The flexibility to meet specific customer requirements and the capability
to achieve innovative product development has enabled Purite to
develop a new range of units. This exciting new range will be exhibited
this year on stand D31.
Address: Purite Ltd, Bandet Way,
Thame, Oxon OX9 3SJ
Telephone: + 44 (0) 1844 217141
Fax: + 44 (0) 1844 217141
Email: contactus@purite.com
Web site: http://www.purite.com/en/
NxStage Medical UK
NxStage Medical UK, Ltd is a subsidiary of NxStage Medical, Inc a
medical device company headquartered in Lawrence, Massachusetts,
USA that develops, manufactures, and markets innovative systems to
simplify the delivery of treatments for end-stage renal disease and acute
kidney failure.
NxStage Medical UK, Ltd began selling products and services directly in
the United Kingdom (UK) in April 2013. A NxStage team based in the UK
is solely dedicated to establishing and supporting home haemodialysis
(HHD) programmes with the NxStage® System One™ through its work
with UK Trusts, health care professionals, and patients.
The NxStage System One has been designed specifically to overcome
the challenges of using traditional dialysis equipment at home. The
System One, a small and portable device, does not require any specialist
home conversion and makes more frequent home haemodialysis a
practical reality, helping patients fit dialysis around their lives.
Thousands of home patients now enjoy the freedom, flexibility and travel
potential of the NxStage System One, the first truly portable system for
more frequent home haemodialysis.
Address: NxStage Medical UK Ltd,
Compass House, Vision Park, Chivers Way
Cambridge CB24 9AD
Telephone: +44 (0) 1223 257700
Fax: +44 (0) 1223 257 801
Web site: http://www.nxstage.com/
UK Renal Registry
An important and integral part of the Renal Association, the UK Renal
Registry plays a vital role in monitoring the quality of care provided to
kidney patients on renal replacement therapy. As one of the leading
registries in the world it collects basic demographic data as well as
important biochemical markers. The future of the Registry will focus on
quality improvement work as well as gathering a broader range of data
on patients with CKD 4 and 5, PROMS and PREMS and Acute Kidney
Injury. The data will be vital for patients and commissioners to help plan
the shape of future services.
This is your Renal Registry, so come
along and let us know how we can help you.
Email: renalregistry@renalregistry.nhs.uk.
Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients’ needs. Sanofi
has core strengths in the field of healthcare with seven growth platforms:
diabetes solutions, human vaccines, innovative drugs, rare diseases,
consumer healthcare, emerging markets and animal health. Sanofi is
listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
www.sanofi.com
The Sanofi Group has over 2,500 employees located in the UK across
the business units of Sanofi Pharmaceutical Operations, Genzyme,
Merial, and our vaccines joint venture Sanofi Pasteur-MSD. These staff
work in Commercial and head office functions as well as R&D,
manufacturing and distribution.
Sanofi has its UK headquarters in Guildford, Surrey, along with its
Clinical Research Unit which runs clinical trials in the UK.
Sanofi Pharmaceutical Operations is focused on transforming scientific
innovations into medicines for chronic and life-threatening diseases; with
four operating divisions: Diabetes, Oncology, Commercial, and PCS
(Pharmaceutical Customer Solutions). The PCS business focuses on
products for cardiovascular, bio-surgery and renal disorders.
Address: UK Head Office:
One Onslow Street, Guildford,
Surrey, GU1 4YS
Telephone: +44 (0)1483 505515
Web site: http://www.sanofi.co.uk/l/gb/en/index.jsp
Vitaflo International Limited
Vitaflo International Limited is a specialist clinical Nutrition Company
involved, for over 30 years, in the research and innovative development
of foods for special medical purposes. We will be showcasing our
products, which are specifically designed for the nutritional management
of renal disease, both for adult and paediatric patients at our stand.
Please come and visit us to find out more!
Vitaflo International LTD
Suite 1.11, South Harrington Building,
182, Sefton Street
Brunswick Business Park,
Liverpool L3 4BQ
Head office Tel: 0151 709 9020
E-mail: Vitaflo@vitaflo.co.uk
Web: www.vitafloweb.com
44
Stanningley Pharma
Stanningley Pharma is pleased to be supporting the BRS/RA conference.
The development and approval of Renavit in 2013 has been of significant
value to renal patients. This is the first multivitamin specifically indicated
for dialysis patients and available on prescription to both Hospitals and
GP’s. This simple, once daily regimen has generated considerable
interest as it is in line with European Best Practice Guidelines and those
of the Renal Association.
The NICE guideline for the management of hyperphosphataemia has
positioned Calcium Acetate as the first line drug treatment. Stanningley
Pharma has added to the treatment options in this therapy area with the
marketing and distribution of PhosLo®. This encapsulated presentation
of Calcium Acetate addresses many of the issues associated with taste/
tablet size, which will help healthcare professionals as they follow the
NICE guidance.
Maintaining vascular access and successful maturation of AV fistula
continues to be a challenge with dialysis patients. Thus, Stanningley is
pleased to announce a considerable improvement in maturation
outcomes with a study using Far Infrared therapy. This was published in
the American Journal of Kidney Disease. The usage of Far infrared
therapy unit for dialysis patients has grown significantly in 2013, with
many renal units reporting good results for AV fistula care.
The achievements of Stanningley Pharma in 2013/14, demonstrate its
commitment to innovation, serving both the needs of renal patients and
healthcare professionals.
Address: Stanningley Pharma Ltd, BioCity, Pennyfoot Street,
Nottingham, NG1 1GF
Telephone: 01159124253
Fax: 01159124289
Email: info@stanningleypharma.co.uk
Web site: http://www.stanningleypharma.com/
Syner-Med (PP) Ltd
Syner-Med (PP) Ltd has been bringing innovative pharmaceutical
products and medical devices to healthcare professionals and patients
for 20 years. Throughout our history, Syner-Med has been committed to
providing healthcare professionals with education to enable them to
deliver cost effective evidence based patient care. Currently Syner-Med
is focused on the management of central venous catheters helping our
customer’s manage occlusions and reduce infections, as well as
successfully developing innovative products in Urology.
On our stand at this year’s UK Kidney week we have -
• Zonis® (silver alginate antimicrobial catheter dressing) Zonis® is
suitable for percutanious medical devices including haemodialysis
catheters and peritoneal dialysis catheters providing antimicrobial
protection from organisms including bacteria e.g. MRSA, VRE, and
fungi e.g. Candida.
• Syner-Kinase® (urokinase) the only thrombolytic licensed for infusion
through the catheter to treat both the internal occlusions and external
fibrin sheath causes of catheter dysfunction. Syner-Kinase® is human
albumin free.
• Citra-Lock™ (trisodium citrate) catheter lock solution to help maintain
catheter patency and reduce catheter related infections.
Please visit stand D20 for more information. Visit Syner-Med and see
what’s new in Catheter Management.
Address: 2nd Floor, Beech House,
840 Brighton Road, Purley, Surrey,
CR8 2BH
Telephone: + 44(0)208 655 6380
Fax: +44 (0) 208 655 6398
Email: mail@syner-med.com
Web site: http://www.syner-med.com/
Vasculitis UK
Vasculitis UK is a national charity run for the benefit of others with a
Vasculitis condition. Our objectives can be found at
http://www.vasculitis.org.uk/ Vasculitis UK provide support for Vasculitis
patients and their families through a web site, a helpline manned by
people knowledgeable about Vasculitis, two active sites for raising
questions regarding living with a vasculitis condition.
In addition to these facilities, we provide
members with a bi-annual newsletter and
email updates covering topics varied as
nutrition to Vasculitis research.
In addition to providing support,
Vasculitis UK also funds Vasculitis research
and we are continually looking opportunities
to raise awareness of the condition.
 Held jointly
with

www.era-edta2015.org